<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:art="http://www.rsc.org/schema/rscart38" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rsc="urn:rsc.org" xml:lang="en" lang="en"><head><!--Google Tag Manager--><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&amp;l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-56FZ7G');</script><!--End Google Tag Manager--><title>Superparamagnetic iron oxide nanoparticulate system: synthesis, targeting, drug delivery and therapy in cancer  - Dalton Transactions (RSC Publishing) DOI:10.1039/C9DT00459A</title><link rel="canonical" href="https://pubs.rsc.org/en/content/articlehtml/2019/dt/c9dt00459a"/><meta http-equiv="content-type" content="application/xhtml+xml; charset=utf-8"/><script type="text/javascript">window.NREUM||(NREUM={});NREUM.info = {"beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"NRJS-aaa897feae8feeca979","applicationID":"1313546638","transactionName":"M1wANxQFCEcDVU0PWgoWLzUlSyVbDEJcCEEnVgwXFAsKWAdEFgdHEFABDwMMElkO","queueTime":0,"applicationTime":81,"agent":"","atts":""}</script><script type="text/javascript">(window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"1386013924",accountID:"2851366",trustKey:"1029994",xpid:"Vg4CUFVVDhABV1BRAgUBUFcJ",licenseKey:"NRJS-aaa897feae8feeca979",applicationID:"1313546638"};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{s.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(31),s={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(s.console=!0,o.indexOf("dev")!==-1&&(s.dev=!0),o.indexOf("nr_dev")!==-1&&(s.nrDev=!0))}catch(c){}s.nrDev&&i.on("internal-error",function(t){r(t.stack)}),s.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),s.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(s,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,s){try{l?l-=1:o(s||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,c.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:c.now();i("err",[t,n])}var i=t("handle"),a=t(32),s=t("ee"),c=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError";if(!c.disabled){var l=0;c.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(14),t(13),"addEventListener"in window&&t(7),c.xhrWrappable&&t(15),d=!0)}s.on("fn-start",function(t,e,n){d&&(l+=1)}),s.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),s.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),s.on("internal-error",function(t){i("ierr",[t,c.now(),!0])})}},{}],3:[function(t,e,n){var r=t("loader");r.disabled||(r.features.ins=!0)},{}],4:[function(t,e,n){function r(){U++,L=g.hash,this[u]=y.now()}function o(){U--,g.hash!==L&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var s="-start",c="-end",f="-body",u="fn"+s,d="fn"+c,p="cb"+s,l="cb"+c,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable&&!y.disabled){var x=t(11),b=t(12),E=t(9),R=t(7),O=t(14),T=t(8),S=t(15),P=t(10),M=t("ee"),C=M.get("tracer"),N=t(23);t(17),y.features.spa=!0;var L,U=0;M.on(u,r),b.on(p,r),P.on(p,r),M.on(d,o),b.on(l,o),P.on(l,o),M.buffer([u,d,"xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+c,"clearTimeout"+s,u]),S.buffer([u,"new-xhr","send-xhr"+s]),T.buffer([m+s,m+"-done",m+f+s,m+f+c]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+s]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(T,m+s),a(T,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,N(!0)),w[v]("load",i,N(!0)),w[v]("popstate",function(){i(0,U>1)},N(!0))}},{}],5:[function(t,e,n){function r(){var t=new PerformanceObserver(function(t,e){var n=t.getEntries();s(v,[n])});try{t.observe({entryTypes:["resource"]})}catch(e){}}function o(t){if(s(v,[window.performance.getEntriesByType(w)]),window.performance["c"+p])try{window.performance[h](m,o,!1)}catch(t){}else try{window.performance[h]("webkit"+m,o,!1)}catch(t){}}function i(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var a=t("ee"),s=t("handle"),c=t(14),f=t(13),u=t(6),d=t(23),p="learResourceTimings",l="addEventListener",h="removeEventListener",m="resourcetimingbufferfull",v="bstResource",w="resource",g="-start",y="-end",x="fn"+g,b="fn"+y,E="bstTimer",R="pushState",O=t("loader");if(!O.disabled){O.features.stn=!0,t(9),"addEventListener"in window&&t(7);var T=NREUM.o.EV;a.on(x,function(t,e){var n=t[0];n instanceof T&&(this.bstStart=O.now())}),a.on(b,function(t,e){var n=t[0];n instanceof T&&s("bst",[n,e,this.bstStart,O.now()])}),c.on(x,function(t,e,n){this.bstStart=O.now(),this.bstType=n}),c.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),this.bstType])}),f.on(x,function(){this.bstStart=O.now()}),f.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),"requestAnimationFrame"])}),a.on(R+g,function(t){this.time=O.now(),this.startPath=location.pathname+location.hash}),a.on(R+y,function(t){s("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),u()?(s(v,[window.performance.getEntriesByType("resource")]),r()):l in window.performance&&(window.performance["c"+p]?window.performance[l](m,o,d(!1)):window.performance[l]("webkit"+m,o,d(!1))),document[l]("scroll",i,d(!1)),document[l]("keypress",i,d(!1)),document[l]("click",i,d(!1))}}},{}],6:[function(t,e,n){e.exports=function(){return"PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver}},{}],7:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){s.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),s=t("wrap-function")(a,!0),c=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1];if(null!==n&&("function"==typeof n||"object"==typeof n)){var r=c(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?s(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],8:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var s=r.apply(this,t);return o.emit(n+"start",[t,a],s),s.then(function(t){return o.emit(n+"end",[null,t],s),t},function(t){throw o.emit(n+"end",[t],s),t})})}var o=t("ee").get("fetch"),i=t(32),a=t(31);e.exports=o;var s=window,c="fetch-",f=c+"body-",u=["arrayBuffer","blob","json","text","formData"],d=s.Request,p=s.Response,l=s.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(s,"fetch",c),o.on(c+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(c+"done",[null,e],n)}else o.emit(c+"done",[t],n)}))},{}],9:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],10:[function(t,e,n){function r(t){function e(){f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}function n(){f.emit("jsonp-error",[],l),f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var d=s(a),p="function"==typeof d.parent[d.key];if(p){var l={};u.inPlace(d.parent,[d.key],"cb-",l),t.addEventListener("load",e,c(!1)),t.addEventListener("error",n,c(!1)),f.emit("new-jsonp",[t.src],l)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(d);return e?e[1]:null}function a(t,e){var n=t.match(l),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function s(t){var e=t.match(p);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var c=t(23),f=t("ee").get("jsonp"),u=t("wrap-function")(f);if(e.exports=f,o()){var d=/[?&](?:callback|cb)=([^&#]+)/,p=/(.*)\.([^.]+)/,l=/^(\w+)(\.|$)(.*)$/,h=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?u.inPlace(Node.prototype,h,"dom-"):(u.inPlace(HTMLElement.prototype,h,"dom-"),u.inPlace(HTMLHeadElement.prototype,h,"dom-"),u.inPlace(HTMLBodyElement.prototype,h,"dom-")),f.on("dom-start",function(t){r(t[0])})}},{}],11:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],12:[function(t,e,n){function r(t){var e=i.context(),n=s(t,"executor-",e,null,!1),r=new f(n);return i.context(r).getCtx=function(){return e},r}var o=t("wrap-function"),i=t("ee").get("promise"),a=t("ee").getOrSetContext,s=o(i),c=t(31),f=NREUM.o.PR;e.exports=i,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){i.emit("propagate",[null,!o],a,!1,!1),o=o||!t}}var o=!1;c(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var a=e.apply(f,arguments),s=f.resolve(a);return s}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&i.emit("propagate",[t,!0],n,!1,!1),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),c(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),o.wrapInPlace(f.prototype,"then",function(t){return function(){var e=this,n=o.argsToArray.apply(this,arguments),r=a(e);r.promise=e,n[0]=s(n[0],"cb-",r,null,!1),n[1]=s(n[1],"cb-",r,null,!1);var c=t.apply(this,n);return r.nextPromise=c,i.emit("propagate",[e,!0],c,!1,!1),c}}),i.on("executor-start",function(t){t[0]=s(t[0],"resolve-",this,null,!1),t[1]=s(t[1],"resolve-",this,null,!1)}),i.on("executor-err",function(t,e,n){t[1](n)}),i.on("cb-end",function(t,e,n){i.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),i.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=i.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],13:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],14:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),s="setTimeout",c="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[s,"setImmediate"],s+d),a.inPlace(window,[c],c+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(c+u,r),i.on(s+u,o)},{}],15:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",s)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,y,"fn-",s)}function i(t){x.push(t),m&&(E?E.then(a):w?w(a):(R=-R,O.data=R))}function a(){for(var t=0;t<x.length;t++)r([],x[t]);x.length&&(x=[])}function s(t,e){return e}function c(t,e){for(var n in t)e[n]=t[n];return e}t(7);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=t(23),l=NREUM.o,h=l.XHR,m=l.MO,v=l.PR,w=l.SI,g="readystatechange",y=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],x=[];e.exports=u;var b=window.XMLHttpRequest=function(t){var e=new h(t);try{u.emit("new-xhr",[e],e),e.addEventListener(g,o,p(!1))}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(c(h,b),b.prototype=h.prototype,d.inPlace(b.prototype,["open","send"],"-xhr-",s),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),m){var E=v&&v.resolve();if(!w&&!v){var R=1,O=document.createTextNode(R);new m(a).observe(O,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===g||a()})},{}],16:[function(t,e,n){function r(t){if(!s(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||c(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&c(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",s=1,c="",f="";return o+"@nr="+i+"-"+s+"-"+n+"-"+r+"-"+t+"-"+a+"-"+c+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var s={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(s.d.tk=i),btoa(JSON.stringify(s))}function s(t){return f()&&c(t)}function c(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(28),h=t(18);e.exports={generateTracePayload:r,shouldGenerateTrace:s}},{}],17:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);return e.protocol&&"data"===e.protocol?void g("Ajax/DataUrl/Excluded"):void(e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,s("xhr",[e,n,this.startTime,this.endTime,"xhr"],this)))}}function o(t,e){var n=c(e),r=t.params;r.hostname=n.hostname,r.port=n.port,r.protocol=n.protocol,r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=n,t.sameOrigin=n.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable&&!a.disabled){var s=t("handle"),c=t(18),f=t(16).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(24),m=t(22),v=t(19),w=t(23),g=t(25).recordSupportability,y=NREUM.o.REQ,x=window.XMLHttpRequest;a.features.xhr=!0,t(15),t(8),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,e.params=this.params||{},e.metrics=this.metrics||{},t.addEventListener("load",function(n){i(e,t)},w(!1)),h&&(h>34||h<10)||t.addEventListener("progress",function(t){e.lastSize=t.loaded},w(!1))}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var s=0;s<p;s++)e.addEventListener(d[s],this.listener,w(!1))}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("xhr-resolved",function(){this.endTime=a.now()}),u.on("addEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof x&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url?n=t[0].url:window.URL&&t[0]&&t[0]instanceof URL&&(n=t[0].href),n&&(this.parsedOrigin=c(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]||window.URL&&t[0]&&t[0]instanceof URL){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)}),u.on("fetch-start",function(t,e){this.params={},this.metrics={},this.startTime=a.now(),this.dt=e,t.length>=1&&(this.target=t[0]),t.length>=2&&(this.opts=t[1]);var n,r=this.opts||{},i=this.target;if("string"==typeof i?n=i:"object"==typeof i&&i instanceof y?n=i.url:window.URL&&"object"==typeof i&&i instanceof URL&&(n=i.href),o(this,n),"data"!==this.params.protocol){var s=(""+(i&&i instanceof y&&i.method||r.method||"GET")).toUpperCase();this.params.method=s,this.txSize=m(r.body)||0}}),u.on("fetch-done",function(t,e){if(this.endTime=a.now(),this.params||(this.params={}),"data"===this.params.protocol)return void g("Ajax/DataUrl/Excluded");this.params.status=e?e.status:0;var n;"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var r={txSize:this.txSize,rxSize:n,duration:a.now()-this.startTime};s("xhr",[this.params,r,this.startTime,this.endTime,"fetch"],this)})}},{}],18:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];if(0===(t||"").indexOf("data:"))return{protocol:"data"};var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,s=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||s),"/"===o.pathname&&(r[t]=o),o}},{}],19:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(22);e.exports=r},{}],20:[function(t,e,n){function r(){}function o(t,e,n,r){return function(){return u.recordSupportability("API/"+e+"/called"),i(t+e,[f.now()].concat(s(arguments)),n?null:this,r),n?void 0:this}}var i=t("handle"),a=t(31),s=t(32),c=t("ee").get("tracer"),f=t("loader"),u=t(25),d=NREUM;"undefined"==typeof window.newrelic&&(newrelic=d);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",h=l+"ixn-";a(p,function(t,e){d[e]=o(l,e,!0,"api")}),d.addPageAction=o(l,"addPageAction",!0),d.setCurrentRouteName=o(l,"routeName",!0),e.exports=newrelic,d.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(h+"tracer",[f.now(),t,n],r),function(){if(c.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw c.emit("fn-err",[arguments,this,t],n),t}finally{c.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){m[e]=o(h,e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),u.recordSupportability("API/noticeError/called"),i("err",[t,f.now(),!1,e])}},{}],21:[function(t,e,n){function r(t){if(NREUM.init){for(var e=NREUM.init,n=t.split("."),r=0;r<n.length-1;r++)if(e=e[n[r]],"object"!=typeof e)return;return e=e[n[n.length-1]]}}e.exports={getConfiguration:r}},{}],22:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],23:[function(t,e,n){var r=!1;try{var o=Object.defineProperty({},"passive",{get:function(){r=!0}});window.addEventListener("testPassive",null,o),window.removeEventListener("testPassive",null,o)}catch(i){}e.exports=function(t){return r?{passive:!0,capture:!!t}:!!t}},{}],24:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],25:[function(t,e,n){function r(t,e){var n=[a,t,{name:t},e];return i("storeMetric",n,null,"api"),n}function o(t,e){var n=[s,t,{name:t},e];return i("storeEventMetrics",n,null,"api"),n}var i=t("handle"),a="sm",s="cm";e.exports={constants:{SUPPORTABILITY_METRIC:a,CUSTOM_METRIC:s},recordSupportability:r,recordCustom:o}},{}],26:[function(t,e,n){function r(){return s.exists&&performance.now?Math.round(performance.now()):(i=Math.max((new Date).getTime(),i))-a}function o(){return i}var i=(new Date).getTime(),a=i,s=t(33);e.exports=r,e.exports.offset=a,e.exports.getLastTimestamp=o},{}],27:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?l("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&l("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();if(n.length>0){var r=n[n.length-1];if(f&&f<r.startTime)return;var o=[r],i=a({});i&&o.push(i),l("lcp",o)}}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||l("cls",[t])})}function a(t){var e=navigator.connection||navigator.mozConnection||navigator.webkitConnection;if(e)return e.type&&(t["net-type"]=e.type),e.effectiveType&&(t["net-etype"]=e.effectiveType),e.rtt&&(t["net-rtt"]=e.rtt),e.downlink&&(t["net-dlink"]=e.downlink),t}function s(t){if(t instanceof w&&!y){var e=Math.round(t.timeStamp),n={type:t.type};a(n),e<=h.now()?n.fid=h.now()-e:e>h.offset&&e<=Date.now()?(e-=h.offset,n.fid=h.now()-e):e=h.now(),y=!0,l("timing",["fi",e,n])}}function c(t){"hidden"===t&&(f=h.now(),l("pageHide",[f]))}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var f,u,d,p,l=t("handle"),h=t("loader"),m=t(30),v=t(23),w=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){u=new PerformanceObserver(r);try{u.observe({entryTypes:["paint"]})}catch(g){}d=new PerformanceObserver(o);try{d.observe({entryTypes:["largest-contentful-paint"]})}catch(g){}p=new PerformanceObserver(i);try{p.observe({type:"layout-shift",buffered:!0})}catch(g){}}if("addEventListener"in document){var y=!1,x=["click","keydown","mousedown","pointerdown","touchstart"];x.forEach(function(t){document.addEventListener(t,s,v(!1))})}m(c)}},{}],28:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",s=0;s<i.length;s++)o=i[s],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(t)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],29:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var s=navigator.userAgent,c=s.match(a);c&&s.indexOf("Chrome")===-1&&s.indexOf("Chromium")===-1&&(o="Safari",i=c[1])}e.exports={agent:o,version:i,match:r}},{}],30:[function(t,e,n){function r(t){function e(){t(s&&document[s]?document[s]:document[i]?"hidden":"visible")}"addEventListener"in document&&a&&document.addEventListener(a,e,o(!1))}var o=t(23);e.exports=r;var i,a,s;"undefined"!=typeof document.hidden?(i="hidden",a="visibilitychange",s="visibilityState"):"undefined"!=typeof document.msHidden?(i="msHidden",a="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(i="webkitHidden",a="webkitvisibilitychange",s="webkitVisibilityState")},{}],31:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],32:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],33:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?f(t,c,a):a()}function n(n,r,o,i,a){if(a!==!1&&(a=!0),!l.aborted||i){t&&a&&t(n,r,o);for(var s=e(o),c=m(n),f=c.length,u=0;u<f;u++)c[u].apply(s,r);var p=d[y[n]];return p&&p.push([x,n,r,s]),s}}function i(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return p[t]=p[t]||o(n)}function w(t,e){l.aborted||u(t,function(t,n){e=e||"feature",y[n]=e,e in d||(d[e]=[])})}var g={},y={},x={on:i,addEventListener:i,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:s,aborted:!1};return x}function i(t){return f(t,c,a)}function a(){return new r}function s(){(d.api||d.feature)&&(l.aborted=!0,d=l.backlog={})}var c="nr@context",f=t("gos"),u=t(31),d={},p={},l=e.exports=o();e.exports.getOrSetContext=i,l.backlog=d},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!T++){var t=O.info=NREUM.info,e=m.getElementsByTagName("script")[0];if(setTimeout(f.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return f.abort();c(E,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+O.offset],null,"api"),s("timing",["load",n]);var r=m.createElement("script");0===t.agent.indexOf("http://")||0===t.agent.indexOf("https://")?r.src=t.agent:r.src=l+"://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===m.readyState&&i()}function i(){s("mark",["domContent",a()+O.offset],null,"api")}var a=t(26),s=t("handle"),c=t(31),f=t("ee"),u=t(29),d=t(21),p=t(23),l=d.getConfiguration("ssl")===!1?"http":"https",h=window,m=h.document,v="addEventListener",w="attachEvent",g=h.XMLHttpRequest,y=g&&g.prototype,x=!1;NREUM.o={ST:setTimeout,SI:h.setImmediate,CT:clearTimeout,XHR:g,REQ:h.Request,EV:h.Event,PR:h.Promise,MO:h.MutationObserver};var b=""+location,E={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1216.min.js"},R=g&&y&&y[v]&&!/CriOS/.test(navigator.userAgent),O=e.exports={offset:a.getLastTimestamp(),now:a,origin:b,features:{},xhrWrappable:R,userAgent:u,disabled:x};if(!x){t(20),t(27),m[v]?(m[v]("DOMContentLoaded",i,p(!1)),h[v]("load",r,p(!1))):(m[w]("onreadystatechange",o),h[w]("onload",r)),s("mark",["firstbyte",a.getLastTimestamp()],null,"api");var T=0}},{}],"wrap-function":[function(t,e,n){function r(t,e){function n(e,n,r,c,f){function nrWrapper(){var i,a,u,p;try{a=this,i=d(arguments),u="function"==typeof r?r(i,a):r||{}}catch(l){o([l,"",[i,a,c],u],t)}s(n+"start",[i,a,c],u,f);try{return p=e.apply(a,i)}catch(h){throw s(n+"err",[i,a,h],u,f),h}finally{s(n+"end",[i,a,p],u,f)}}return a(e)?e:(n||(n=""),nrWrapper[p]=e,i(e,nrWrapper,t),nrWrapper)}function r(t,e,r,o,i){r||(r="");var s,c,f,u="-"===r.charAt(0);for(f=0;f<e.length;f++)c=e[f],s=t[c],a(s)||(t[c]=n(s,u?c+r:r,o,c,i))}function s(n,r,i,a){if(!h||e){var s=h;h=!0;try{t.emit(n,r,i,e,a)}catch(c){o([c,n,r,i],t)}h=s}}return t||(t=u),n.inPlace=r,n.flag=p,n}function o(t,e){e||(e=u);try{e.emit("internal-error",t)}catch(n){}}function i(t,e,n){if(Object.defineProperty&&Object.keys)try{var r=Object.keys(t);return r.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(i){o([i],n)}for(var a in t)l.call(t,a)&&(e[a]=t[a]);return e}function a(t){return!(t&&t instanceof Function&&t.apply&&!t[p])}function s(t,e){var n=e(t);return n[p]=t,i(t,n,u),n}function c(t,e,n){var r=t[e];t[e]=s(r,n)}function f(){for(var t=arguments.length,e=new Array(t),n=0;n<t;++n)e[n]=arguments[n];return e}var u=t("ee"),d=t(32),p="nr@original",l=Object.prototype.hasOwnProperty,h=!1;e.exports=r,e.exports.wrapFunction=s,e.exports.wrapInPlace=c,e.exports.argsToArray=f},{}]},{},["loader",2,17,5,3,4]);</script><meta charset="UTF-8"/><meta name="robots" content="index, follow"/><meta name="DC.Creator" content="Sathyadevi Palanisamy"/><meta name="DC.Creator" content="Yun-Ming Wang"/><meta name="DC.title" content="Superparamagnetic iron oxide nanoparticulate system: synthesis, targeting, drug delivery and therapy in cancer "/><meta name="DC.publisher" content="Royal Society of Chemistry"/><meta name="DC.Date" content="2019/07/02"/><meta name="DC.Identifier" scheme="doi" content="10.1039/C9DT00459A"/><meta name="DC.Language" content="en"/><meta name="citation_title" content="Superparamagnetic iron oxide nanoparticulate system: synthesis, targeting, drug delivery and therapy in cancer "/><meta name="citation_author" content="Sathyadevi Palanisamy"/><meta name="citation_author" content="Yun-Ming Wang"/><meta name="citation_online_date" content="2019/06/05"/><meta name="citation_date" content="2019"/><meta name="citation_journal_title" content="Dalton Transactions"/><meta name="citation_volume" content="48"/><meta name="citation_issue" content="26"/><meta name="citation_firstpage" content="9490"/><meta name="citation_lastpage" content="9515"/><meta name="citation_doi" content="10.1039/C9DT00459A"/><meta name="citation_pdf_url" content="https://pubs.rsc.org/en/content/articlepdf/2019/dt/c9dt00459a"/><meta name="citation_abstract_html_url" content="https://pubs.rsc.org/en/content/articlelanding/2019/dt/c9dt00459a"/><meta name="citation_fulltext_html_url" content="https://pubs.rsc.org/en/content/articlehtml/2019/dt/c9dt00459a"/><link rel="shortcut icon" href=""/><link type="text/css" rel="stylesheet" href="/content/stylesheets/rschtml2.css?ver=6_2_1"/><link href="https://www.rsc-cdn.org/oxygen/assets/webfonts/fonts.min.css" rel="stylesheet" type="text/css"/><link type="text/css" rel="stylesheet" href="/content/stylesheets/pubs-ui.min.css"/><meta name="viewport" content="width=device-width, initial-scale=1"/><script type="text/javascript" src="/content/scripts/JQueryPlugins.min.js"> </script><script type="text/javascript" src="/content/scripts/GetAnchorText.js"> </script><script type="text/javascript">
    
      $(function() {
      $("table.tgroup tfoot th").attr("colspan", "100");
      $("table.tgroup.rtable").each( function (idx, el) {
      var tw = $(this).width();
      $(this).parent().css("min-width", tw+"px");
      });

      });
      
    </script><!--6_2_1--></head><body class="oxy-ui pubs-ui ahtml-page"><!--Google Tag Manager (noscript)--><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-56FZ7G" height="0" width="0" style="display:none;visibility:hidden"> </iframe></noscript><!--End Google Tag Manager (noscript)--><div class="viewport autopad"><div class="pnl pnl--drop autopad"><span id="top"/><div id="wrapper"><div class="left_head"><a class="simple" href="/"><img class="rsc-logo" border="0" src="/content/NewImages/royal-society-of-chemistry-logo.png" alt="Royal Society of Chemistry"/></a><br/><span class="btnContainer"><a class="btn btn--tiny btn--primary" target="_blank" title="Link to PDF version" href="/en/content/articlepdf/2019/dt/c9dt00459a">View PDF Version</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to previous article (id:c9dt01402k)" href="/en/content/articlehtml/2019/dt/c9dt01402k" target="_BLANK">Previous Article</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to next article (id:c9dt01485c)" href="/en/content/articlehtml/2019/dt/c9dt01485c" target="_BLANK">Next Article</a></span></div><div class="right_head"><div id="crossmark_container"><div id="crossmark-content"><a id="open-crossmark" href="#" data-target="crossmark"><img style="max-width:100px" id="crossmark-logo" src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_square.svg" alt="Check for updates"/></a><script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"> </script></div></div> </div><div class="article_info"> DOI: <a target="_blank" title="Link to landing page via DOI" href="https://doi.org/10.1039/C9DT00459A">10.1039/C9DT00459A</a>
(Perspective)
<span class="italic"><a title="Link to journal home page" href="https://doi.org/10.1039/1477-9234/2003">Dalton Trans.</a></span>, 2019, <strong>48</strong>, 9490-9515</div><h1 id="sect219"><span class="title_heading">Superparamagnetic iron oxide nanoparticulate system: synthesis, targeting, drug delivery and therapy in cancer</span></h1><p class="header_text">
      <span class="bold">
        
          
            Sathyadevi 
            Palanisamy
          
          
        
      </span><sup><span class="sup_ref italic">ab</span></sup><span class="bold"> and </span>
      <span class="bold">
        
          
            Yun-Ming 
            Wang
          
          
        
      </span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Yun-Ming Wang (orcid.org/0000-0001-7179-5179) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0001-7179-5179"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span>*<sup><span class="sup_ref italic">abc</span></sup>
      <br/><a id="affa"><sup><span class="sup_ref italic">a</span></sup></a><span class="italic">Department of Biological Science and Technology, Institute of Molecular Medicine and Bioengineering, National Chiao Tung University, 75 Bo-Ai Street, Hsinchu 300, Taiwan. E-mail: <a href="mailto:ymwang@mail.nctu.edu.tw">ymwang@mail.nctu.edu.tw</a>;  Fax: +886-3-5729288;   Tel: +886-3-5712121 ext. 56972</span>
      <br/><a id="affb"><sup><span class="sup_ref italic">b</span></sup></a><span class="italic">Center For Intelligent Drug Systems and Smart Bio-devices (IDS<small><sup>2</sup></small>B), National Chiao Tung University, 75 Bo-Ai Street, Hsinchu 300, Taiwan</span>
      <br/><a id="affc"><sup><span class="sup_ref italic">c</span></sup></a><span class="italic">Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung 807, Taiwan</span>
    </p><div id="art-admin"><span class="italic bold">Received 
      31st January 2019
    </span><span class="bold italic">, Accepted 5th June 2019</span></div><p class="bold italic">First published on 5th June 2019</p><hr/><div class="abstract"><h2>Abstract</h2><p>Cancer is a global epidemic and is considered a leading cause of death. Various cancer treatments such as chemotherapy, surgery, and radiotherapy are available for the cure but those are generally associated with poor long-term survival rates. Consequently, more advanced and selective methods that have better outcomes, fewer side effects, and high efficacies are highly in demand. Among these is the use of superparamagnetic iron oxide nanoparticles (SPIONs) which act as an innovative kit for battling cancer. Low cost, magnetic properties and toxicity properties enable SPIONs to be widely utilized in biomedical applications. For example, magnetite and maghemite (Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> and γ-Fe<small><sub>2</sub></small>O<small><sub>3</sub></small>) exhibit superparamagnetic properties and are widely used in drug delivery, diagnosis, and therapy. These materials are termed SPIONs when their size is smaller than 20 nm. This review article aims to provide a brief introduction on SPIONs, focusing on their fundamental magnetism and biological applications. The quality and surface chemistry of SPIONs are crucial in biomedical applications; therefore an in-depth survey of synthetic approaches and surface modifications of SPIONs is provided along with their biological applications such as targeting, site-specific drug delivery and therapy.</p></div><hr/><table><tr><td class="biogPlate"><a href="/image/article/2019/DT/c9dt00459a/c9dt00459a-p1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9dt00459a-p1.tif" src="/image/article/2019/DT/c9dt00459a/c9dt00459a-p1.gif"/></a><p><span class="graphic_title">Sathyadevi Palanisamy</span></p></td><td><i><p>Sathyadevi Palanisamy received her M.S. degree from Madurai Kamaraj University in 2007. She received her M.Phil. degree from Bharathiar University in 2009. She obtained her Ph.D. degree at Bharathiar University in 2012. Currently, she is working as a Post-doctoral fellow under the supervision of Prof. Yun-Ming Wang at the Department of Biological Science and Technology, Institute of Molecular Medicine and Bioengineering, National Chiao Tung University, Taiwan. Her research interests focus on coordination compounds, bio-inorganic chemistry, biosensors, electrochemical sensors and metal–organic frameworks.</p></i></td></tr></table><table><tr><td class="biogPlate"><a href="/image/article/2019/DT/c9dt00459a/c9dt00459a-p2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9dt00459a-p2.tif" src="/image/article/2019/DT/c9dt00459a/c9dt00459a-p2.gif"/></a><p><span class="graphic_title">Yun-Ming Wang</span></p></td><td><i><p>Yun-Ming Wang received his Ph.D. degree in chemistry from National Tsing Hua University, Taiwan in 1990, with Prof. Chung-Sun Chung. He is currently a Professor at National Chiao Tung University Taiwan. His research interests focus on the development of MRI contrast agents and optical imaging probes, cancer diagnosis and therapy, and biosensors and bioelectronics.</p></i></td></tr></table><hr/>
    
      
      <h2 id="sect282"><span class="a_heading">1 Introduction</span></h2>
      <span>Nanotechnology offers a variable platform for the evolution of successful therapeutic materials which can combine with a target and generate an appropriate response. Nanoparticles have emerged as a substantial tool for diverse nanomedicine applications owing to their properties inherent to the nanoscale.<a title="Select to navigate to reference" href="#cit1"><sup><span class="sup_ref">1–4</span></sup></a> Among the nanomaterials studied, iron oxide-based nanomaterials have appeared as a prominent candidate for cancer treatment. Iron-based nanoparticles received particular attention since iron is a well-proven biocompatible material. A majority of their uses are a result of magnetic characteristics that significantly vary from the properties of bulk materials.<a title="Select to navigate to references" href="#cit5"><sup><span class="sup_ref">5</span></sup></a> The SPIONs applied in various biological applications are illustrated in <a title="Select to navigate to figure" href="#imgfig1">Fig. 1</a>.</span>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig1"><a href="/image/article/2019/DT/c9dt00459a/c9dt00459a-f1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9dt00459a-f1.tif" src="/image/article/2019/DT/c9dt00459a/c9dt00459a-f1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 1 </b> <span id="fig1"><span class="graphic_title">SPIONs applied in biomedical applications.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">Recently, various research studies have been conducted on SPIONs in the field of biomedical applications.<a title="Select to navigate to references" href="#cit6"><sup><span class="sup_ref">6</span></sup></a> The magnetic behavior of SPIONs gained special attention during the 20th century due to the development of domain theory. This theory explains that the size of the particle significantly tunes magnetic behavior. The superparamagnetic behavior is noticed for a particle when the size is smaller than the corresponding exchange interaction ability with a usual size of 10–15 nm at a particular temperature. The SPIONs cannot exhibit any magnetization right after removing them from an external magnetic field. Hence, the aggregation effect should be carefully avoided.<a title="Select to navigate to references" href="#cit7"><sup><span class="sup_ref">7</span></sup></a> This kind of SPION received special attention when applied in biological applications involving magnetic resonance (MR) imaging, drug delivery, cancer therapy, and other aspects.<a title="Select to navigate to reference" href="#cit8"><sup><span class="sup_ref">8–13</span></sup></a> In addition, the presence of a small size, high surface area, and potential magnetic and optical effects also created a new opening for SPION applications.<a title="Select to navigate to references" href="#cit14"><sup><span class="sup_ref">14</span></sup></a></p>
      <p class="otherpara">Owing to their facile synthetic approaches, unique magnetic behavior, and effective biocompatibility, SPIONs have been broadly developed for a variety of biomedical uses such as drug delivery,<a title="Select to navigate to reference" href="#cit15"><sup><span class="sup_ref">15,16</span></sup></a> molecular imaging,<a title="Select to navigate to reference" href="#cit17"><sup><span class="sup_ref">17,18</span></sup></a> hyperthermia treatment,<a title="Select to navigate to reference" href="#cit19"><sup><span class="sup_ref">19,20</span></sup></a> stem cell tracking,<a title="Select to navigate to reference" href="#cit21"><sup><span class="sup_ref">21,22</span></sup></a> and tissue repair.<a title="Select to navigate to reference" href="#cit23"><sup><span class="sup_ref">23,24</span></sup></a> The inherent superparamagnetic behavior provides more benefits for biological applications. A typical SPION possesses three major components: (1) an iron oxide nanoparticle (IONP) core which can act as a carrier agent in cancer treatment and a contrast agent in MR imaging, (2) a surface coated IONP can assist beneficial interactions between the SPION and the involved biological unit, and (3) a targeting ligand required to carry out a specific <span class="italic">in vivo</span> application such as identifying the overexpressed receptors on the cancer cell surface.<a title="Select to navigate to references" href="#cit25"><sup><span class="sup_ref">25</span></sup></a></p>
      <p class="otherpara">The targeting, drug delivery, and cancer treatment are important factors required for a favorable prognosis. Cancer targeting and therapeutics are emerging fields in nanotechnology. Tremendous attempts in the biomedical research area have been made to increase the sensitivity and specificity of cancer diagnosis and therapy with the help of early detection systems.<a title="Select to navigate to reference" href="#cit26"><sup><span class="sup_ref">26–28</span></sup></a> The tunable magnetic behaviors of SPIONs play a prominent role in their applications such as imaging, targeting, and treatment, and sometimes as multifunctional platforms with a combination of two or more applications.<a title="Select to navigate to reference" href="#cit29"><sup><span class="sup_ref">29,30</span></sup></a> The superparamagnetic effect is a crucial property chiefly existing in single-domain nanoparticles. The SPION magnetic properties are prominently dependent on their structure, size, shape, surface coating thickness, and functionalization.<a title="Select to navigate to reference" href="#cit31"><sup><span class="sup_ref">31,32</span></sup></a> The therapeutic applications of surface engineered SPIONs are depicted in <a title="Select to navigate to figure" href="#imgfig2">Fig. 2</a>.</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig2"><a href="/image/article/2019/DT/c9dt00459a/c9dt00459a-f2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9dt00459a-f2.tif" src="/image/article/2019/DT/c9dt00459a/c9dt00459a-f2.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 2 </b> <span id="fig2"><span class="graphic_title">Schematic representation of surface engineered SPIONs for therapeutic applications: (a) SPIONs containing iron oxide as the core with different coating materials, and (b) surface engineered SPIONs composed of polymer micelles with a hydrophilic shell and a hydrophobic core. The hydrophilic surface conjugated with targeting antibodies, peptides, aptamers, and small molecules.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">Some other interesting properties of SPIONs were also revealed along with their biocompatible, biodegradable and potential non-toxicity characteristics. It is interesting to know about their superparamagnetic behavior, additional magnetic anisotropic contributions, high field saturation, irreversibility of high field magnetization, <span class="italic">etc</span>.<a title="Select to navigate to references" href="#cit33"><sup><span class="sup_ref">33</span></sup></a> Hence, these particles cannot exhibit magnetization when removed from the magnetic field. Based on these unique behaviors, SPION-integrated biomolecules can be tagged and magnetically detected to demonstrate their utility in targeting, drug delivery, and therapeutic applications.<a title="Select to navigate to reference" href="#cit34"><sup><span class="sup_ref">34–36</span></sup></a> Recently, there has been an increase in the production of nanomaterials for selective targeting. An appropriate particle size is critical for magnetic drug targeting.<a title="Select to navigate to references" href="#cit37"><sup><span class="sup_ref">37</span></sup></a> In addition, the particles should undergo magnetization when supplied with an external magnetic field.<a title="Select to navigate to reference" href="#cit13"><sup><span class="sup_ref">13,36</span></sup></a> Chemotherapeutic treatments often result in a multitude of adverse side effects due to systemic toxicities of these treatments. Localized hyperthermia has also been shown as an adjunct medical treatment.<a title="Select to navigate to references" href="#cit38"><sup><span class="sup_ref">38</span></sup></a> However, a potential method for site-specific drug release is still required.</p>
      <p class="otherpara">With the aim of improving therapeutic efficiency of drugs and minimizing side effects, investigations were carried out on nanoparticles by employing them as drug delivery vehicles. The architecture of SPIONs as multimodal systems combined with different targeting moieties and drugs routes them towards cancer cells for site-specific drug release.<a title="Select to navigate to references" href="#cit39"><sup><span class="sup_ref">39</span></sup></a> A higher efficiency is noted when compared to administering drugs alone. It is fundamentally connected to various drug delivery mechanisms that SPION drugs bypass healthy areas and thus induce little adverse effects.<a title="Select to navigate to reference" href="#cit40"><sup><span class="sup_ref">40–42</span></sup></a> This review deals with the synthesis of SPIONs based on both aqueous and non-aqueous methods.</p>
      <p class="otherpara">Recently, inorganic nanocarriers have become the center of interest in biomedicine research owing to their specific physiochemical features including magnetism, optical properties, size distribution, shape and their capacity to function as imaging and therapeutic drug platforms. Most of these carriers are presently at preclinical stages rather than at clinical trials.<a title="Select to navigate to references" href="#cit43"><sup><span class="sup_ref">43</span></sup></a> It has been revealed that the nanocarriers can be used in drug delivery and cancer treatment since they can deliver drugs on the specific tumor site thereby overcoming the systemic toxicity risks.<a title="Select to navigate to references" href="#cit44"><sup><span class="sup_ref">44</span></sup></a> Furthermore, the biocompatibility can be increased by integrating them with targeting moieties such as antibodies, nucleic acids, enzymes, and cell lines. The multifunctional applications of organized SPIONs have an intense impact on different areas of cancer therapy. In addition, they are capable of improving their contrasting qualities in drug delivery, imaging, and hyperthermia due to their biocompatible and biodegradable features.<a title="Select to navigate to reference" href="#cit45"><sup><span class="sup_ref">45–48</span></sup></a></p>
      <p class="otherpara">The different physiochemical properties of SPIONs are shown in <a title="Select to navigate to figure" href="#imgfig3">Fig. 3</a>. These unique characteristics received special attention among active researchers to introduce new findings into their biomedical practices, which have been included in this review. To start with, a brief introduction of SPIONs is discussed, followed by various types of synthetic methods. Then the biomedical applications of SPIONs are reviewed under three major heads as targeting, drug delivery, and treatment which further revealed that SPIONs possess significant abilities for various biomedical applications owing to their unique characteristics. The unique magnetic characteristics and excellent tumor targeting efficacy of SPIONs may lead to effective cancer treatments. This review discusses the potential utility of SPIONs in cancer biology such as targeting, drug delivery, and therapy.</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig3"><a href="/image/article/2019/DT/c9dt00459a/c9dt00459a-f3_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9dt00459a-f3.tif" src="/image/article/2019/DT/c9dt00459a/c9dt00459a-f3.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 3 </b> <span id="fig3"><span class="graphic_title">The physiochemical properties of SPIONs affect their bio-kinetics and fates <span class="italic">in vivo</span>. These changes can be observed in uptake, distribution, metabolism, and excretion of SPIONs from the body. The protein corona is yet another factor that is influenced by various physiochemical features of nanoparticles and can, in turn, affect the targeting capabilities of SPIONs in imaging applications. Not only can the protein corona alter the toxicity, uptake, targeting, and circulation time of SPIONs, but it can also affect the relaxivity of SPIONs as MR imaging contrast agents. Reproduced with permission from <a title="Select to navigate to references" href="#cit49">ref. 49</a>.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">It is evident that the applications of SPIONs have created new prospects for image-guided cancer therapy upon integrating them with various therapeutic agents such as chemical drugs and gene therapeutics. Many reviews have discussed the formation, surface functionalization, and biofunctionalization of SPIONs. This review discusses several synthesis aspects of SPIONs, chemistry and properties of SPIONs, and SPIONs in targeting, drug delivery and cancer therapeutics. Many studies dealt with different synthetic methods but no review discussed all the available synthetic methods. Hence, it is decided to discuss all the synthetic methods in this review. In addition, chemistry and properties of SPIONs and the role of SPIONs in targeting, drug delivery, and therapeutics are also discussed.<a title="Select to navigate to references" href="#cit31"><sup><span class="sup_ref">31</span></sup></a> Moreover, challenges and difficulties involved in the development of SPION-based nanoplatforms as active agents for targeting, drug delivery, and therapeutic treatments were also discussed.</p>
    
    
      
      <h2 id="sect333"><span class="a_heading">2 Synthesis of SPIONs</span></h2>
      <span>Several SPION synthetic methods are available in the literature so far.<a title="Select to navigate to references" href="#cit50"><sup><span class="sup_ref">50</span></sup></a> The synthesis can be carried out based on physical and chemical approaches, including traditional methods, and chemical synthesis to more fascinating techniques. Chemical synthesis is generally applied when aimed to prepare SPIONs with a uniform size and composition. However, the interconnection of SPION properties plays a critical role in displaying their characteristics.</span>
      
        
        <h3 id="sect338"><span class="b_heading">2.1 Co-precipitation method</span></h3>
        <span>This is one of the most widely used standard methods for aqueous phase SPION synthesis.<a title="Select to navigate to references" href="#cit51"><sup><span class="sup_ref">51</span></sup></a> In simple terms, Fe<small><sup>2+</sup></small> and Fe<small><sup>3+</sup></small> salts in 2<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1 molar ratio are prepared in aqueous solution followed by the addition of sodium hydroxide (NaOH) or ammonium hydroxide (NH<small><sub>4</sub></small>OH) at elevated temperatures to precipitate the nanoparticles. This is carried out in a pH range of 9–14. The surfaces of the nanoparticles are found to be rich in hydroxyl groups which further helps them to dissolve in water.<a title="Select to navigate to references" href="#cit52"><sup><span class="sup_ref">52</span></sup></a> It is important that the particle size and shape are maintained within the desired range. To this aim, it is necessary to consider (1) the molar ratio of salts, (2) types of iron sources used for example, chloride, nitrate, or sulfate salts, (3) pH in solution, (4) temperature, and (5) ionic strength of the reaction mixture.<a title="Select to navigate to references" href="#cit53"><sup><span class="sup_ref">53</span></sup></a> The drawback of this method is the oxidation/reduction potential of iron salts used since they affect both the physical and chemical properties of the prepared nanoparticles. To overcome this issue, the precipitation should be performed in an inert environment under nitrogen as this will prevent deterioration of the SPIONs.<a title="Select to navigate to references" href="#cit54"><sup><span class="sup_ref">54</span></sup></a></span>
      
      
        
        <h3 id="sect349"><span class="b_heading">2.2 Thermal decomposition</span></h3>
        <span>This is the conventional technique to prepare nanocrystals of a smaller size than other methods. It results in the transformation of iron-based organometallics in the presence of organic solvents and surfactants at a high boiling point.<a title="Select to navigate to references" href="#cit55"><sup><span class="sup_ref">55</span></sup></a> The coordination/organometallic compounds used are iron(<span class="small_caps">III</span>) acetylacetonate Fe(acac)<small><sub>3</sub></small>, tris(acetylacetonato)iron(<span class="small_caps">III</span>) (Fe(C<small><sub>5</sub></small>H<small><sub>7</sub></small>O<small><sub>2</sub></small>)<small><sub>3</sub></small>), and iron pentacarbonyl (Fe(CO)<small><sub>5</sub></small>).<a title="Select to navigate to references" href="#cit56"><sup><span class="sup_ref">56</span></sup></a> This method is similar to that used for producing high-quality nanocrystals and oxide semiconductors.<a title="Select to navigate to references" href="#cit57"><sup><span class="sup_ref">57</span></sup></a> Precise size and shape control is mainly determined by the ratios and volumes of different reagents as well as the reaction conditions. Hyeon <span class="italic">et al.</span> described a thermal decomposition strategy to produce 20–160 nm sized monodisperse nanocubes using oleic acid and benzyl ether at 260 °C.<a title="Select to navigate to references" href="#cit58"><sup><span class="sup_ref">58</span></sup></a> They noted that the particle sizes differ by varying reactions and 4-biphenylcarboxylic acid yielded a smaller particle size than oleic acid. The main drawbacks of this method are: (1) high reaction temperatures, (2) the use of toxic reagents, and (3) nanoparticles can be dispersed only in organic solvents.</span>
      
      
        
        <h3 id="sect366"><span class="b_heading">2.3 Hydrothermal method</span></h3>
        <span>This method is a popular chemical approach for synthesizing inorganic nanocrystals mainly for metals and their oxides.<a title="Select to navigate to references" href="#cit59"><sup><span class="sup_ref">59</span></sup></a> This method requires relatively high pressure and temperature to generate nanocrystals. Merits of this method are: (1) high reactivity of reagents, (2) ease of control of the morphology of the compounds, and (3) good crystallization. However, it is crucial that the solubility of reactants is maintained to produce desired products under such conditions. Moreover, there is a possibility of forming metastable and condensed phases. The nanospheres, nanoparticles, nanosheets, nanoplates, nanorods, nanocubes, nanorings, and nanowires have been successfully synthesized using this method.<a title="Select to navigate to references" href="#cit60"><sup><span class="sup_ref">60</span></sup></a> Chen <span class="italic">et al.</span> were able to prepare quasi-sphere polyhedron nanocrystalline particles of 50 nm. They used sodium thiosulphate (Na<small><sub>2</sub></small>S<small><sub>2</sub></small>O<small><sub>3</sub></small>) as a phase controlling agent and the ratio of sodium sulfite (Na<small><sub>2</sub></small>SO<small><sub>3</sub></small>)/iron(<span class="small_caps">II</span>) sulphate (FeSO<small><sub>4</sub></small>) determined whether the Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> phase can be produced.<a title="Select to navigate to references" href="#cit61"><sup><span class="sup_ref">61</span></sup></a></span>
      
      
        
        <h3 id="sect383"><span class="b_heading">2.4 Hydrothermal and solvothermal syntheses</span></h3>
        <span>The hydrothermal method utilizes an aqueous solution to prepare SPIONs. This method also employs high pressure and temperature to produce nanocrystals. The advantages of this method include: (1) low cost of reactants, (2) simple reaction conditions, and (3) high purity and degree of crystallinity along with great water solubility of products.<a title="Select to navigate to references" href="#cit62"><sup><span class="sup_ref">62</span></sup></a> For example, Ge <span class="italic">et al.</span> produced highly pure crystalline nanoparticles with high tunable saturation magnetization, using an oxidative reaction of FeCl<small><sub>2</sub></small>·4H<small><sub>2</sub></small>O and oxygen in a basic solution at 134 °C and 2 bar pressure.<a title="Select to navigate to references" href="#cit63"><sup><span class="sup_ref">63</span></sup></a> The size of nanoparticles was also controlled between 15 and 30 nm by varying the concentration of the reactants. Moreover, Wang <span class="italic">et al.</span> were able to hydrothermally synthesize SPIONs in NaOH using diamine hydrate as an oxidant for transforming Fe<small><sup>2+</sup></small> into Fe<small><sup>3+</sup></small>.<a title="Select to navigate to references" href="#cit64"><sup><span class="sup_ref">64</span></sup></a> The increase in the particle size and high crystallinity were achieved by increasing the reaction temperature.</span>
        <p class="otherpara">The synthetic procedure of the solvothermal method mimics that of the hydrothermal synthetic method. This method works in an organic medium. Stojanović <span class="italic">et al.</span> developed a simple solvothermal method to prepare SPIONs in which the water–ethanol–oleic acid system served as a reaction medium.<a title="Select to navigate to references" href="#cit65"><sup><span class="sup_ref">65</span></sup></a> The oleate anion and glucose were used as stabilizing and reducing agents, respectively. The size and morphological properties of the synthesized SPIONs are better than those obtained from the hydrothermal method. The main disadvantages are its surface hydrophobicity which may result in poor water solubility and further affects its biocompatibility.</p>
      
      
        
        <h3 id="sect399"><span class="b_heading">2.5 Thermal parsing</span></h3>
        <span>This technique requires high temperatures and intricate operation for the production of SPIONs with a controllable size.<a title="Select to navigate to references" href="#cit66"><sup><span class="sup_ref">66</span></sup></a> Highly uniform SPIONs are obtained by thermal parsing of organometallic composites and oxidation in an organic medium. The medium contains most commonly used surfactants such as oleic acid and hexadecylamine.<a title="Select to navigate to reference" href="#cit67"><sup><span class="sup_ref">67,68</span></sup></a> The accurate particle size, starting reagents used, morphology, time, and temperature were controlled following the reported article<a title="Select to navigate to references" href="#cit69"><sup><span class="sup_ref">69</span></sup></a> in order to produce the nanoparticles using the thermal parsing method. They found that after covering, MR imaging of the heterograft tumor animal model proved the benefits of the manufactured SPIONs against LumirenV<small><sub>R</sub></small>.<a title="Select to navigate to references" href="#cit70"><sup><span class="sup_ref">70</span></sup></a> However, the disadvantage of this method lies in the solubility, <span class="italic">i.e.</span> the nanoparticles synthesized by this method can be dissolved only in non-polar solvents.</span>
      
      
        
        <h3 id="sect409"><span class="b_heading">2.6 Mild reduction</span></h3>
        <span>The nanoparticles are synthesized using the reduction of Fe<small><sup>3+</sup></small> under specific reaction conditions which are stabilized by polymers <span class="italic">via</span> photochemical <span class="italic">in situ</span> polymerization.<a title="Select to navigate to references" href="#cit71"><sup><span class="sup_ref">71</span></sup></a> The general principles for a mild reduction are: (1) Fe<small><sup>3+</sup></small> is partially reduced to Fe<small><sup>2+</sup></small> by sodium sulfate and (2) ammonium hydroxide is added to co-precipitate Fe<small><sup>3+</sup></small>/Fe<small><sup>2+</sup></small> salts to obtain nanoparticles.</span>
        <p class="otherpara">Shi <span class="italic">et al.</span> created polyethyleneimine (PEI)-coated nanoparticles using a modified mild-reduction method to obtain nanoparticles with high <span class="italic">r</span>2 relaxivity.<a title="Select to navigate to references" href="#cit72"><sup><span class="sup_ref">72</span></sup></a> Their results showed that the synthesized nanoparticles exhibited an ultrahigh <span class="italic">r</span>2 relaxivity value (461.29 nM<small><sup>−1</sup></small> s<small><sup>−1</sup></small>) and a large <span class="italic">r</span>2/<span class="italic">r</span>1 ratio,<a title="Select to navigate to references" href="#cit73"><sup><span class="sup_ref">73</span></sup></a> implying that the PEI-coated nanoparticles had significant influence on <span class="italic">T</span>2-weighted MR imaging applications. They reported that the exact mechanism of the ultrahigh <span class="italic">r</span>2 relaxivity is unclear but it should be inspected under two main different aspects such as high magnetic moments of Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> as per the reported protocol,<a title="Select to navigate to references" href="#cit74"><sup><span class="sup_ref">74</span></sup></a> and the coating of Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> with PEI. Do <span class="italic">et al.</span> outlined the contribution of PEI, 0.5 wt%, by generating nanoparticles with high <span class="italic">r</span>2 relaxivity (22.7 nM<small><sup>−1</sup></small> s<small><sup>−1</sup></small>) when compared with 0.02 and 0.08 wt% PEI (45 nM<small><sup>−1</sup></small> s<small><sup>−1</sup></small> and 29.5 nM<small><sup>−1</sup></small> s<small><sup>−1</sup></small>, respectively).<a title="Select to navigate to references" href="#cit75"><sup><span class="sup_ref">75</span></sup></a> This is because of the fact that there is no bigger cluster size because of the obvious aggregation of nanoparticles prepared at 0.05 wt%. Thus, both the reasonable hydrodynamic cluster size and limited aggregation of the particles contribute to a higher <span class="italic">r</span>2 value of the particles.</p>
      
      
        
        <h3 id="sect448"><span class="b_heading">2.7 Reduction–precipitation method</span></h3>
        <span>Qu <span class="italic">et al.</span> first reported this method as an improvement to the co-precipitation method for the synthesis of SPIONs.<a title="Select to navigate to references" href="#cit76"><sup><span class="sup_ref">76</span></sup></a> This method can produce sub-10 nm spherical shaped SPIONs using ferric chloride (FeCl<small><sub>3</sub></small>) as the starting material. This can be reduced to Fe<small><sup>3+</sup></small> in the presence of Na<small><sub>2</sub></small>S<small><sub>2</sub></small>O<small><sub>3</sub></small> and ammonia. The formation of a red-colored intermediate prevents the re-oxidation of iron employed in this synthesis, which is the main advantage of this method.</span>
      
      
        
        <h3 id="sect459"><span class="b_heading">2.8 Reverse micelle method</span></h3>
        <span>This method helps to synthesize metallic magnetic nanoparticles by employing hydrazine and cetyltrimethylammonium bromide as a reducing agent and a surfactant, respectively. The prepared micelles are a surfactant stabilized water-in-oil (W/O) microemulsion by forming nano-reactors for synthesis.<a title="Select to navigate to references" href="#cit77"><sup><span class="sup_ref">77</span></sup></a> Since then, the reaction conditions for this method are well established to obtain good yields.<a title="Select to navigate to references" href="#cit78"><sup><span class="sup_ref">78</span></sup></a> This method is also named “growth confined co-precipitation method” because the reactants are similar to those used in co-precipitation and reduction–precipitation methods. The advantage is the use of a nanoreactor capable of controlling the size and morphology by limiting crystal growth and preventing aggregation of the particles. The disadvantages are: (1) low yield with poor solubility in water compared to that of the other two methods, (2) broader size distribution, (3) biosafety concerns of the surfactants and those attached to the nanoparticles, and (4) complexity in the purification process which hampers mass production.</span>
      
      
        
        <h3 id="sect465"><span class="b_heading">2.9 Polyol method</span></h3>
        <span>The polyol method aims to synthesize water-soluble SPIONs. In this process, a thermal decomposition takes place with organometallic compounds in the presence of polyol solvents which could serve both as a surfactant and/or a reducing agent.<a title="Select to navigate to references" href="#cit79"><sup><span class="sup_ref">79</span></sup></a> Hu <span class="italic">et al.</span> synthesized SPIONs under a one-pot reaction. They obtained ultra-small sized (3–6 nm) particles with a uniform size and structure, and medium solubility in water.<a title="Select to navigate to references" href="#cit80"><sup><span class="sup_ref">80</span></sup></a> However, the major disadvantage of this method lies in the difficulty in the removal of polyol solvents used.</span>
      
      
        
        <h3 id="sect472"><span class="b_heading">2.10 Micro/nanoemulsion</span></h3>
        <span>Immiscible solvents are the backbone of emulsion where precursors are generally soluble in low or high dielectric solvents. Ultrasonication of precursors creates a homogeneous environment before creating a micro/nanoemulsion system composed of metals, coating agents, and targeting moieties. This is followed by the addition of a dispersant with a dielectric constant which helps to dissolve the combined reagents under vigorous mixing.<a title="Select to navigate to references" href="#cit81"><sup><span class="sup_ref">81</span></sup></a> It is important to establish (O/W) or similar solvents that solubilized the targeting molecule forming corresponding beads dispersed in a lower dielectric solvent medium to obtain an oil phase. In some cases, it may be preferred to establish an O/W system as shown in <a title="Select to navigate to figure" href="#imgfig4">Fig. 4</a>. A similar method is the membrane emulsion method which uses synthetic membranes to create microbeads. Another crucial factor to this method is the development of separate phases using a capping agent and an iron core dissolved in the same phase. Often it is easy to generate a bead emulsion of polystyrene monomers through ultrasonication or membrane sonication.<a title="Select to navigate to references" href="#cit82"><sup><span class="sup_ref">82</span></sup></a></span>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig4"><a href="/image/article/2019/DT/c9dt00459a/c9dt00459a-f4_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9dt00459a-f4.tif" src="/image/article/2019/DT/c9dt00459a/c9dt00459a-f4.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 4 </b> <span id="fig4"><span class="graphic_title">Schematic illustration of the microemulsion method (O/W reaction) for nanoparticle synthesis.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      
      
        
        <h3 id="sect481"><span class="b_heading">2.11 Physical vapor deposition (PVD)</span></h3>
        <span>PVD is referred to as a vacuum deposition method that can deposit thin films using a condensation method of the material used. This process is purely physical with high-temperature vacuum evaporation with subsequent condensation. Many reports are available for the preparation of iron oxides using PVD. Pulsed laser deposition, sputtering, and molecular beam epitaxy are the most commonly used PVD methods for growing spinel ferrites. Pandya <span class="italic">et al.</span> deposited a SPION film on Si(100) under the aid of the pulsed DC sputtering method and electric field. The formation of γ-Fe<small><sub>2</sub></small>O<small><sub>3</sub></small> or Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> can be confirmed using X-ray diffraction (XRD) patterns or Raman or Mossbauer spectroscopy.<a title="Select to navigate to reference" href="#cit83"><sup><span class="sup_ref">83–86</span></sup></a> XRD is one of the most commonly used techniques for the nanoparticle characterization. The XRD technique provides detailed information on the crystalline structure, crystallite size, nature of the phase and lattice parameters. The main advantage of using XRD techniques is the usage of samples in a powder form, generally after drying respective colloidal solutions which further results in statistically indicative, volume-averaged values. The particle composition can also be identified upon comparing the peak intensity and position with the reference patterns that are already available from the standard International Centre for Diffraction Data (ICDD) database. However, this pattern is not suitable for amorphous materials and broad XRD peaks will appear for particles possessing 3 nm or below.</span>
      
      
        
        <h3 id="sect491"><span class="b_heading">2.12 Chemical vapor deposition (CVD)</span></h3>
        <span>CVD is reported for synthesizing SPIONs; however, fewer reports are available. Tristao <span class="italic">et al.</span> showed that CVD can be utilized to prepare carbon-based SPIONs upon γ-Fe<small><sub>2</sub></small>O<small><sub>3</sub></small> reduction in the presence of nitrogen and methane.<a title="Select to navigate to references" href="#cit87"><sup><span class="sup_ref">87</span></sup></a> Recently, Mantovan <span class="italic">et al.</span> used the CVD method to synthesize a Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> based thin film with an organometallic compound as a precursor and they noted an improvement in the stoichiometric ratio when compared with the starting precursor.<a title="Select to navigate to reference" href="#cit88"><sup><span class="sup_ref">88,89</span></sup></a> Meanwhile, the CVD pulses can regulate the Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> thickness but this method is not suitable to produce iron oxide in the nanoparticle form. Some other reports are available that require post-synthesis treatments to tune the iron particles into their nanoparticles like scrapping powder from substrates and the same can be dispersed in a solvent by using the sonication method or surface modification.</span>
      
      
        
        <h3 id="sect505"><span class="b_heading">2.13 Electrodeposition</span></h3>
        <span>It is similar to the vapor deposition method and it deposits the starting materials into a substrate to produce nanostructures. The solubilized Fe<small><sup>2+</sup></small>/Fe<small><sup>3+</sup></small> ions are the precursors and the reaction is carried out at room temperature. The mass production of SPIONs can be achieved using this approach.<a title="Select to navigate to references" href="#cit90"><sup><span class="sup_ref">90</span></sup></a> Reports from the literature indicate that changing the composition of the electrolyte used can alter the film formation, size, and crystallinity.<a title="Select to navigate to references" href="#cit87"><sup><span class="sup_ref">87</span></sup></a> It is also found that acetate played a crucial role in modulating the ratios of Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> and γ-Fe<small><sub>2</sub></small>O<small><sub>3</sub></small>.</span>
      
      
        
        <h3 id="sect517"><span class="b_heading">2.14 High-temperature (thermal) decomposition using organometallic precursors</span></h3>
        <span>It is highly challenging to produce nanoparticles with an optimized size and distribution. The difficulty in achieving their crystallinity and control on the shape of the particles is also reported.<a title="Select to navigate to references" href="#cit91"><sup><span class="sup_ref">91</span></sup></a> This is due to an occurrence of low-temperature co-precipitation reactions where the kinetics can be regulated by reagent concentration and thus results in limited nucleation. Thus, by using high-temperature the crystallization is also improved and it is very easy to modulate high temperature synthetic methods.</span>
      
      
        
        <h3 id="sect522"><span class="b_heading">2.15 Sedimentation technique</span></h3>
        <span>This procedure is an easy and convenient method to synthesize SPIONs. It involves resuscitation of metals using salt solution and base at high/room temperatures. The sedimentation technique proved that the attributes of the SPIONs like the size and shape are prominently dependent on the salt source, temperature, pH, and ionic strength.<a title="Select to navigate to references" href="#cit92"><sup><span class="sup_ref">92</span></sup></a> High yield is the main advantage of applying this technique but it is highly challenging to control the distribution of the particles since kinetic doers are monitoring the crystal growth. Despite this, uniform nanoparticles are usually synthesized through homogeneous sedimentation reactions.<a title="Select to navigate to reference" href="#cit50"><sup><span class="sup_ref">50,93</span></sup></a> There are two processes involved: (1) nucleation blast when the sample concentration exceeds the saturation and (2) a slow development of nuclei using the dissemination technique of the surface solutes.<a title="Select to navigate to references" href="#cit94"><sup><span class="sup_ref">94</span></sup></a> Magnetic fluid (MF) prepared by this method showed excellent performance and a rapid magnetothermal reaction. This method is extensively used because of the comfort in implementation and the lack of need for risky materials and action.<a title="Select to navigate to references" href="#cit95"><sup><span class="sup_ref">95</span></sup></a> The sedimentation method is extensively applied in the production of SPIONs for cancer diagnosis and therapy.</span>
      
      
        
        <h3 id="sect530"><span class="b_heading">2.16 Sonochemical method</span></h3>
        <span>In this method, high energy ultrasound is used for the synthesis of SPIONs. Ultrasound generates cavitation bubbles which can be used to transform the reactants into desired products at ambient temperature. The size and shape of the SPIONs can be controlled by regulating the refluxing temperature, power, and irradiation time. Recently, Dolores <span class="italic">et al.</span> synthesized SPIONs using ethylene glycol as a surfactant. It was found that increasing reaction time increased the particle formation at a specific ultrasonic frequency.<a title="Select to navigate to references" href="#cit96"><sup><span class="sup_ref">96</span></sup></a></span>
      
      
        
        <h3 id="sect536"><span class="b_heading">2.17 Microwave-assisted synthesis</span></h3>
        <span>Microwaves from the electromagnetic spectrum can also be used for the synthesis of SPIONs consuming less energy and in shorter time. In this method, the reaction container provides uniform microwave energy to all sides of the container which results in synthesizing stable and highly crystalline nanoparticles. However, lower energy surface crystallinity makes these particles to get reduced surface reactivity but the low surface reactivity can increase the particle stability. This property is determined based on the particle and water interactions and the agglomeration effect. Finally, manipulation of the surfactant dose, reaction/irradiation time, and power allows controlled SPION properties.<a title="Select to navigate to reference" href="#cit97"><sup><span class="sup_ref">97,98</span></sup></a></span>
      
    
    
      
      <h2 id="sect541"><span class="a_heading">3 SPIONs (Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> and γ-Fe<small><sub>2</sub></small>O<small><sub>3</sub></small>): chemistry, geometry, and physiochemical properties</span></h2>
      
        
        <h3 id="sect548"><span class="b_heading">3.1 Chemistry</span></h3>
        <span>Magnetic iron oxide nanoparticles have attracted particular interest in many biomedical applications owing to their superparamagnetic properties and low toxicity.<a title="Select to navigate to reference" href="#cit99"><sup><span class="sup_ref">99,100</span></sup></a> These nanoparticles are superparamagnetic when the size of the particles is below 20 nm.<a title="Select to navigate to references" href="#cit101"><sup><span class="sup_ref">101</span></sup></a> The nano-sized diameter and magnetic characteristics enable SPIONs to exhibit diverse functions.<a title="Select to navigate to references" href="#cit102"><sup><span class="sup_ref">102</span></sup></a> During the past few decades, SPIONs have been widely used in clinical applications such as MR imaging, gene delivery, and drug delivery.<a title="Select to navigate to reference" href="#cit100"><sup><span class="sup_ref">100,103,104</span></sup></a> The Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> &amp; γ-Fe<small><sub>2</sub></small>O<small><sub>3</sub></small> particles possess superparamagnetism since they can be oriented in the direction of the magnetic field and can be retained in their original state after removing from the external magnetic field. SPIONs are originally positively charged and can be readily incorporated with negatively charged materials such as drugs and nucleic acids<a title="Select to navigate to references" href="#cit105"><sup><span class="sup_ref">105</span></sup></a> which also contribute to clinical applications.</span>
        <p class="otherpara">SPIONs are considered as Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> and they become γ-Fe<small><sub>2</sub></small>O<small><sub>3</sub></small> when oxidized.<small><sub>.</sub></small> These particles are explored in biomedical applications. These particles can be easily metabolized and can be transported by proteins and stored in endogenous iron pools for later use.<a title="Select to navigate to references" href="#cit106"><sup><span class="sup_ref">106</span></sup></a> The nanoparticles derived from Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> vary from the IONPs due to the existence of iron in the forms of Fe<small><sup>2+</sup></small> and Fe<small><sup>3+</sup></small>. The divalent ions occupy the octahedral sites whereas the trivalent ions can be arranged across both the tetrahedral and octahedral sites. However, trivalent ions in α-Fe<small><sub>2</sub></small>O<small><sub>3</sub></small> reside in their octahedral sites but the Fe<small><sup>3+</sup></small> ions in the case of γ-Fe<small><sub>2</sub></small>O<small><sub>3</sub></small> are distributed in both the sides along with the formation of Fe<small><sup>2+</sup></small> ion vacancies in octahedral sites.<a title="Select to navigate to references" href="#cit107"><sup><span class="sup_ref">107</span></sup></a></p>
        <p class="otherpara">Oxygen in both Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> and γ-Fe<small><sub>2</sub></small>O<small><sub>3</sub></small> particles can form a cubic close-packed crystal system. Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> possesses an inverse spinel structure and the ions are arranged randomly between tetrahedral and octahedral sites whereas the Fe<small><sup>2+</sup></small> ions occupy octahedral sites.<a title="Select to navigate to reference" href="#cit13"><sup><span class="sup_ref">13,108</span></sup></a> γ-Fe<small><sub>2</sub></small>O<small><sub>3</sub></small> has a similar structure to Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> but varies in the presence of cation vacancies formed at the octahedral sites in which almost the iron is present in its trivalent state and more than half of the sites are occupied by Fe<small><sup>3+</sup></small> ions in a regular distribution with two filled sites being followed by one vacant site.<a title="Select to navigate to reference" href="#cit13"><sup><span class="sup_ref">13,108</span></sup></a> The iron atoms present on the surface behave as Lewis acids by coordinating with other compounds with electron donating ability. The iron oxide is in the form of hydroxyls owing to its binding ability with water present in an aqueous solution. The isoelectric point of iron oxide nanoparticles is around pH 6.8 and dependent on the solution pH; the nanoparticle surface can be positive or negative. Below the isoelectric point, nanoparticles undergo protonation and lead to the formation of <img class="charmap" src="https://www.rsc.org/images/entities/char_e002.gif" alt="[triple bond, length as m-dash]"/>FeOH<small><sub>2</sub></small><small><sup>+</sup></small> whereas above the isoelectric point, deprotonation is observed and results in the formation of <img class="charmap" src="https://www.rsc.org/images/entities/char_e002.gif" alt="[triple bond, length as m-dash]"/>Fe–O<small><sup>−</sup></small> on the nanoparticle surface. Thus, pH-dependent surface charge has a great influence on the coating materials that are being attached onto the surface.<a title="Select to navigate to reference" href="#cit13"><sup><span class="sup_ref">13,109</span></sup></a></p>
      
      
        
        <h3 id="sect598"><span class="b_heading">3.2 Geometry</span></h3>
        <span>Magnetite, Fe<small><sub>3</sub></small>O<small><sub>4</sub></small>, is a ferromagnetic oxide. The electronic configuration of Fe<small><sup>3+</sup></small> ions present in Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> is 1s<small><sup>2</sup></small>2s<small><sup>2</sup></small>2p<small><sup>6</sup></small>3s<small><sup>2</sup></small>3p<small><sup>6</sup></small>3d<small><sup>5</sup></small>. The Fe<small><sup>3+</sup></small> present in Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> has five unpaired electrons in the ground state. It possesses a high Curie temperature (<span class="italic">T</span><small><sub>c</sub></small> = 858 K). It has a face-centered cubic (fcc) unit cell with a length of <span class="italic">a</span> = 0.839 nm based on the total 32 O<small><sup>2−</sup></small> ions along the [111] direction and each unit cell contains 8 formula units. The formula is given as Fe<small><sup>3+</sup></small>(A)[Fe<small><sup>2+</sup></small>Fe<small><sup>3+</sup></small>](B)O<small><sub>4</sub></small> since the structure possesses octahedral/mixed octahedral and tetrahedral stacked layers along [111]. A in the formula refers to the tetrahedral site possessing Fe<small><sup>3+</sup></small> ions enclosed with 4 oxygen atoms whereas B refers to the octahedral sites with mixed Fe<small><sup>2+</sup></small>/Fe<small><sup>3+</sup></small> ions enclosed with 6 oxygen atoms. Thus, Fe<small><sup>3+</sup></small> engages both tetrahedral and octahedral sites.<a title="Select to navigate to references" href="#cit110"><sup><span class="sup_ref">110</span></sup></a></span>
        <p class="otherpara">The Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> magnetic properties are attributed to splitting of a 3d orbital. Due to the presence of the oxide ligand, the 3d orbital is divided into two subsets and hence all Fe<small><sup>3+</sup></small> and Fe<small><sup>2+</sup></small> ions contain four unpaired electrons. The Fe<small><sup>2+</sup></small>/Fe<small><sup>3+</sup></small> ions in the octahedral site are coupled ferromagnetically <span class="italic">via</span> the double exchange method. The electron spin located in the opposite direction of the rest is interchanged between two sites. In contrast, Fe<small><sup>3+</sup></small> ions in mixed sites are associated antiferromagnetically through the oxygen. It indicates that the Fe<small><sup>3+</sup></small> spins cancel out each other and the unpaired spins of Fe<small><sup>2+</sup></small> found in the octahedral site are solely responsible for causing magnetization. In Fe<small><sub>3</sub></small>O<small><sub>4</sub></small>, the electrons bouncing between divalent and trivalent ions at B sites can generate conductivity. This can behave like a half metal since the polarization arrives from negative polarization at the Fermi level.<a title="Select to navigate to reference" href="#cit111"><sup><span class="sup_ref">111,112</span></sup></a> Maghemite (γ-Fe<small><sub>2</sub></small>O<small><sub>3</sub></small>) is a ferromagnetic oxide and the electronic configuration of Fe<small><sup>2+</sup></small> ions in γ-Fe<small><sub>2</sub></small>O<small><sub>3</sub></small> is 1s<small><sup>2</sup></small>2s<small><sup>2</sup></small>2p<small><sup>6</sup></small>3s<small><sup>2</sup></small>3p<small><sup>6</sup></small>3d<small><sup>6</sup></small>. The Fe<small><sup>2+</sup></small> present here contains two and four unpaired electrons. The electronic, magnetic and some other spectroscopic characteristics are determined by the availability of 3d electrons in the iron. The difference between magnetite and maghemite lies in oxidation states balanced by cation vacancies. The unit cell has 64/3 Fe<small><sup>3+</sup></small> ions, 32 O<small><sup>2−</sup></small>, and 7/3 vacancies. One cation occupied the tetrahedral site and the rest are randomly distributed in the octahedral sites but are limited to octahedral sites.</p>
      
      
        
        <h3 id="sect657"><span class="b_heading">3.3 Optical properties</span></h3>
        <span>Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> and γ-Fe<small><sub>2</sub></small>O<small><sub>3</sub></small> are the major forms of stable iron oxide that exist in the environment. They are available in the forms of rocks, soils, and bacterial species, as well as in the human body. The magnetite can be oxidized to maghemite over time and can be converted to hematite when subjected to high temperature.<a title="Select to navigate to references" href="#cit113"><sup><span class="sup_ref">113</span></sup></a> Many investigations are made on the optical properties of hematite. These studies show that hematite has a 2.1–2.2 eV band gap which is strong enough for solar energy conversion.<a title="Select to navigate to references" href="#cit114"><sup><span class="sup_ref">114</span></sup></a> Magnetite is an important member for solar applications owing to its absorption from the visible to infrared region. In particular, magnetite in the ferrofluid state composed of small-sized nanoparticles has various applications including biological applications. Magnetite gained much importance in the earlier days owing to its transition of a semiconductor to metal state at a Verwey transition temperature of constant interest.</span>
        <p class="otherpara">Despite various interpretations for different transitions, the structure of the electronic band of Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> is still a matter of debate. Bulk Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> possesses a fcc lattice and an inverse spinel structure with the expression (Fe<small><sup>3+</sup></small>)[Fe<small><sup>3+</sup></small>Fe<small><sup>2+</sup></small>](O<small><sup>2−</sup></small>)<small><sub>4</sub></small> in which the (A) tetrahedral site is occupied by trivalent ions and roughly mixed Fe<small><sup>2+</sup></small>/Fe<small><sup>3+</sup></small> ions engage in the (B) octahedral site. Previous reports revealed that the valence band of the oxygen 2p orbital is separated from the empty iron 4s orbital by 4–6 eV.<a title="Select to navigate to references" href="#cit115"><sup><span class="sup_ref">115</span></sup></a> The crystal field bands of octahedral/tetrahedral sites having the metal 3d orbital lie between these bands. Experimental and theoretical studies show that the energy gap due to crystal field splitting into octahedral and tetrahedral sites is ∼2.2 eV and ∼0.9 eV. Alvarado <span class="italic">et al.</span> showed the one-electron energy level of Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> based on various terms such as the energy distribution curve, photoelectron spectroscopy, crystal field model and electron spin polarization to explain the photoelectronic excitation properties.<a title="Select to navigate to references" href="#cit116"><sup><span class="sup_ref">116</span></sup></a> Balberg <span class="italic">et al.</span> provided complete results by incorporating Alvadro's study of the Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> one-electron energy level.<a title="Select to navigate to references" href="#cit117"><sup><span class="sup_ref">117</span></sup></a> By assuming that FeO, Fe<small><sub>3</sub></small>O<small><sub>4</sub></small>, and γ-Fe<small><sub>2</sub></small>O<small><sub>3</sub></small> possess the same spectral properties, the reflection and absorption studies were carried out over 0.1–0.5 eV and 0.5–0.6 eV, respectively. These studies showed the appearance of an absorption edge at 2 eV which is attributed to the transition of the last occupied d band to a 4s band of iron. The energy level diagram of Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> octahedral sites is illustrated based on the results obtained from crystal field splitting (<span class="italic">Δ</span><small><sub>cf</sub></small> = 1.7 eV), Hund's rule exchange splitting (<span class="italic">Δ</span><small><sub>ex</sub></small> = 2.7 eV), cathodoluminescence,<a title="Select to navigate to references" href="#cit118"><sup><span class="sup_ref">118</span></sup></a> and soft X-ray studies, as shown in <a title="Select to navigate to figure" href="#imgfig5">Fig. 5</a>. Antonov <span class="italic">et al.</span> also investigated the Kerr effect and electronic properties of Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> using local spin density approximations (LSDAs)<a title="Select to navigate to references" href="#cit119"><sup><span class="sup_ref">119</span></sup></a> and the obtained results were consistent with the theoretical studies carried out using LSDA methods.</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig5"><a href="/image/article/2019/DT/c9dt00459a/c9dt00459a-f5_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9dt00459a-f5.tif" src="/image/article/2019/DT/c9dt00459a/c9dt00459a-f5.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 5 </b> <span id="fig5"><span class="graphic_title">A one-electron energy scheme of an octahedral site in Fe<small><sub>3</sub></small>O<small><sub>4</sub></small>. The interpretations of the various optical transitions are represented by the dashed arrows. Interpretations of other spectroscopic transitions are also indicated. Reproduced with permission from <a title="Select to navigate to references" href="#cit117">ref. 117</a>. Copyright 1978, Elsevier.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      
      
        
        <h3 id="sect709"><span class="b_heading">3.4 Electronic properties and charge carrier dynamics</span></h3>
        <span>Knowledge on the electronic band structures and charge carrier dynamics of iron oxide is critical in order to apply it in biomedical and magneto-optic device fields. Many researchers reported the band structure of iron oxide nanoparticles based on photoluminescence, photoelectrophoresis, <span class="italic">etc</span>.<a title="Select to navigate to references" href="#cit120"><sup><span class="sup_ref">120</span></sup></a> The charge carrier dynamics of these particles is studied using absorption, fluorescence, and photoluminescence methods.<a title="Select to navigate to references" href="#cit121"><sup><span class="sup_ref">121</span></sup></a> Photoluminescence is an important technique applied on bulk materials to study light emission characteristics but recent reports revealed that each nanoparticle system such as quantum dots, gold nanorods, silicon nanorods, and zinc nanorods is studied for its photoluminescence to exhibit its emission characteristics using the same method. The photoemission properties of these materials are exhibited between visible to infrared regions and their corresponding mechanisms fall from excitation of quantum dots to surface plasmons in nanoparticles. Sadat <span class="italic">et al.</span> subjected the broad-sized (10 nm–5 μm) Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> nanoparticles to this measurement. Three prominent peaks at 560, 695, and 840 nm were noted when irradiated under 407 nm laser light, as shown in <a title="Select to navigate to figure" href="#imgfig6">Fig. 6a</a>. Similar results were obtained from optical measurements when excited at 350 nm, as shown in <a title="Select to navigate to figure" href="#imgfig6">Fig. 6b</a>. The spatial arrangement of Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> in the polystyrene matrix and its appropriate electronic band structures obtained from photoluminescence measurements and the corresponding model are given in <a title="Select to navigate to figure" href="#imgfig6">Fig. 6c–d</a>. The peak around 565 nm was ascribed to the transition of radiation of moving electrons from t<small><sub>2g</sub></small> → e<small><sub>g</sub></small> with 2.2 eV on the octahedral site whereas the peak around 690 nm was responsible for the transition of the octahedral site to O(2p) or t<small><sub>2g</sub></small> → O(2p) of the tetrahedral site. The peak around 840 nm was attributed to the transition of trapped electrons on the tetrahedral site. Along with these changes, a blue shift was also noticed due to the confinement effect of Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> particles that are coated with polyacrylic acid (PAA) (10 nm diameter). Higher luminescence intensity can be noticed when the particles are embedded in a polystyrene matrix because of its emission. The conversion efficacy of the nanoparticles embedded in the polyacrylic matrix was better (76%) than that of the particles embedded in the polystyrene matrix (28%) after photothermal measurements at 785 nm.<a title="Select to navigate to references" href="#cit122"><sup><span class="sup_ref">122</span></sup></a></span>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig6"><a href="/image/article/2019/DT/c9dt00459a/c9dt00459a-f6_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9dt00459a-f6.tif" src="/image/article/2019/DT/c9dt00459a/c9dt00459a-f6.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 6 </b> <span id="fig6"><span class="graphic_title">(a) The PL spectra of different surface modified iron oxide nanoparticles. The spectra represented in (a) are the cumulative peak fit to the experimental PL data; the vertical dashed lines show the shift in the PL peak due to the quantum confinement effect; (b) fluorescence spectra of Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> nanoparticles as a function of emission wavelength; (c) schematic representation of spatially confined Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> nanoparticles embedded in a spherical polystyrene matrix, denoted as PS/Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> and Si/PS/Fe<small><sub>3</sub></small>O<small><sub>4</sub></small>. (d) Schematic energy bands of the Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> nanoparticle systems. Reproduced with permission from <a title="Select to navigate to references" href="#cit119">ref. 119</a>. Copyright 2014, AIP Publishing.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Boxall <span class="italic">et al.</span> revealed that colloidal Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> particles displayed well-defined moving out at 1.8, 2.2, and 3.1 eV that are in good agreement with the electronic band structure of Fe<small><sub>3</sub></small>O<small><sub>4</sub></small>. Based on these data, it was claimed that both Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> and γ-Fe<small><sub>2</sub></small>O<small><sub>3</sub></small> possess nearly identical electronic band structures.<a title="Select to navigate to references" href="#cit123"><sup><span class="sup_ref">123</span></sup></a> To carry out a charge carrier dynamics study of these particles, transient absorption studies were performed. Here, the particles were excited with picosecond (ps) or femtosecond (fs) laser pulses. The excited species was probed again using one more laser pulse which is detained with an excitation laser; Cherepy <span class="italic">et al.</span> reported the electronic dynamics in different sized Fe<small><sub>2</sub></small>O<small><sub>3</sub></small> such as γ-Fe<small><sub>2</sub></small>O<small><sub>3</sub></small> (1–2 nm), commercial γ-Fe<small><sub>2</sub></small>O<small><sub>3</sub></small> (50 nm), and spindle-shaped α-Fe<small><sub>2</sub></small>O<small><sub>3</sub></small> (1 × 5 nm). The decay profiles were not dependent on the pH, power, and wavelength of the probe. The optical properties of these particles demonstrated great features identical to their electronic structure. The weak emission from these particles indicates the non-radiative decay process. The exhibited photothermal effect due to the non-radiative process can have great applications in cancer therapy.<a title="Select to navigate to references" href="#cit121"><sup><span class="sup_ref">121</span></sup></a></p>
      
      
        
        <h3 id="sect764"><span class="b_heading">3.5 Superparamagnetic feature</span></h3>
        <span>Superparamagnetism is considered as an essential property of IONPs since it allows their detection by diagnostic methods.<a title="Select to navigate to references" href="#cit124"><sup><span class="sup_ref">124</span></sup></a> The particles are said to be paramagnetic when the particle size is small enough; they should have any quantifiable dipole moment in the absence of an applied magnetic field.<a title="Select to navigate to references" href="#cit125"><sup><span class="sup_ref">125</span></sup></a> The nanoparticle suspension possesses greater magnetic susceptibility when compared to the paramagnetic materials. It can be highly magnetized only in the presence of an applied magnetic field.<a title="Select to navigate to references" href="#cit126"><sup><span class="sup_ref">126</span></sup></a> The superparamagnetic property is not only dependent on the core size but also on surface modifications. The surface coating is particularly important since it can reduce magnetic dipole–dipole interactions.<a title="Select to navigate to references" href="#cit127"><sup><span class="sup_ref">127</span></sup></a> The pictorial representation of multilayered SPIONs containing a nanoparticle core, coatings, and targeting moieties is shown in <a title="Select to navigate to figure" href="#imgfig7">Fig. 7</a>.</span>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig7"><a href="/image/article/2019/DT/c9dt00459a/c9dt00459a-f7_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9dt00459a-f7.tif" src="/image/article/2019/DT/c9dt00459a/c9dt00459a-f7.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 7 </b> <span id="fig7"><span class="graphic_title">Pictorial representation of multilayered SPIONs containing a nanoparticle core, coatings and targeting moieties.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">The probes used in molecular imaging typically consist of nanoparticles functionalized with some targeting moieties. Some elements show a strong magnetic effect and some elements exhibit weak magnetic behavior. Bulk or macroscale materials possess multiple domains and exhibit strong ferromagnetic properties. Such materials tend to possess only one domain when the size is reduced below 20 nm. Depending on the presence or absence of electromagnetic forces, the paramagnetic or ferromagnetic properties can be displayed in that particular state.<a title="Select to navigate to references" href="#cit128"><sup><span class="sup_ref">128</span></sup></a> This kind of phenomenon is termed superparamagnetism and can be observed in particles smaller than a certain size. When the magnetic field is removed, the loop cannot be seen and probably the paramagnetic behavior cannot be observed.<a title="Select to navigate to references" href="#cit129"><sup><span class="sup_ref">129</span></sup></a> Another characteristic feature to be mentioned is Neel relaxation formed as a result of energy absorption. When SPIONs are treated under alternating magnetic fields, their corresponding dipole moments can be rapidly rearranged based on factors including the particle size, magnetic field strength, frequency, and temperature. The energy can be dissipating in heat and further increase the temperature in the environment. This methodology is utilized in the treatment of magnetic hyperthermia to eradicate cancer cells.<a title="Select to navigate to references" href="#cit130"><sup><span class="sup_ref">130</span></sup></a></p>
      
      
        
        <h3 id="sect779"><span class="b_heading">3.6 Design considerations</span></h3>
        <span>The therapeutic design of the nanocore can help in the recognition of certain agents. This approach generates end products that fulfill the requirements for <span class="italic">in vivo</span> monitoring, targeting, and therapy. Therapeutic agents are usually chosen for biocompatibility while performing their functions. The process is complex since these agents are well-connected with biological units and there are some limitations in understanding the interactions. The integrity should be regulated for the assembly of these materials during their mobility inside the human bodies until they reach the tumor site. The binding of these agents is considered a complex process.<a title="Select to navigate to references" href="#cit131"><sup><span class="sup_ref">131</span></sup></a></span>
      
      
        
        <h3 id="sect785"><span class="b_heading">3.7 Superparamagnetic core</span></h3>
        <span>The conversion of particles from the macro to nanoscale can bring out distinct physical properties. The iron oxide is termed superparamagnetic when the particle is composed of a single magnetic domain. In addition, thermal energy must be stronger to handle the energy barrier below 20 nm. In MR imaging, SPIONs in the human body make that particular region darker. This approach is used to calculate the amount of SPION uptake to determine the efficacy of targeting.<a title="Select to navigate to references" href="#cit132"><sup><span class="sup_ref">132</span></sup></a> Hyperthermia also can be performed with the availability of an alternating magnetic field and SPIONs.<a title="Select to navigate to references" href="#cit133"><sup><span class="sup_ref">133</span></sup></a> Among these, manganese doped SPIONs exhibited a higher efficiency. Therefore, magnetic properties can be fine-tuned upon controlling the dopant types and dose of the SPION. The size and shape also affect magnetic properties. An improved MR imaging contrast effect and hyperthermia effect can be achieved by increasing the SPION aspect ratio and coercivity. In addition, small-sized SPIONs generally have a high surface area and this helps to generate smaller mass magnetizations when compared with larger SPIONs due to their major help with the non-magnetic layer available on the particle surface. Therefore, it is concluded that larger SPIONs have good magnetic properties but no other properties due to their size.</span>
      
      
        
        <h3 id="sect791"><span class="b_heading">3.8 Attractive SPION features</span></h3>
        <span>Stable, biocompatible, and non-toxic nanoparticles may be efficient tools in biological applications. The SPIONs possess the following features when designed as part or whole in cancer therapeutics:</span>
        <p class="otherpara">• Small size and high magnetization</p>
        <p class="otherpara">• Improved contrast enhancement for tracking and imaging</p>
        <p class="otherpara">• Surface coating using biodegradable compounds to avoid agglomeration</p>
        <p class="otherpara">• Conjugation with a wide range of targeting moieties</p>
        <p class="otherpara">• Targeting and site-specific drug delivery</p>
        <p class="otherpara">• A requirement of standard and optimized zeta potential values</p>
        <p class="otherpara">• Improved half-life</p>
        <p class="otherpara">• Need greater influence with heat, pH, and magnetic field.</p>
      
      
        
        <h3 id="sect803"><span class="b_heading">3.9 Tailor-made SPIONs with targeting moieties</span></h3>
        <span>SPION-based systems typically contain a surface coated inorganic core to obtain stability, biocompatibility, and solubility in aqueous solution. Tuning the size and surface characteristics can alter the circulation time and biodistribution of nanoparticles. Generally, solid tumors have a poor developed lymphatic drainage system and damaged vasculatures. Nanoparticles usually occupy these systems to a higher extent in a process known as passive targeting, due to enhanced permeability and retention (EPR) of the tumors.<a title="Select to navigate to references" href="#cit134"><sup><span class="sup_ref">134</span></sup></a> Some reports indicated that such a targeting approach is particularly effective when dextran-coated SPIONs were applied on gliosarcoma and the efficiency was 10-fold higher than that of the normal brain tissue animal model.<a title="Select to navigate to references" href="#cit135"><sup><span class="sup_ref">135</span></sup></a> The first generation SPIONs applied in this technique showed poor specificity and hence in the second generation SPIONs, surface modifications using several targeting agents including small ligands, monoclonal antibodies, and aptamers enabled recognition of the corresponding receptors. This active targeting<a title="Select to navigate to references" href="#cit136"><sup><span class="sup_ref">136</span></sup></a> is applied to increase its specificity to accumulate abundant nanoparticles in the target area. Active targeting of nanoparticles reduces off-target and harmful side effects. An alternative targeting methodology called magnetic targeting makes use of inherent magnetic properties that are found in magnetic particles including SPIONs. Here, magnetic field is applied externally to a specific site to promote accumulation of the magnetic particles. The SPION targeting mechanisms are clearly explained in the review article.</span>
      
    
    
      
      <h2 id="sect810"><span class="a_heading">4 SPIONs in targeting, drug delivery, and cancer therapeutics</span></h2>
      
        
        <h3 id="sect813"><span class="b_heading">4.1 Targeting and mechanisms</span></h3>
        <span>The interactions between magnetic nanoparticles, magnetic forces, and other forces have a great impact on targeting efficacy. Therefore, it is of particular importance to discuss those effects. SPIONs can be used for tumor targeting through different mechanisms including active targeting, antibody-based targeting, nucleic acid-based targeting, aptamer-based targeting, passive targeting, and magnetic targeting upon using an applied magnetic field.<a title="Select to navigate to references" href="#cit137"><sup><span class="sup_ref">137</span></sup></a> In the passive targeting approach, nano-based drug assembly easily enters the tumors using tumor vasculatures due to its small size and ability to attain longer retention time and enhanced cell permeability.<a title="Select to navigate to references" href="#cit138"><sup><span class="sup_ref">138</span></sup></a> This feature suffers from drawbacks of selectivity that may cause nonspecific SPION distribution. To avoid this issue, SPION targeting is improved by inserting unique targeting molecules on their surfaces. The antibodies, peptides, and vitamins are most commonly used targeting agents for this purpose. Kumar <span class="italic">et al.</span> prepared folic acid-conjugated SPIONs which bind effectively to folate receptors and showed an enhanced effect in imaging application compared to that of free SPIONs. Wang <span class="italic">et al.</span> developed a SPION cluster which contains folic acid and Pluronic F127 for combined applications such as targeting, diagnosis, and therapy. Lee <span class="italic">et al.</span> reported Mtb antibody conjugated SPIONs for biomarker imaging involved in extra pulmonary Mtb infection.<a title="Select to navigate to reference" href="#cit139"><sup><span class="sup_ref">139–141</span></sup></a></span>
        <p class="otherpara">He <span class="italic">et al.</span> demonstrated that anti-chemokine 4 receptor (CXCR4) antibody bound SPIONs bind pancreatic tumor cells expressing CXCR4 receptors.<a title="Select to navigate to references" href="#cit142"><sup><span class="sup_ref">142</span></sup></a> Meng <span class="italic">et al.</span> described luteinizing hormone releasing hormone combined with SPIONs for targeting breast cancer cells.<a title="Select to navigate to references" href="#cit143"><sup><span class="sup_ref">143</span></sup></a> These reports clearly conveyed the use of active targeting towards cancer treatment and its sensitivity and selectivity. When compared with the traditional techniques, active targeting has improved internalization ability for SPIONs and a minimized dosage level of drugs is needed for cancer treatment. Another popular technique is magnetic targeting in the presence of external magnets.<a title="Select to navigate to references" href="#cit144"><sup><span class="sup_ref">144</span></sup></a> Neodymium–iron–boron magnets are used to produce highly magnetized SPIONs in the tumor sites. One of the studies revealed that DNA conjugated SPIONs and coated with chitosan express an enhanced green fluorescent protein. When an external magnetic field with 25 gausses was applied for 6 h, effective targeting towards heart and kidneys was noted.<a title="Select to navigate to references" href="#cit40"><sup><span class="sup_ref">40</span></sup></a> A scheme for different targeting mechanisms is given in <a title="Select to navigate to figure" href="#imgfig8">Fig. 8</a>.</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig8"><a href="/image/article/2019/DT/c9dt00459a/c9dt00459a-f8_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9dt00459a-f8.tif" src="/image/article/2019/DT/c9dt00459a/c9dt00459a-f8.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 8 </b> <span id="fig8"><span class="graphic_title">Scheme for different targeting mechanisms.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <div>
          
          <span id="sect833"/><span class="c_heading_indent">4.1.1 Active targeting. </span>
          <span>Active targeting of magnetic drugs through functional moieties such as antibodies and peptides is a promising approach for tumor targeting. Magnetic drugs make use of SPIONs with some active molecules.<a title="Select to navigate to references" href="#cit145"><sup><span class="sup_ref">145</span></sup></a> Magnetic drug targeting operates under an external magnetic field to apply on the tumor surface which maintains magnetic nanoparticles conjugated with active molecules into the target site. Consistent results were obtained from clinical trials and animal experimental studies.<a title="Select to navigate to references" href="#cit146"><sup><span class="sup_ref">146</span></sup></a> The delivery of the magnetic targeting is improved by using the external magnetic force. For example, magnetic aerosol helped in the treatments of lung cancer, respiratory infections, chronic pulmonary disease, and cystic fibrosis.<a title="Select to navigate to references" href="#cit147"><sup><span class="sup_ref">147</span></sup></a></span>
        </div>
        <div>
          
          <span id="sect840"/><span class="c_heading_indent">4.1.2 Antibody-based targeting. </span>
          <span>Antibody-based targeting is an effective method to improve the sensitivity and selectivity of SPIOs. This approach integrates targeting agents into SPIONs for efficient delivery to tumor sites rather than depending on an EPR effect to enhance the SPION accumulation in the tumor tissues. Different targeting agents including aptamers, nucleic acids, antibodies, and small molecules are used for this purpose. Antibodies possess greater binding affinity and selectivity for antigen detection. For instance, Chen <span class="italic">et al.</span> evaluated Herceptin (Her)-immobilized SPIONs toward breast cancer cells to diagnose Her/neu receptors in cancer for about 15–25% patients.<a title="Select to navigate to references" href="#cit148"><sup><span class="sup_ref">148</span></sup></a> Different antigens (prostate specific membrane (PSMA) and carcinoembryonic antigen (CEA)) were also detected using the corresponding antibodies.<a title="Select to navigate to references" href="#cit149"><sup><span class="sup_ref">149</span></sup></a> Although antibody showed promising results as a targeting agent, it has disadvantages. First is the immune response generated by immunogenicity of the antibody since the antibody used is derived from the nonhuman source. The use of humanized antibody shows reduced immunogenicity but still produces immune reactions.<a title="Select to navigate to references" href="#cit150"><sup><span class="sup_ref">150</span></sup></a> Second is the use of high molecular weight antibodies which retards the penetration of the antibody-coupled SPIONs into tumors.<a title="Select to navigate to references" href="#cit151"><sup><span class="sup_ref">151</span></sup></a> To overcome this issue, antibody fragments (Fab’ or single chain variable fragments), owing to their low molecular weight, may be used. For example, Natarajan <span class="italic">et al.</span> reported an anti-Muc-1 antibody fragment-conjugated SPION targeted Muc-1 protein that is overexpressed in human epithelial cancer cells.<a title="Select to navigate to references" href="#cit152"><sup><span class="sup_ref">152</span></sup></a></span>
        </div>
        <div>
          
          <span id="sect851"/><span class="c_heading_indent">4.1.3 Nucleotide-based targeting. </span>
          <span>Some of the short nucleotides, aptamers have a tendency to bind with various target molecules including antigens, nucleic acids, and small ligands. The size, low resistance, ease of production, and high specificity make aptamers an ideal candidate for targeting. For example, Wang <span class="italic">et al.</span> produced an aptamer-based targeting moiety, A10RNA aptamers that can specifically identify the extracellular PSMA domains.<a title="Select to navigate to references" href="#cit153"><sup><span class="sup_ref">153</span></sup></a> PSMA is generally expressed in prostate cancer cells, and the SPION-aptamers can selectively recognize PSMA-expressing androgen-sensitive human prostate adenocarcinoma cells (LNCaP) compared to the PC3 cancer cells that do not express PSMA. The uptake efficiency of MR imaging result studies clearly indicated the specificity of SPION-aptamers towards PSMA-expressing LNCaP prostate cells.</span>
        </div>
        <div>
          
          <span id="sect857"/><span class="c_heading_indent">4.1.4. Receptor ligand-based targeting. </span>
          <span>Different receptors including the epidermal growth factor receptor (EGFR), vascular endothelial growth factor receptor (VEGFR), and folate receptors are commonly expressed on the cancer cell surface. This specific characteristic makes their ligand a potential targeting agent.<a title="Select to navigate to references" href="#cit154"><sup><span class="sup_ref">154</span></sup></a> Landmark <span class="italic">et al.</span> prepared folic acid-conjugated SPIONs and applied them toward folate expressing KB tumor cells (an oral epidermoid carcinoma cell line) to monitor their uptake efficiency and binding affinity.<a title="Select to navigate to references" href="#cit155"><sup><span class="sup_ref">155</span></sup></a> Li <span class="italic">et al.</span> utilized SPION-conjugated octreotide (OCT) and somatostatin (SST) analogs and detected the corresponding receptors which are overexpressed in breast cancer cells.<a title="Select to navigate to references" href="#cit156"><sup><span class="sup_ref">156</span></sup></a> The delivery of the SPION-conjugated urokinase plasminogen activator (uPAR) to pancreatic tumor tissues was also carried out because its corresponding receptor uPAR is highly expressed in a majority (86%) of pancreatic cancer tissues. SPION-conjugated transferrin has also been used to deliver SPIONs to tumor sites through transferring receptor pathways.<a title="Select to navigate to references" href="#cit157"><sup><span class="sup_ref">157</span></sup></a></span>
        </div>
        <div>
          
          <span id="sect867"/><span class="c_heading_indent">4.1.5. Peptide-based targeting. </span>
          <span>The small size, minimized immunogenicity, and ease of production make the peptides attracting targeting agents.<a title="Select to navigate to references" href="#cit158"><sup><span class="sup_ref">158</span></sup></a> Currently, peptide-conjugated SPIONs are fabricated for targeted cancer diagnoses and treatments. Peptide-based targeting agents can be recognized by different methods. Generally, they are obtained from the specific binding site of a desired protein. The peptide-targeting moieties can be identified by the phage display methodology. A cyclic peptide called cilengitide having integrin binding is in clinical practice for pancreatic/non-small lung cancer.<a title="Select to navigate to references" href="#cit159"><sup><span class="sup_ref">159</span></sup></a> Medarova <span class="italic">et al.</span> reported a breast tumor targeted drug to particularly direct siRNA to breast cancer while subsequently permitting non-invasive siRNA delivery.<a title="Select to navigate to references" href="#cit160"><sup><span class="sup_ref">160</span></sup></a> The drug used is a nanodrug which contains SPIONs for diagnosing, cyanine 5.5 (Cy5.5) dye for optical imaging and siRNA for knocking down BIRC5 antiapoptotic gene. It is known that underglycosylated mucin-1 (uMuc-1) is abundantly expressed by breast cancer cells. Researchers designed a nano-drug conjugated with uMuc-1 targeting peptides (EPPT). Dextran-coated SPIONs were prepared and Cy5.5 dye is incorporated on the nanoparticle surface to produce SPION-Cy5.5. Similarly, fluorescein isothiocyanate (FITC) labeled siRNA and EPPT peptides are conjugated with SPION-Cy5.5 and the final composition exhibits diagnostic and therapeutic properties. Zhang <span class="italic">et al.</span> reported a brain tumor targeting probe based on chlorotoxin (CTX) that can selectively accumulate on brain tumors across the blood–brain barrier.<a title="Select to navigate to references" href="#cit161"><sup><span class="sup_ref">161</span></sup></a> CTX is a peptide composed of 36 amino acids which acts as a targeting agent owing to its permeability across the blood–brain barrier.<a title="Select to navigate to references" href="#cit162"><sup><span class="sup_ref">162</span></sup></a> Cheresh <span class="italic">et al.</span> utilized an arginine–glycine–aspartic acid (RGD) sequence peptide as a targeting agent towards integrin α<small><sub>v</sub></small>β<small><sub>3</sub></small> to design a liposomal Dox for metastatic disease treatments.<a title="Select to navigate to references" href="#cit163"><sup><span class="sup_ref">163</span></sup></a> Lee <span class="italic">et al.</span> also developed a similar drug with a lung tumor-targeted peptide.<a title="Select to navigate to references" href="#cit164"><sup><span class="sup_ref">164</span></sup></a></span>
        </div>
        <div>
          
          <span id="sect884"/><span class="c_heading_indent">4.1.6 Aptamer-based targeting. </span>
          <span>In 2004, the FDA approved Pegaptanib, a VEGF<small><sub>165</sub></small> targeted aptamer for neovascular treatment. Another nucleolin aptamer, AS1411, is under a phase II clinical trial.<a title="Select to navigate to references" href="#cit165"><sup><span class="sup_ref">165</span></sup></a> However, aptamers have drawbacks such as degradation by nucleases, and rapid blood clearance. To overcome such properties, pyrimidine and chemical modifications have been carried out with PEG to improve their pharmacokinetic properties.<a title="Select to navigate to references" href="#cit166"><sup><span class="sup_ref">166</span></sup></a> Jon <span class="italic">et al.</span> reported a CG-rich duplex made of iron oxide nanoparticle conjugated PSMA aptamers as a prostate cancer-specific theranostic agent.<a title="Select to navigate to references" href="#cit167"><sup><span class="sup_ref">167</span></sup></a></span>
        </div>
        <div>
          
          <span id="sect893"/><span class="c_heading_indent">4.1.7 Small molecule-based targeting. </span>
          <span>Folic acid is a commonly studied small molecule as a targeting agent. Fast cell division and growth during embryonic development are regulated by folates, a water-soluble vitamin.<a title="Select to navigate to references" href="#cit168"><sup><span class="sup_ref">168</span></sup></a> Some of the currently available folate agents in the clinical trials are the <small><sup>99m</sup></small>Tc-folate conjugate (E20), diacetylvinylblastine hydrazide folate (EC154), and folate-linked fluorescent hepten (EC17). These agents can be coupled with an inorganic core or targeting agents to perform targeted drug delivery. Carbohydrate is another class of small molecule targeting agents. It can specifically bind with lectins.<a title="Select to navigate to references" href="#cit169"><sup><span class="sup_ref">169</span></sup></a> The asislo glycoprotein (ASGP) is found on hepatocytes and has the ability to readily bind with carbohydrates coupled on targeting agents.<a title="Select to navigate to reference" href="#cit170"><sup><span class="sup_ref">170,171</span></sup></a> Riboflavin vitamin is abundant in metabolically active cells and an endogenous riboflavin carrier protein (RCP) ligand, and flavin mononucleotide (FMN) can serve a target agent towards these active cells.<a title="Select to navigate to references" href="#cit172"><sup><span class="sup_ref">172</span></sup></a></span>
        </div>
        <div>
          
          <span id="sect902"/><span class="c_heading_indent">4.1.8 Passive targeting. </span>
          <span>Passive targeting is considered as an essential approach since diagnosis could be improved by accumulating the magnetic nanoparticles in tumor regions. The abnormal vessels are produced by cancer-induced angiogenesis and the nanoparticles can target this specific site.<a title="Select to navigate to references" href="#cit173"><sup><span class="sup_ref">173</span></sup></a> The particle size, hydrophobicity, and surface charge of nanoparticles play a vital role in passive targeting.<a title="Select to navigate to references" href="#cit145"><sup><span class="sup_ref">145</span></sup></a> The nanoparticles with small sizes (&lt;20 nm) are excreted by kidneys whereas particles over 30–150 nm or large are found to be accumulated in the heart, stomach, bone marrow, liver and spleen. Furthermore, suitably sized particles show an improved permeability and retention effect. Defects in lymphatic and vasculature systems in tumors can increase the particle pore size and result in the retention effect. The end result is that the small particles can penetrate easily into the tumors whereas the large-sized particles have a great difficulty with permeability. Based on these factors, it is believed that nanoparticles ranging from 10–100 nm in size can favorably accumulate in the tumor sites. The positively charged particles with hydrophobic nature result in short circulation time owing to the opsonisation whereas negatively charged particles with a hydrophilic character have a longer circulation time.<a title="Select to navigate to references" href="#cit174"><sup><span class="sup_ref">174</span></sup></a> Even though leaky vasculature is advantageous for tumor targeting, the passive targeting does not accumulate sufficient nanoparticles in the tumor site for diagnosis and treatment.</span>
        </div>
      
      
        
        <h3 id="sect909"><span class="b_heading">4.2 The biomedical applications of SPIONs in drug delivery</span></h3>
        <div>
          
          <span id="sect912"/><span class="c_heading_indent">4.2.1 Effect of theranostic medicines on cancer treatments. </span>
          <span>The field of nanomedicine utilizes nanotechnology in various applications such as diagnosis, targeting and treatment. Theranostic nanomedicine based on nanoparticles is capable of performing multiple functions at the same time. The aim of the production of nanomedicine is not only limited to improving detection ability but also to increasing the efficacy of cancer treatment. Hence, it is important to target and deliver the drugs to a specific location. The main use of this medicine in cancer treatment is to decide whether to follow the next stage of treatment or to continue the same therapy.<a title="Select to navigate to references" href="#cit175"><sup><span class="sup_ref">175</span></sup></a> Magnetic nanoparticles are increasingly applied in cancer treatment and seem to possess important features required for cancer therapy including their paramagnetic properties, active targeting ability, and ability to generate heat.<a title="Select to navigate to reference" href="#cit176"><sup><span class="sup_ref">176,177</span></sup></a> In general, combined regimens are required for cancer treatment such as chemotherapy, surgery, thermal therapy, radiotherapy or magnetic nanoparticles with different anticancer agents or synthetic compounds that can provide a nanomaterial-based agent for combined treatments against different cancer.<a title="Select to navigate to references" href="#cit178"><sup><span class="sup_ref">178</span></sup></a></span>
        </div>
        <div>
          
          <span id="sect919"/><span class="c_heading_indent">4.2.2 SPIONs in site-specific drug delivery. </span>
          <span>The term drug delivery refers to any pharmaceutical drug that is encapsulated within, or integrated with, or attached onto the core, inorganic particles or an organic polymer. The use of these agents helps to increase drug safety, and potential and new targeted therapies are possible.<a title="Select to navigate to references" href="#cit179"><sup><span class="sup_ref">179</span></sup></a> The SPIONs may be used for diagnosis and therapeutic applications simultaneously. They are a multifunctional carrier used to improve the specific targeting and potential delivery of upcoming therapeutics such as nucleotides, proteins, and chemical drugs.<a title="Select to navigate to references" href="#cit180"><sup><span class="sup_ref">180</span></sup></a></span>
          <p class="otherpara">Dumitrescu <span class="italic">et al.</span> prepared nickel ferrite for drug delivery by incorporating nickel ferrite into the matrix made of a polyacrylamide-based hydrogel.<a title="Select to navigate to references" href="#cit181"><sup><span class="sup_ref">181</span></sup></a> Nacev <span class="italic">et al.</span> studied the properties of magnetic nanoparticles in blood vessels and surrounding tissues. The samples displayed high antimicrobial activity with high purity. Many factors, such as diffusion, extravasation, and external magnetic field, can alter the SPION properties.<a title="Select to navigate to references" href="#cit182"><sup><span class="sup_ref">182</span></sup></a> The magnetic and luminescent up conversion abilities of nanoribbons are also used for targeting drug delivery. Some nanocarriers possessing magnetic silicon dioxide may be used for drug delivery and targeting.<a title="Select to navigate to references" href="#cit183"><sup><span class="sup_ref">183</span></sup></a> A controlled drug release was observed using these nanocarriers, as shown in <a title="Select to navigate to figure" href="#imgfig9">Fig. 9</a>. Furthermore, stimuli-responsive agents were also prepared. The change in the morphology and aggregation properties of these agents can vary under different physical conditions in order to regulate controlled drug release.<a title="Select to navigate to references" href="#cit184"><sup><span class="sup_ref">184</span></sup></a></p>
          <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig9"><a href="/image/article/2019/DT/c9dt00459a/c9dt00459a-f9_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9dt00459a-f9.tif" src="/image/article/2019/DT/c9dt00459a/c9dt00459a-f9.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 9 </b> <span id="fig9"><span class="graphic_title">SPION based drug delivery system.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
          <p class="otherpara">The SPION systems for site-specific targeting and drug delivery have been tested for various cancer treatments and some have reached the clinical use.<a title="Select to navigate to reference" href="#cit185"><sup><span class="sup_ref">185,186</span></sup></a> Chemotherapy is the long lasting technique ever used for cancer treatment but the traditional methods depend on the circulatory unit for drug delivery into tumor cells thereby lacking specificity. This regimen demands a higher quantity of drugs to enhance toxicity against tumors and, however, can damage normal tissues. This dilemma may be solved by targeted drug delivery which focuses on specific sites and has gained great attention as a replacing methodology to chemotherapy.<a title="Select to navigate to references" href="#cit187"><sup><span class="sup_ref">187</span></sup></a> SPION-based drug delivery is more favorable over the other methods and utilizes diverse methods such as ultrasound, applied magnetic field, <span class="italic">etc</span>. Magnetic targeted drug delivery (MTD) makes use of altered SPIONs to attach with drugs. The nanodrug is then directed towards tumor sites upon introducing magnetic field. Furthermore, it can help to enhance the accumulation of nano-drugs at the target area and perform cancer treatment. Many factors play crucial roles in MTD.<a title="Select to navigate to references" href="#cit188"><sup><span class="sup_ref">188</span></sup></a> Karamipour <span class="italic">et al.</span> designed SPIONs conjugated with folic acid [Fe<small><sub>3</sub></small>O<small><sub>4</sub></small>/Au/Cys-Folate] to target folate receptors overexpressed on cancer for a site-specific drug delivery.<a title="Select to navigate to references" href="#cit189"><sup><span class="sup_ref">189</span></sup></a> Elbialy <span class="italic">et al.</span> demonstrated Fe<small><sub>3</sub></small>O<small><sub>4</sub></small>/Au Css [Fe<small><sub>3</sub></small>O<small><sub>4</sub></small>/Au-PEG-Dox] as a Dox carrier in MTD therapy at various pH levels.<a title="Select to navigate to references" href="#cit190"><sup><span class="sup_ref">190</span></sup></a> The dose of 100 μg Dox per mg is the maximum loading capacity of Css. Drug delivery was tested at different pH levels but best efficiency was found at pH 5.5. <span class="italic">In vitro</span> results on MCF-7 cells showed more therapeutic potential with nontoxic effects when compared to free Dox coupled Css. Similarly, Ramos-Tejada <span class="italic">et al.</span><a title="Select to navigate to references" href="#cit189"><sup><span class="sup_ref">189</span></sup></a> investigated Dox and Bevacizumab (BEV) antibody functionalized Fe<small><sub>3</sub></small>O<small><sub>4</sub></small>/Au Css and found an enhanced therapeutic effect using Dox.<a title="Select to navigate to references" href="#cit191"><sup><span class="sup_ref">191</span></sup></a></p>
          <p class="otherpara">The main disadvantages of chemotherapy are its non-specificity that kills both the affected and normal cells. SPIONs can be used to rectify this issue by site-specific delivery of drugs to chosen regions, unloading the drugs at the tumor site using an external magnetic field. Site-specific, controlled, drug delivery requires maintenance of a right amount of dosage at that site, removing over dosage and dipping side effects. The targeting agent can be combined either on the SPION surface or can be immobilized within the nanocomposites. This methodology protects the drug until it reaches the specific site. The active release of drugs in SPION-based drug delivery is also carried out under various conditions such as pH, heat, or degradation of targeting agents. Zhang <span class="italic">et al.</span> reported the reduced magnetic field on drug delivery rates owing to its accumulation.<a title="Select to navigate to references" href="#cit192"><sup><span class="sup_ref">192</span></sup></a> Yu <span class="italic">et al.</span> designed SiO<small><sub>2</sub></small> based magnetic nanoparticles and revealed that particles were found to be pH and magnetic field sensors.<a title="Select to navigate to references" href="#cit193"><sup><span class="sup_ref">193</span></sup></a> Shakeri-Zadeh <span class="italic">et al.</span> developed 5-fluorouracil conjugated poly(lactic-<span class="italic">co</span>-glycolic acid) (PLGA) magnetic capsules for magnetic targeting to CT26 colon tumors.<a title="Select to navigate to references" href="#cit194"><sup><span class="sup_ref">194</span></sup></a> Liposome loaded magnetic particles can permit magnetic targeting; thus, the lipid vesicles can behave more like artificial cells. The major use is their ability to combine with cellular membranes that permit drug delivery to different cells.<a title="Select to navigate to references" href="#cit195"><sup><span class="sup_ref">195</span></sup></a> In various cancer treatments, multidrug resistance is a major obstacle which results from the overexpression of adenosine triphosphate (ATP) binding cassette (ABC)-type receptors on the cell surface that pumps out various hydrophobic chemotherapeutic drugs out of cancer cells.<a title="Select to navigate to references" href="#cit196"><sup><span class="sup_ref">196</span></sup></a> Kievit <span class="italic">et al.</span> helped out to overcome this issue by examining free Dox and SPION conjugated Dox by using Dox-resistant C6 and wild C6 cells and comparison with free drug groups.<a title="Select to navigate to references" href="#cit197"><sup><span class="sup_ref">197</span></sup></a> The results revealed that Dox conjugated SPIONs improved difficulties that stemmed from MDR.</p>
        </div>
      
      
        
        <h3 id="sect969"><span class="b_heading">4.3 SPIONs in therapies</span></h3>
        <div>
          
          <span id="sect972"/><span class="c_heading_indent">4.3.1 Chemotherapy. </span>
          <span>Many chemotherapeutic drugs inhibit DNA replication and they need to access the nucleus to carry out this inhibition. Other drugs affect activities of the mitochondria and cell motility, among others. Drug delivery at the tumor site potentially improves the therapeutic efficiency. The usage of the limited dose is the main disadvantages of chemotherapy and the cancer cells acquire drug resistance on using these drugs. The multimodal nanoparticles provide better drug biodistribution and permit administration of high drug doses.<a title="Select to navigate to references" href="#cit198"><sup><span class="sup_ref">198</span></sup></a> To improve the therapy outcome, therapeutic systems are developed by combining the diagnostic probe, targeting moieties, and therapeutic drugs. Among the available nanodrug systems, a unique core–shell structure is created by self-assembled nanoparticles or polymeric micelles. The hydrophilic and hydrophobic cores serve as a particle stabilization agent and a carrier agent for hydrophobic drugs, respectively.<a title="Select to navigate to references" href="#cit199"><sup><span class="sup_ref">199</span></sup></a></span>
          <p class="otherpara">The stability of hydrophobic drugs can be increased by loading to SPIONs. For example, Jian <span class="italic">et al.</span> used poly(ethylene oxide) (PEO) and poly(propylene oxide) (PPO) diblock copolymer, pluronic F127 to attach on oleic acid-coated SPIONs.<a title="Select to navigate to references" href="#cit132"><sup><span class="sup_ref">132</span></sup></a> The SPION uptake was also monitored using MR imaging. Drugs can be directly conjugated with SPIONs to offer better control over the drug loading and release but the presence of fewer functional moieties on the SPION surface results in low drug loading capacity. A docking molecule is employed to improve drug loading efficacy by binding with a large capacity of drugs before being coupled with SPIONs. One commonly chosen docking molecule is PEI which helps to attach Dox with SPIONs which has a capacity to occupy over 1000 Dox. Dox combined SPIONs in this method showed high drug accumulation on tumor sites and overcame multidrug resistance in glioblastoma.</p>
        </div>
        <div>
          
          <span id="sect981"/><span class="c_heading_indent">4.3.2 Protein therapy. </span>
          <span>The aim of this approach is to send protein drugs into the cancer cells as a therapy. This approach is considered safe and direct in cancer treatment. In protein therapy, blocking of receptors or intracellular protein delivery involved in carcinogenesis or cell signaling to either induce apoptosis or slow cell growth is conducted. However, protein delivery is also challenging since proteins used in therapy undergo protease degradation before reaching the tumor site. SPIONs play a major role in protecting these proteins and enhance the protein delivery by acting as a intracellular access vehicle. In addition, this kind of therapy can be improved <span class="italic">via</span> the multivalent effect by arranging more proteins on the particle surface and the effect is stronger than using a single moiety on the nanoparticle surface. For example, CTX-coated SPIONs exhibited a greater inhibition for glioblastoma compared to free CTX.<a title="Select to navigate to references" href="#cit200"><sup><span class="sup_ref">200</span></sup></a> By using EGFRvariant III (EGFRvIII) antibody bound SPIONs, the inhibition of cancer was achieved.<a title="Select to navigate to references" href="#cit201"><sup><span class="sup_ref">201</span></sup></a> These SPIONs can enhance delivery to specifically inhibit EGFRvIII to induce apoptosis, thereby increasing the survival time. Cytochrome c can induce apoptosis only after internalization, but a poor uptake by cells. When cytochrome c is loaded into nanoparticles, it can induce apoptosis in breast cancer cells by increasing its cytoplasmic concentration.</span>
        </div>
        <div>
          
          <span id="sect988"/><span class="c_heading_indent">4.3.3 Gene therapy. </span>
          <span>This is a novel treatment which involves the transfer of DNA or RNA into a targeted cell.<a title="Select to navigate to references" href="#cit202"><sup><span class="sup_ref">202</span></sup></a> Finding a potential transfection method is a main goal owing to rapid enzymatic degradation of RNA/DNA and poor permeability across cell membranes. Magnetofection is a commonly used method for non-viral transfection. Nucleic acid-bound nanoparticles can target cells when applying a magnetic field.<a title="Select to navigate to references" href="#cit203"><sup><span class="sup_ref">203</span></sup></a> Most of the gene delivery systems make use of the positively charged, functionalized polymers and the proton sponge effect to release iron oxide-polymer-nucleic acid from lysosomes to the cytoplasm.</span>
          <p class="otherpara">Designing a nanoscale delivery system possessing iron oxide nanoparticles with various dendrimer polymers could overcome the issues related to this method such as diffusion across the cell membrane and enzymatic degradation. For example, Pan <span class="italic">et al.</span> synthesized polyamidoamine (PAMAM)-coated SPIONs and attained efficient gene therapy.<a title="Select to navigate to references" href="#cit204"><sup><span class="sup_ref">204</span></sup></a> Prijic <span class="italic">et al.</span> fabricated PAA and PEI-functionalized SPIONs and proved that they are effective for magnetofection of cells and mice tumors.<a title="Select to navigate to references" href="#cit48"><sup><span class="sup_ref">48</span></sup></a> Kievit <span class="italic">et al.</span> designed SPIONs conjugated with PEG/PEI and revealed high loading and protection of nucleic acids.<a title="Select to navigate to references" href="#cit205"><sup><span class="sup_ref">205</span></sup></a> A high level of DNA expression makes it an efficient member of DNA delivery gene therapy in a xenograft mouse model. Wang <span class="italic">et al.</span> reported hapten derived SPIONs for targeting gene expression by multimodality imaging.<a title="Select to navigate to references" href="#cit206"><sup><span class="sup_ref">206</span></sup></a></p>
        </div>
        <div>
          
          <span id="sect1003"/><span class="c_heading_indent">4.3.4 Photodynamic therapy. </span>
          <span>The photodynamic therapy (PDT) is a promising method for cancer therapy.<a title="Select to navigate to references" href="#cit207"><sup><span class="sup_ref">207</span></sup></a> This method makes use of a photosensitizing agent and a lower power light source to produce singlet oxygen or free radicals in tumor tissues.<a title="Select to navigate to references" href="#cit208"><sup><span class="sup_ref">208</span></sup></a> PDT utilizes low optical densities to evade the cancer cells.<a title="Select to navigate to references" href="#cit209"><sup><span class="sup_ref">209</span></sup></a> No systemic phototoxicity is seen since the ROS is generated under a local light-activated process.<a title="Select to navigate to references" href="#cit210"><sup><span class="sup_ref">210</span></sup></a> Porphyrin-based molecules are a representative example of commonly employed photosensitizers (PS). Most of the PS used are hydrophobic, allowing accumulation in the lipid layers of organelle cancer cell membranes<a title="Select to navigate to references" href="#cit211"><sup><span class="sup_ref">211</span></sup></a> but the majority of PS inhibit their systemic administration.<a title="Select to navigate to references" href="#cit212"><sup><span class="sup_ref">212</span></sup></a> Based on this context, PS carriers are really needed and two different methodologies are adapted to generate SPION based PS carriers for PDT (1) Usage of synthetic or polymer-coated biodegradable nanoparticles since they allow enzymatic degradation or hydrolysis and can be readily excreted from the biological system, and (2) use of non-biodegradable metals or ceramic-coated nanoparticles which cannot undergo degradation.</span>
          <p class="otherpara">To create new PDT carriers, a near-infrared (NIR) laser is required since it could excite the PDT carriers with good tissue penetration. For example, Li <span class="italic">et al.</span> designed Chlorin e6 (Ce6) (PS molecule) loaded iron oxide nanoclusters.<a title="Select to navigate to references" href="#cit213"><sup><span class="sup_ref">213</span></sup></a> The Ce6-loaded complex exhibited a red shift from 650 nm to 700 nm which was attributed to the formation of chemical bonding instead of simple physical adsorption between SPIONs and Ce6. The SPION carrier has several advantages: (1) enhancement in the cellular uptake is noticed due to the polymer coated nanoclusters which further leads to a better efficiency in the PDT effect and (2) internal magnetism enables these nanocomplexes to show potential magnetic targeting under magnetic field. This further allows accumulation of these compounds into the tumor sites and results in an efficient PDT effect under low-power laser irradiation towards tumor cells. The PS-combined particles displayed some benefits such as an increase in water solubility, and enhanced accumulation; nanoparticle carriers alone can improve the PDT potential. For example, Shi <span class="italic">et al.</span> fabricated fullerene (C60)-Fe<small><sub>3</sub></small>O<small><sub>4</sub></small>-PEG-conjugated iron oxide nanocomposites by constructing NPs on the C60 surface, followed by PEGylation to improve their biocompatibility and water solubility. This was followed by addition of PS, hematoporphyrin monomethyl ether (HMME) into (C60)-Fe<small><sub>3</sub></small>O<small><sub>4</sub></small>-PEG to produce (C60)-Fe<small><sub>3</sub></small>O<small><sub>4</sub></small>-PEG-HMME. Upon magnetic targeting, the HMME added (C60)-Fe<small><sub>3</sub></small>O<small><sub>4</sub></small>-PEG was able to accumulate on the tumor site, resulting in an efficient PDT effect under laser irradiation. C60 has inherent potential to generate ROS; thus C60-based SPIONs were able to exhibit improved PDT on cancer cells.</p>
        </div>
        <div>
          
          <span id="sect1025"/><span class="c_heading_indent">4.3.5 Photothermal therapy (PTT). </span>
          <span>Generally, PTT does not use direct oxygen species generated from the photosensitizers; instead this approach employs heat to cause tissue damage upon light absorbance by the nanomaterials. In order to achieve high thermal ablations, high absorptivity materials are used. Moreover, the nanomaterials should have access to the near-infrared therapeutic window range. This method has a major disadvantage called photobleaching when organic or polymeric materials are used. This can be overcome by replacing those materials with inorganic materials, graphene oxide conjugated SPIONs, gold, <span class="italic">etc</span>. For example, Zhang <span class="italic">et al.</span> studied the molar extinction coefficient and self-assembly correlation of nanoparticles.<a title="Select to navigate to references" href="#cit214"><sup><span class="sup_ref">214</span></sup></a> They showed a two-fold increased molar extinction coefficient of SPIONs when using polypyrrole as a PTT agent. Fu <span class="italic">et al.</span> reported another PTT agent called Prussian blue which is widely used by growing it on the SPION surface up to a thickness of around 3–6 nm.<a title="Select to navigate to references" href="#cit215"><sup><span class="sup_ref">215</span></sup></a> Prussian-coated SPIONs were found to evade 80% of Hela cancer cells at a minimal dosage. It achieves 87% tumor hindrance effect upon NIR irradiation and targeting. Wang <span class="italic">et al.</span> reported one-dimensional (1D) magnetic nanoparticles containing fluorescent carbon and Dox to perform disease diagnosis, fluorescence imaging and PTT.<a title="Select to navigate to references" href="#cit216"><sup><span class="sup_ref">216</span></sup></a> Similarly, Alegret <span class="italic">et al.</span> developed Dox-loaded SPIONs (graphene oxide and PEG coupled SPIONs) for cancer therapy.<a title="Select to navigate to references" href="#cit217"><sup><span class="sup_ref">217</span></sup></a> Shi <span class="italic">et al.</span> produced a metal and graphene oxide-based nanocomposite for imaging and therapy using electrostatic interactions of PEI.<a title="Select to navigate to references" href="#cit218"><sup><span class="sup_ref">218</span></sup></a> When applying this material on 4T1 tumors and performing 5 min laser irradiation, a noticeable temperature change is observed due to laser irradiation. The tumor volume in the mice was reduced to a greater extent, than the control group, upon laser irradiation.</span>
        </div>
        <div>
          
          <span id="sect1040"/><span class="c_heading_indent">4.3.6 Hyperthermia. </span>
          <span>Hyperthermia is an alternative method available for cancer treatment. This method deals with the body tissues when exposed to a high temperature range of 42 to 48 °C. Generally, the tumor cells are more sensitive to heat than normal ones. Thus, it is expected that exposure of tumor cells/tissues to a high temperature can result in cell/tissue death. It is shown that cell apoptosis can take place when a temperature of 42–46 °C is applied, whereas cell necrosis can be seen when temperature exceeds 46–48 °C and both necrosis and apoptosis can lead to tumor cell death. Such therapy may be limited to tumors thus reducing damage to normal cells.<a title="Select to navigate to references" href="#cit219"><sup><span class="sup_ref">219</span></sup></a></span>
        </div>
        <div>
          
          <span id="sect1045"/><span class="c_heading_indent">4.3.7 Magnetic fluid hyperthermia. </span>
          <span>SPIONs or magnetic nanoparticle-based hyperthermia have also received great attention in cancer therapy. In this strategy, SPIONs are targeted to the tumor site and heat is produced under a magnetic field. These particles display the Neel and Brownian losses and generate heat. The SPIONs lack magnetization when the external magnetic is stopped, thus minimizing aggregation of particles.<a title="Select to navigate to references" href="#cit220"><sup><span class="sup_ref">220</span></sup></a> Some of the reviews are reported by Salunkhe <span class="italic">et al.</span> for the SPION-based magnetic fluid hyperthermia.<a title="Select to navigate to references" href="#cit221"><sup><span class="sup_ref">221</span></sup></a> Bakhtiary and Piñeiro <span class="italic">et al.</span> explained the effects of combined therapies of magnetic hyperthermia with MR imaging and controlled drug delivery.<a title="Select to navigate to reference" href="#cit222"><sup><span class="sup_ref">222–224</span></sup></a> Lee <span class="italic">et al.</span> tuned the magnetic properties using exchange coupling properties of magnetically soft and hard cores (MnFe<small><sub>2</sub></small>O<small><sub>4</sub></small> and CoFe<small><sub>2</sub></small>O<small><sub>4</sub></small>) with some power loss.<a title="Select to navigate to references" href="#cit225"><sup><span class="sup_ref">225</span></sup></a> These tuned particles (SPIONs-Cs) achieved magnetic-induced hyperthermia operating under 44–430 Hz, compared to other magnetic nanoparticles that require kHz to MHz operating frequencies.<a title="Select to navigate to references" href="#cit226"><sup><span class="sup_ref">226</span></sup></a> Temperature change was observed between modified and unmodified SPIONs under the same reaction conditions. Experimental results revealed that the modified SPIONs can reach the therapeutic temperature faster than the free SPIONs and 4–5 fold improved heat generation was noted. In addition, less cytotoxic effect was achieved when tested against Michigan Cancer Foundation-7 (MCF 7)-breast carcinoma cell lines and H9c2 cardiomyoblasts. These results make these modified SPIONs a potential candidate for MHF based cancer treatment.</span>
        </div>
        <div>
          
          <span id="sect1061"/><span class="c_heading_indent">4.3.8 Optical hyperthermia. </span>
          <span>Optical hyperthermia referred to as the product of the PTT effect regulated the electromagnetic radiation (EMR) with the iron core through surface plasmon resonance (SPR) and absorption. The PTT effect of Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> is generally achieved by application of EMR in the NIR region.<a title="Select to navigate to references" href="#cit227"><sup><span class="sup_ref">227</span></sup></a> This EMR spectrum matches with the average minimal absorption of water, and oxygenated and deoxygenated hemoglobin. It is highly suitable to use the nanoparticle system along with this combined absorption that can trigger a photo-thermal response when exposed to EMR in the NIR region. This can be seen in the temperature profile of PAA/Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> particles when irradiated at 785 nm laser and 38.5 kW m<small><sup>−2</sup></small>. At least a minimum of 42 °C is needed for a normal cellular thermal ablation to take place, which can either lead to the apoptosis or necrosis pathway.<a title="Select to navigate to references" href="#cit228"><sup><span class="sup_ref">228</span></sup></a> Based on clinical oncology, removal of tumor lesions and the time required for complete thermal ablation at 42 °C are not practical only when operated under thermal energy. Therefore, a specific set up using the nanoparticle architecture, dosage, EMR wavelength, local environment, and irradiance power is required in order to allow for a temperature greater than 42 °C or to create new treatment modalities.</span>
        </div>
        <div>
          
          <span id="sect1072"/><span class="c_heading_indent">4.3.9 Magnetic hyperthermia. </span>
          <span>Magnetic hyperthermia refers to the cancer therapy in which a heat-triggered tumor treatment takes place. SPIONs as heat generators can be performed systemically or locally. The magnetic targeting is used to localize SPIONs near the tumor site and an external magnetic field is applied for certain time to generate heat about 42–45 °C to induce apoptosis. Heat generation may vary depending on certain factors such as the size, shape, magnetic properties, crystallinity of SPIONs, and magnetic field applied. The efficiency is measured using the specific absorption rate (SAR) that helps to convert the magnetic field into heat, based on Neel and Brownian relaxations of SPIONs involved. This hyperthermia helps to reduce the side effects. For example, Cervadoro <span class="italic">et al.</span> described the relaxations needed for heat generation of SPIONs of 5, 7, and 14 nm size, &lt;1 MHz. Heat generation is ineffective when tested over 30 MHz. The same group reported that a magnetic nanoflake composed of chitosan polymer-coated nanocubes resulted in a high SAR value of 373.8 ± 2.3 W g<small><sub>Fe</sub></small><small><sup>−1</sup></small>, 512 kHz when compared to free nanocubes. Furthermore, hyperthermia can be enhanced by doping the SPIONs with metal atoms.<a title="Select to navigate to references" href="#cit229"><sup><span class="sup_ref">229</span></sup></a> Hayashi <span class="italic">et al.</span> prepared a folic acid-conjugated magnetic cluster and tested it in CB17/Icr-Prkdcscid mice at 8 kA m<small><sup>−1</sup></small> magnetic field and 230 kHz frequency.<a title="Select to navigate to references" href="#cit230"><sup><span class="sup_ref">230</span></sup></a> They showed that the tumor size decreased to 1/10 of tumors in control mice. In addition, the lifespan extended 4 weeks after treatment with hyperthermia in the mouse model. Hainfeld <span class="italic">et al.</span> reported similar results in which the tumor volume was reduced using a specific dose of magnetic nanoparticles at 38 kA m<small><sup>−1</sup></small> and 980 kHz.<a title="Select to navigate to references" href="#cit231"><sup><span class="sup_ref">231</span></sup></a></span>
        </div>
        <div>
          
          <span id="sect1086"/><span class="c_heading_indent">4.3.10 Magnetofection. </span>
          <span>Transfection carried out using SPIONs is termed magnetofection, in which magnetic nanoparticles are conjugated with negatively charged nucleic acid <span class="italic">via</span> electrostatic attractions, or positively charged polyethyleneimine. PEI is commonly used to encapsulate the SPIONs and performing magnetofection. Furthermore, PEI may trigger a sponge effect to avoid enzyme degradation within a cell. Furthermore, optimization of the size and zeta potential of the SPION-coated polymer is required to carry out effective nucleic acid delivery. Prijic <span class="italic">et al.</span> developed DNA-conjugated PAA-PEI functionalized SPIONs and tested the transfecting efficacy on B16F1 cells.<a title="Select to navigate to references" href="#cit48"><sup><span class="sup_ref">48</span></sup></a> They showed a greater than 12-fold increase in DNA transfection when subjected to an external magnetic field. Prosen <span class="italic">et al.</span> studied the magnetofection potential of the SPIONS-PAA-PEI in another report and demonstrated enhanced efficiency in a basic medium.<a title="Select to navigate to references" href="#cit232"><sup><span class="sup_ref">232</span></sup></a> Prosen <span class="italic">et al.</span> also achieved the potential silencing of melanoma cell adhesion <span class="italic">via</span> magnetofection when pDNA is coupled with SPION-PEI.<a title="Select to navigate to references" href="#cit233"><sup><span class="sup_ref">233</span></sup></a> Li <span class="italic">et al.</span> reported HepG2 cancer cell inhibition upon transfecting with modified disulphide-PEI-SPIONs carrying siRNA that inhibited telomerase reverse transcriptase gene expression.<a title="Select to navigate to references" href="#cit234"><sup><span class="sup_ref">234</span></sup></a></span>
        </div>
        <div>
          
          <span id="sect1100"/><span class="c_heading_indent">4.3.11 Magnetothermal treatment. </span>
          <span>This effect is directly dependent on frequency (<span class="italic">f</span>) and amplitude (<span class="italic">H</span>) of a given magnetic field. It is suggested that the <span class="italic">H</span><small><sub>f</sub></small> value should be below 5 × 10<small><sup>9</sup></small> Am<small><sup>−1</sup></small> s<small><sup>−1</sup></small>.<a title="Select to navigate to references" href="#cit235"><sup><span class="sup_ref">235</span></sup></a> For instance, Megaforce Nano Therm therapy is approved for brain tumor treatment in Europe in which 100 kHz frequency and 2–15 kA m<small><sup>−1</sup></small> are used.<a title="Select to navigate to references" href="#cit236"><sup><span class="sup_ref">236</span></sup></a> Various efforts have been taken to expand the heating efficacy of nanoparticles at a provided frequency and amplitude and also to increase the magnetic field. In a conventional magnet set up, SPIONs dispersed in both normal and affected tissues are evenly heated since the alternating magnetic field is nonspecifically applied within the solenoid. Such a type of non-specific heating is the most serious drawback in this approach. The behavior of SPIONs in a magnetic thermal system is shown in <a title="Select to navigate to figure" href="#imgfig10">Fig. 10</a>.</span>
          <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig10"><a href="/image/article/2019/DT/c9dt00459a/c9dt00459a-f10_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9dt00459a-f10.tif" src="/image/article/2019/DT/c9dt00459a/c9dt00459a-f10.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 10 </b> <span id="fig10"><span class="graphic_title">Behavior of SPIONs in a magnetic thermal system.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
          <p class="otherpara">Accuracy and high resolution temperature readings are critical in thermal therapy.<a title="Select to navigate to references" href="#cit237"><sup><span class="sup_ref">237</span></sup></a> Fluorescent dyes (DyLight549) and thermoresponsive poly(<span class="italic">N</span>-isopropyl acrylamide)-fluorescent modified acrylamide (pNIPAM-<span class="italic">co</span>-FMA) coupled on SPIONs change their fluorescence intensity based on the environmental temperature. The pictorial representation of a magneto-photothermal mechanism for tumor ablation is shown in <a title="Select to navigate to figure" href="#imgfig11">Fig. 11</a>. The detection of real temperature is also possible. The limitations of this method are spatial resolution and high cost. Thus, the low cost and readily available ultrasound technique seems to be an alternating strategy to measure imaging temperature.<a title="Select to navigate to references" href="#cit238"><sup><span class="sup_ref">238</span></sup></a></p>
          <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig11"><a href="/image/article/2019/DT/c9dt00459a/c9dt00459a-f11_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9dt00459a-f11.tif" src="/image/article/2019/DT/c9dt00459a/c9dt00459a-f11.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 11 </b> <span id="fig11"><span class="graphic_title">Pictorial representation of the magneto-photothermal mechanism for tumor ablation.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        </div>
        <div>
          
          <span id="sect1125"/><span class="c_heading_indent">4.3.12 Apoptotic hyperthermia. </span>
          <span>In general, thermal ablation receives the merit for quick removal of the tumor. Healthy tissues around the target site are possibly damaged when operating at a high temperature to kill cancer cells. The temperature range of 42–45 °C can preferentially destroy the cancer cells.<a title="Select to navigate to references" href="#cit239"><sup><span class="sup_ref">239</span></sup></a> Some SPIONs with stabilizers or encapsulated in liposomes have also been investigated for magnetic hyperthermia and approved for clinical tests for glioblastoma in Europe.<a title="Select to navigate to references" href="#cit240"><sup><span class="sup_ref">240</span></sup></a> Current reports show two venues to improve the potential of magnetic hyperthermia. First, carboxymethyl dextran-coated magnetic particles coupled with EGFR help to target the corresponding receptors in cancer cells. Wang <span class="italic">et al.</span> reported folic acid-coupled PEG-SPIONs as a non-invasive system for imaging folate receptors. Another folic acid-conjugated PEG-SPION Nc produced by the click reaction is intravenously injected to inhibit tumor growth in a mice model along with a magnetic field of 8 kA m<small><sup>−1</sup></small> and 230 kHz. A study of dextran-coated SPIONs for prostate cancer was also reported. In the study, nanoparticle treatment in conjunction with an applied magnetic field and laser irradiation caused significant tumor cell death.<a title="Select to navigate to reference" href="#cit230"><sup><span class="sup_ref">230,241,242</span></sup></a></span>
        </div>
        <div>
          
          <span id="sect1134"/><span class="c_heading_indent">4.3.13 Direct injection of SPIONs into the tumor. </span>
          <span>The new treatment method employs SPION injection directly into tumors. The particles are dispersed in aqueous solution, carefully transferred and applied with an external magnetic field to generate heat and carry out site-specific drug release.<a title="Select to navigate to references" href="#cit243"><sup><span class="sup_ref">243</span></sup></a> The aminosilane-coated iron oxide nanoparticles were injected intravenously into glioblastoma tumor bearing mice and 4.5 fold longer survivals have been noticed. They remained in the tumor and allow repeated thermotherapy without additional injections. Reduced proliferation and tumor necrosis were clearly observed.<a title="Select to navigate to references" href="#cit244"><sup><span class="sup_ref">244</span></sup></a></span>
        </div>
      
    
    
      
      <h2 id="sect1140"><span class="a_heading">5 Concluding remarks</span></h2>
      <span>Nanoparticles have their own unique chemical, physical, and biological properties when compared to other materials. Thus, they have gained growing interest in biomedical sciences. Among these, magnetic nanoparticles such as SPIONs are considered as most promising materials because of their multimodal functions. Moreover, SPIONs also use super paramagnets, which are advantageous to target specific tumor sites within a body. SPION synthesis with optimized properties is ideal for <span class="italic">in vivo</span> applications. It is important to carefully design particle surfaces so that they are able to cross biological barriers and target the desired sites. For a successful application, synthesis of SPIONs with desired surface properties and a tunable size is widely required as this will: (1) reduce nonspecific uptakes by unintended cells, (2) decrease its toxicity, (3) increase the quantity of drugs directed to the tumor site, and (4) stimulate its responses in a magnetic field. However, cytotoxicity and other challenges regarding SPIONs are not well addressed. Nonetheless, SPIONs remain efficient, reliable and versatile tools in the development of cancer theranostics. These particles can also be utilized as targeting/site-specific drug delivering and treatment agents. In this review, commonly used targeting mechanisms are illustrated with a view that more advances are forthcoming in the biomedical field. There are also other hurdles which must be surpassed in order to realize the full potential of SPION-based drug delivery systems. Among these is the burst effect of drugs encapsulated within the nanoparticles. It is possible to control this pitfall by utilizing PEG coated SPIONs. This will reduce the amount of drug escaping and toxicity. Thus, identifying and synthesizing polymer-coated SPIONs could help to increase its stability. Another concerning issue is the ability of SPIONs to absorb <span class="italic">in vivo</span> protein molecules which can affect their function; thus, researchers are formulating the particle surface to be filled with lower protein-affinity molecules. Ultimately, this progress may improve the efficacy in cancer therapy in clinics.</span>
    
    
      
      <h2 id="sect1146"><span class="a_heading">6 Current challenges and future perspectives</span></h2>
      <span>SPIONs can function as an effective theranostic tool and this review focused on the theranostic and drug delivery aspects of SPIONs. Despite outstanding results and research advances obtained using SPIONs as a theranostic material, some challenges are left unaddressed. There can be a focus on poor sensitivity and low resolution of particles when used as contrast agents. The dose required for imaging and therapeutic treatment is not always the same, and this fact should be addressed before use in clinical studies. SPION-based nanoplatforms possess several compartments that increased the complexity of the multifaceted system. Another great challenge is the mass-production of the SPIONs. Hence, a simple theranostic SPION platform design through an easy methodology is urgently required for clinical evaluation in the near future.</span>
      <p class="otherpara">Many experiments are under trial even after attaining useful clinical results and there are many challenges to defeat before using NPs as probes for theranostic applications. Even though the SPIONs have been approved by the FDA, further analyses are needed to better understand the physicochemical properties. In addition, the targeting of SPION-based nanoplatforms requires further improvements. Ideally, SPIONs should be delivered to targeting sites without side effects. The short term and long-term <span class="italic">in vivo</span> effects and their corresponding mechanisms at a molecular level should be revealed. The multifunctional SPION-based NPs can be applied to a greater extent in translational medicine after resolving all these issues. Regarding synthesis, aqueous phase methods have been used for SPION synthesis but some challenges remain to be addressed. Care should be taken on the irregular morphology, uniform particle size and improved monodispersity of the particles prepared. Effective strategies can be followed to overcome these challenges upon reducing the reaction rate and increasing the corresponding reaction time. Concerning the organic phase synthesis, the methods may be further optimized by using hydrophilic stabilizers and post-synthetic surface modification strategies to enhance water solubility. The purification of the synthesized materials can be accomplished by removing the byproducts formed during the reactions using different purification methodologies.</p>
      <p class="otherpara">Tremendous efforts have been invested in the developments of SPIONs and their utility in biomedical applications. Some success has emerged as SPIONs are approved in the name of NanoTherm for hyperthermia. With the appropriate evolution, SPIONs can provide new and effective cancer treatments by improving their targeting, drug delivery, and in therapy. Being a matter of deep exploration within the past few decades, a detailed survey of SPIONs has been added in this review article to reveal their ability to change the medical field through their roles as nano-based theranostics. The majority of the probing techniques involve the use of metal nanoparticles and their corresponding derivatives. The efficacy of such systems is improved by conjugating with chemotherapeutic agents, targeting ligands, and fluorophores. The complete risk profile has not been fully agreed. To realize the role of SPIONs in nanomedicine in the near future, pre-clinical inventions are required to overcome some limits hindering their development towards a potential tool for targeting, drug delivery, and therapy.</p>
    
    
      <h2 id="sect1153"><span class="a_heading">Conflicts of interest</span></h2>
      <span>Authors declare that there is no conflicts of interest.</span>
    
  
    <h2 id="sect1157"><span class="a_heading">Acknowledgements</span></h2>
      <span>We are grateful to the Ministry of Science and Technology, Taiwan, R.O.C. for financial support under MOST 106-2113-M-009-023, 107-2218-E-009-010, and 106-3114-E-009-005. This work was financially supported by the “Center For Intelligent Drug Systems and Smart Bio-devices (IDS2B)” from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan.</span>
    
    <span id="sect1159"><h2 id="sect1156"><span class="a_heading">References</span></h2></span><ol type="1">
      <li><span id="cit1">Z. Qiao and X. Y. Shi, <span class="italic">Prog. Polym. Sci.</span>, 2015, <span class="bold">44</span>, 1–27 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.progpolymsci.2014.08.002" title="DOI Link to resource 10.1016/j.progpolymsci.2014.08.002">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhsFyru7bM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/1_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit2">J. Gao, H. Gu and B. Xu, <span class="italic">Acc. Chem. Res.</span>, 2009, <span class="bold">42</span>, 1097–1107 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ar9000026" title="DOI Link to resource 10.1021/ar9000026">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXmsVOmtb8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19476332%5Buid%5D" title="PubMed Link to resource 19476332">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/2_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit3">R. Hao, R. Xing, Z. Xu, Y. Hou, S. Gao and S. Sun, <span class="italic">Adv. Mater.</span>, 2010, <span class="bold">22</span>, 2729–2742 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201000260" title="DOI Link to resource 10.1002/adma.201000260">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXovVCkt74%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20473985%5Buid%5D" title="PubMed Link to resource 20473985">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/3_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit4">X. Chen, S. S. Gambhir and J. Cheon, <span class="italic">Acc. Chem. Res.</span>, 2011, <span class="bold">44</span>, 841 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ar200231d" title="DOI Link to resource 10.1021/ar200231d">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhtlSlurfL" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22004477%5Buid%5D" title="PubMed Link to resource 22004477">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/4_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit5">J. Conde, J. T. Dias, V. Grazu, M. Moros, P. V. Baptista and J. M. de la Fuente, <span class="italic">Front. Chem.</span>, 2014, <span class="bold">2</span>, 48 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Front.%20Chem.%5BJour%5D%20AND%202%5Bvolume%5D%20AND%2048%5Bpage%5D%20and%202014%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/5_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit6">H. Gupta, P. Paul and N. Kumar, <span class="italic">Procedia Mater. Sci.</span>, 2014, <span class="bold">5</span>, 198–203 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.mspro.2014.07.258" title="DOI Link to resource 10.1016/j.mspro.2014.07.258">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhsFCgurjJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/6_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit7">B. Jagannathan, N. Suriyanarayanan and J. Rajan, <span class="italic">J. Magn. Magn. Mater.</span>, 2014, <span class="bold">362</span>, 135–140 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jmmm.2014.03.005" title="DOI Link to resource 10.1016/j.jmmm.2014.03.005">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/7_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit8">K. M. Bennett, J. Jo, H. Cabral, R. Bakalova and I. Aoki, <span class="italic">Adv. Drug Delivery Rev.</span>, 2014, <span class="bold">74</span>, 75–94 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.addr.2014.04.007" title="DOI Link to resource 10.1016/j.addr.2014.04.007">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhtlOlur3M" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24787226%5Buid%5D" title="PubMed Link to resource 24787226">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/8_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit9">K. Chatterjee, S. Sarkar, K. Jagajjanani Rao and S. Paria, <span class="italic">Adv. Colloid Interface Sci.</span>, 2014, <span class="bold">209</span>, 8–39 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.cis.2013.12.008" title="DOI Link to resource 10.1016/j.cis.2013.12.008">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CqsLk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24491963%5Buid%5D" title="PubMed Link to resource 24491963">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/9_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit10">M. Colombo, S. Carregal-Romero, M. F. Casula, L. Gutiérrez, M. P. Morales, I. B. Böhm, J. T. Heverhagen, D. Prosperi and W. J. Parak, <span class="italic">Chem. Soc. Rev.</span>, 2012, <span class="bold">41</span>, 4306–4334 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C2CS15337H&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C2CS15337H">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/10_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit11">N. Freidoonimehr, M. M. Rashidi and S. Mahmud, <span class="italic">Int. J. Therm. Sci.</span>, 2015, <span class="bold">87</span>, 136–145 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.ijthermalsci.2014.08.009" title="DOI Link to resource 10.1016/j.ijthermalsci.2014.08.009">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhsVKmsL3F" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/11_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit12">Y. G. Ko and U. S. Choi, <span class="italic">Compos. Sci. Technol.</span>, 2013, <span class="bold">79</span>, 77–86 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.compscitech.2013.02.016" title="DOI Link to resource 10.1016/j.compscitech.2013.02.016">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXlsFCjtr4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/12_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit13">L. H. Reddy, J. L. Arias, J. Nicolas and P. Couvreur, <span class="italic">Chem. Rev.</span>, 2012, <span class="bold">112</span>, 5818–5878 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/cr300068p" title="DOI Link to resource 10.1021/cr300068p">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XhsVOiu77O" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23043508%5Buid%5D" title="PubMed Link to resource 23043508">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/13_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit14">M. Nedyalkova, B. Donkova, J. Romanova, G. Tzvetkov, S. Madurga and V. Simeonov, <span class="italic">Adv. Colloid Interface Sci.</span>, 2017, <span class="bold">249</span>, 192–212 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.cis.2017.05.003" title="DOI Link to resource 10.1016/j.cis.2017.05.003">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXntl2ht7s%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28499604%5Buid%5D" title="PubMed Link to resource 28499604">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/14_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit15">L. T. T. Huong, N. H. Nam, D. H. Doan, H. T. M. Nhung, B. T. Quang, P. H. Nam, P. Q. Thong, N. X. Phuc and H. P. Thu, <span class="italic">Mater. Chem. Phys.</span>, 2016, <span class="bold">172</span>, 98–104 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.matchemphys.2015.12.065" title="DOI Link to resource 10.1016/j.matchemphys.2015.12.065">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XnvV2rsA%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/15_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit16">D. Zhang, J. Wang, Z. Wang, R. Wang, L. Song, T. Zhang, X. Lin, P. Shi, H. Xin and X. Pang, <span class="italic">Sci. Adv. Mater.</span>, 2015, <span class="bold">7</span>, 1058–1064 <a target="_blank" class="DOILink" href="https://doi.org/10.1166/sam.2015.2178" title="DOI Link to resource 10.1166/sam.2015.2178">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXpsFCqsL4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/16_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit17">X. Shi, S. H. Wang, S. D. Swanson, S. Ge, Z. Cao, M. E. Van Antwerp, K. J. Landmark and J. R. Baker Jr., <span class="italic">Adv. Mater.</span>, 2008, <span class="bold">20</span>, 1671–1678 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.200702770" title="DOI Link to resource 10.1002/adma.200702770">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXmslSqtbc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/17_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit18">Y. Yuan, Z. Ding, J. Qian, J. Zhang, J. Xu, X. Dong, T. Han, S. Ge, Y. Luo, Y. Wang, K. Zhong and G. Liang, <span class="italic">Nano Lett.</span>, 2016, <span class="bold">16</span>, 2686–2691 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.nanolett.6b00331" title="DOI Link to resource 10.1021/acs.nanolett.6b00331">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28Xlt1Gju7Y%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27031226%5Buid%5D" title="PubMed Link to resource 27031226">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/18_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit19">K. H. Bae, M. Park, M. J. Do, N. Lee, J. H. Ryu, G. W. Kim, C. Kim, T. G. Park and T. Hyeon, <span class="italic">ACS Nano</span>, 2012, <span class="bold">6</span>, 5266–5273 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/nn301046w" title="DOI Link to resource 10.1021/nn301046w">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XmvFGhtbo%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22588093%5Buid%5D" title="PubMed Link to resource 22588093">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/19_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit20">Y. V. Kolen'ko, M. Bañobre-López, C. Rodriguez-Abreu, E. Carbo-Argibay, A. Sailsman, Y. piñeiro, M. Cerqueira, D. Petrovykh, K. Kovnir, O. Lebedev and J. Rivas, <span class="italic">J. Phys. Chem. C</span>, 2014, <span class="bold">118</span>, 8691–8701 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jp500816u" title="DOI Link to resource 10.1021/jp500816u">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/20_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit21">T. Kim, E. Momin, J. Choi, K. Yuan, H. Zaidi, J. Kim, M. Park, N. Lee, M. T. McMahon, A. Quinones-Hinojosa, J. W. Bulte, T. Hyeon and A. A. Gilad, <span class="italic">J. Am. Chem. Soc.</span>, 2011, <span class="bold">133</span>, 2955–2961 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja1084095" title="DOI Link to resource 10.1021/ja1084095">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhvVWjtb0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21314118%5Buid%5D" title="PubMed Link to resource 21314118">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/21_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit22">V. P. Lara, P. Caramelli, A. L. Teixeira, M. T. Barbosa, K. C. Carmona, M. G. Carvalho, A. P. Fernandes and K. B. Gomes, <span class="italic">Clin. Chim. Acta</span>, 2013, <span class="bold">423</span>, 18–22 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.cca.2013.04.013" title="DOI Link to resource 10.1016/j.cca.2013.04.013">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXoslWnsrs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23611893%5Buid%5D" title="PubMed Link to resource 23611893">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/22_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit23">B. Son, H. D. Kim, M. Kim, J. A. Kim, J. Lee, H. Shin, N. S. Hwang and T. H. Park, <span class="italic">Adv. Healthcare Mater.</span>, 2015, <span class="bold">4</span>, 1339–1347 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adhm.201400835" title="DOI Link to resource 10.1002/adhm.201400835">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXlslentr0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25846518%5Buid%5D" title="PubMed Link to resource 25846518">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/23_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit24">Q. Wang, B. Chen, M. Cao, J. Sun, H. Wu, P. Zhao, J. Xing, Y. Yang, X. Zhang, M. Ji and N. Gu, <span class="italic">Biomaterials</span>, 2016, <span class="bold">86</span>, 11–20 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2016.02.004" title="DOI Link to resource 10.1016/j.biomaterials.2016.02.004">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XitFejtbk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26874888%5Buid%5D" title="PubMed Link to resource 26874888">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/24_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit25">F. M. Kievit and M. Zhang, <span class="italic">Acc. Chem. Res.</span>, 2011, <span class="bold">44</span>, 853–862 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ar2000277" title="DOI Link to resource 10.1021/ar2000277">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXlsVOjs7w%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21528865%5Buid%5D" title="PubMed Link to resource 21528865">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/25_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit26">R. Torres Martin de Rosales, R. Tavare, A. Glaria, G. Varma, A. Protti and P. J. Blower, <span class="italic">Bioconjugate Chem.</span>, 2011, <span class="bold">22</span>, 455–465 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/bc100483k" title="DOI Link to resource 10.1021/bc100483k">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21338098%5Buid%5D" title="PubMed Link to resource 21338098">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/26_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit27">R. Misri, D. Meier, A. C. Yung, P. Kozlowski and U. O. Hafeli, <span class="italic">Nanomedicine</span>, 2012, <span class="bold">8</span>, 1007–1016 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.nano.2011.10.013" title="DOI Link to resource 10.1016/j.nano.2011.10.013">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XhtVymt7rO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22100757%5Buid%5D" title="PubMed Link to resource 22100757">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/27_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit28">D. K. Kirui, I. Khalidov, Y. Wang and C. A. Batt, <span class="italic">Nanomedicine</span>, 2013, <span class="bold">9</span>, 702–711 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.nano.2012.11.009" title="DOI Link to resource 10.1016/j.nano.2012.11.009">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXksFOntLw%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23219875%5Buid%5D" title="PubMed Link to resource 23219875">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/28_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit29">D. Horák, B. Rittich, A. Španová and M. J. Beneš, <span class="italic">Polymer</span>, 2005, <span class="bold">46</span>, 1245–1255 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.polymer.2004.11.049" title="DOI Link to resource 10.1016/j.polymer.2004.11.049">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/29_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit30">T. Neuberger, B. Schöpf, H. Hofmann, M. Hofmann and B. von Rechenberg, <span class="italic">J. Magn. Magn. Mater.</span>, 2005, <span class="bold">293</span>, 483–496 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jmmm.2005.01.064" title="DOI Link to resource 10.1016/j.jmmm.2005.01.064">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2MXktVagsbo%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/30_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit31">G. Kandasamy and D. Maity, <span class="italic">Int. J. Pharm.</span>, 2015, <span class="bold">496</span>, 191–218 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.ijpharm.2015.10.058" title="DOI Link to resource 10.1016/j.ijpharm.2015.10.058">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhslyktrvE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26520409%5Buid%5D" title="PubMed Link to resource 26520409">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/31_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit32">E. Tombacz, R. Turcu, V. Socoliuc and L. Vekas, <span class="italic">Biochem. Biophys. Res. Commun.</span>, 2015, <span class="bold">468</span>, 442–453 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.bbrc.2015.08.030" title="DOI Link to resource 10.1016/j.bbrc.2015.08.030">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCqt7vM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26275707%5Buid%5D" title="PubMed Link to resource 26275707">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/32_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit33">M. Mahmoudi, S. Sant, B. Wang, S. Laurent and T. Sen, <span class="italic">Adv. Drug Delivery Rev.</span>, 2011, <span class="bold">63</span>, 24–46 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.addr.2010.05.006" title="DOI Link to resource 10.1016/j.addr.2010.05.006">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXjvV2ksbc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20685224%5Buid%5D" title="PubMed Link to resource 20685224">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/33_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit34">J. Dobson, <span class="italic">Drug Dev. Res.</span>, 2006, <span class="bold">67</span>, 55–60 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/ddr.20067" title="DOI Link to resource 10.1002/ddr.20067">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XltF2msb4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/34_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit35">A. K. Gupta and M. Gupta, <span class="italic">Biomaterials</span>, 2005, <span class="bold">26</span>, 3995–4021 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2004.10.012" title="DOI Link to resource 10.1016/j.biomaterials.2004.10.012">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2MXisFWr" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=15626447%5Buid%5D" title="PubMed Link to resource 15626447">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/35_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit36">S. Laurent, A. A. Saei, S. Behzadi, A. Panahifar and M. Mahmoudi, <span class="italic">Expert Opin. Drug Delivery</span>, 2014, <span class="bold">11</span>, 1449–1470 <a target="_blank" class="DOILink" href="https://doi.org/10.1517/17425247.2014.924501" title="DOI Link to resource 10.1517/17425247.2014.924501">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWrur%252FO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24870351%5Buid%5D" title="PubMed Link to resource 24870351">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/36_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit37">C. Alexiou, R. Jurgons, R. J. Schmid, C. Bergemann, J. Henke, W. Erhardt, E. Huenges and F. Parak, <span class="italic">J. Drug Targeting</span>, 2003, <span class="bold">11</span>, 139–149 <a target="_blank" class="DOILink" href="https://doi.org/10.3109/1061186031000150791" title="DOI Link to resource 10.3109/1061186031000150791">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3sXntFCmtLY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=13129824%5Buid%5D" title="PubMed Link to resource 13129824">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/37_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit38">A. Chicheł, J. Skowronek, M. Kubaszewska and M. Kanikowski, <span class="italic">Rep. Pract.
Oncol. Radiother.</span>, 2007, <span class="bold">12</span>, 267–275 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S1507-1367(10)60065-X" title="DOI Link to resource 10.1016/S1507-1367(10)60065-X">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/38_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit39">A. Latorre, P. Couleaud, A. Aires, A. L. Cortajarena and A. Somoza, <span class="italic">Eur. J. Med. Chem.</span>, 2014, <span class="bold">82</span>, 355–362 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.ejmech.2014.05.078" title="DOI Link to resource 10.1016/j.ejmech.2014.05.078">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhtVCqu73O" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24927055%5Buid%5D" title="PubMed Link to resource 24927055">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/39_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit40">A. Kumar, P. K. Jena, S. Behera, R. F. Lockey, S. Mohapatra and S. Mohapatra, <span class="italic">Nanomedicine</span>, 2010, <span class="bold">6</span>, 64–69 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.nano.2009.04.002" title="DOI Link to resource 10.1016/j.nano.2009.04.002">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXjtlarsrw%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19446653%5Buid%5D" title="PubMed Link to resource 19446653">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/40_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit41">S. F. Medeiros, A. M. Santos, H. Fessi and A. Elaissari, <span class="italic">Int. J. Pharm.</span>, 2011, <span class="bold">403</span>, 139–161 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.ijpharm.2010.10.011" title="DOI Link to resource 10.1016/j.ijpharm.2010.10.011">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCltbrN" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20951779%5Buid%5D" title="PubMed Link to resource 20951779">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/41_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit42">G. Salas, C. Casado, F. J. Teran, R. Miranda, C. J. Serna and M. P. Morales, <span class="italic">J. Mater. Chem.</span>, 2012, <span class="bold">22</span>, 21065–21075 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C2JM34402E&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C2JM34402E">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/42_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit43">S. R. Sirsi and M. A. Borden, <span class="italic">Adv. Drug Delivery Rev.</span>, 2014, <span class="bold">72</span>, 3–14 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.addr.2013.12.010" title="DOI Link to resource 10.1016/j.addr.2013.12.010">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhtFSjt7g%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24389162%5Buid%5D" title="PubMed Link to resource 24389162">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/43_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit44">N. Singh, G. J. S. Jenkins, R. Asadi and S. H. Doak, <span class="italic">Nano Rev.</span>, 2010, <span class="bold">1</span>, 5358 <a target="_blank" class="DOILink" href="https://doi.org/10.3402/nano.v1i0.5358" title="DOI Link to resource 10.3402/nano.v1i0.5358">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22110864%5Buid%5D" title="PubMed Link to resource 22110864">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/44_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit45">A. Wadajkar, J. Menon and K. Nguyen, <span class="italic">Rev. Nanosci. Nanotechnol.</span>, 2012, <span class="bold">1</span>, 284–297 <a target="_blank" class="DOILink" href="https://doi.org/10.1166/rnn.2012.1019" title="DOI Link to resource 10.1166/rnn.2012.1019">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOrurrJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/45_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit46">F. Dilnawaz, A. Singh, C. Mohanty and S. K. Sahoo, <span class="italic">Biomaterials</span>, 2010, <span class="bold">31</span>, 3694–3706 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2010.01.057" title="DOI Link to resource 10.1016/j.biomaterials.2010.01.057">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXisFSlt78%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20144478%5Buid%5D" title="PubMed Link to resource 20144478">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/46_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit47">H. J. Lee, Y. T. Nguyen, M. Muthiah, H. Vu-Quang, R. Namgung, W. J. Kim, M. K. Yu, S. Jon, I. K. Lee, Y. Y. Jeong and I. K. Park, <span class="italic">J. Biomed. Nanotechnol.</span>, 2012, <span class="bold">8</span>, 361–371 <a target="_blank" class="DOILink" href="https://doi.org/10.1166/jbn.2012.1407" title="DOI Link to resource 10.1166/jbn.2012.1407">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XotFWmtL8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22764405%5Buid%5D" title="PubMed Link to resource 22764405">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/47_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit48">S. Prijic, L. Prosen, M. Cemazar, J. Scancar, R. Romih, J. Lavrencak, V. B. Bregar, A. Coer, M. Krzan, A. Znidarsic and G. Sersa, <span class="italic">Biomaterials</span>, 2012, <span class="bold">33</span>, 4379–4391 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2012.02.061" title="DOI Link to resource 10.1016/j.biomaterials.2012.02.061">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XktFSgt7g%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22429983%5Buid%5D" title="PubMed Link to resource 22429983">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/48_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit49">S. Sharifi, H. Seyednejad, S. Laurent, F. Atyabi, A. A. Saei and M. Mahmoudi, <span class="italic">Contrast Media Mol. Imaging</span>, 2015, <span class="bold">10</span>, 329–355 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/cmmi.1638" title="DOI Link to resource 10.1002/cmmi.1638">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXmsF2mtb0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25882768%5Buid%5D" title="PubMed Link to resource 25882768">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/49_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit50">S. Laurent, D. Forge, M. Port, A. Roch, C. Robic, L. Vander Elst and R. N. Muller, <span class="italic">Chem. Rev.</span>, 2008, <span class="bold">108</span>, 2064–2110 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/cr068445e" title="DOI Link to resource 10.1021/cr068445e">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXmvFCjtb0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18543879%5Buid%5D" title="PubMed Link to resource 18543879">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/50_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit51">K. T. Wu, P. C. Kuo, Y. D. Yao and E. H. Tsai, <span class="italic">IEEE Trans. Magn.</span>, 2001, <span class="bold">37</span>, 2651–2653 <a target="_blank" class="DOILink" href="https://doi.org/10.1109/20.951263" title="DOI Link to resource 10.1109/20.951263">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3MXnt1yms7k%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/51_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit52">X. Liang, X. Wang, J. Zhuang, Y. Chen, D. Wang and Y. Li, <span class="italic">Adv. Funct. Mater.</span>, 2006, <span class="bold">16</span>, 1805–1813 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.200500884" title="DOI Link to resource 10.1002/adfm.200500884">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XhtVKgur3J" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/52_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit53">L. Zhang, J. Wu, H. Liao, Y. Hou and S. Gao, <span class="italic">Chem. Commun.</span>, 2009, <span class="bold">29</span>, 4378–4380 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=B906636E&amp;newsite=1" title="Link to RSC resource DOI:10.1039/B906636E">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/53_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit54">M. F. Casula, Y.-w. Jun, D. J. Zaziski, E. M. Chan, A. Corrias and A. P. Alivisatos, <span class="italic">J. Am. Chem. Soc.</span>, 2006, <span class="bold">128</span>, 1675–1682 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja056139x" title="DOI Link to resource 10.1021/ja056139x">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XjvV2kuw%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=16448141%5Buid%5D" title="PubMed Link to resource 16448141">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/54_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit55">F. X. Redl, C. T. Black, G. C. Papaefthymiou, R. L. Sandstrom, M. Yin, H. Zeng, C. B. Murray and S. P. O'Brien, <span class="italic">J. Am. Chem. Soc.</span>, 2004, <span class="bold">126</span>, 14583–14599 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja046808r" title="DOI Link to resource 10.1021/ja046808r">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2cXos1Wjtr0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=15521779%5Buid%5D" title="PubMed Link to resource 15521779">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/55_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit56">J. Xie, K. Chen, H. Y. Lee, C. Xu, A. R. Hsu, S. Peng, X. Chen and S. Sun, <span class="italic">J. Am. Chem. Soc.</span>, 2008, <span class="bold">130</span>, 7542–7543 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja802003h" title="DOI Link to resource 10.1021/ja802003h">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXmtlWnu7w%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18500805%5Buid%5D" title="PubMed Link to resource 18500805">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/56_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit57">S. O'Brien, L. Brus and C. B. Murray, <span class="italic">J. Am. Chem. Soc.</span>, 2001, <span class="bold">123</span>, 12085–12086 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja011414a" title="DOI Link to resource 10.1021/ja011414a">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/57_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit58">D. Kim, N. Lee, M. Park, B. H. Kim, K. An and T. Hyeon, <span class="italic">J. Am. Chem. Soc.</span>, 2009, <span class="bold">131</span>, 454–455 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja8086906" title="DOI Link to resource 10.1021/ja8086906">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXhsFaisrrF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19099480%5Buid%5D" title="PubMed Link to resource 19099480">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/58_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit59">M. Zhu and G. Diao, <span class="italic">J. Phys. Chem. C</span>, 2011, <span class="bold">115</span>, 18923–18934 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jp200418j" title="DOI Link to resource 10.1021/jp200418j">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCmtbvP" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/59_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit60">X. Li, Z. Si, Y. Lei, J. Tang, S. Wang, S. Su, S. Song, L. Zhao and H. Zhang, <span class="italic">CrystEngComm.</span>, 2010, <span class="bold">12</span>, 2060–2063 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=B926780H&amp;newsite=1" title="Link to RSC resource DOI:10.1039/B926780H">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/60_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit61">R. Fan, X. H. Chen, Z. Gui, L. Liu and Z. Y. Chen, <span class="italic">Mater. Res. Bull.</span>, 2001, <span class="bold">36</span>, 497–502 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S0025-5408(01)00527-X" title="DOI Link to resource 10.1016/S0025-5408(01)00527-X">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3MXjtFehsbw%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/61_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit62">G. S. Demirer, A. C. Okur and S. Kizilel, <span class="italic">J. Mater. Chem. B</span>, 2015, <span class="bold">3</span>, 7831–7849 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C5TB00931F&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C5TB00931F">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/62_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit63">S. Ge, X. Y. Shi, K. Sun, C. P. Li, C. Uher, J. R. Baker, M. M. B. Holl and B. G. Orr, <span class="italic">J. Phys. Chem. C</span>, 2009, <span class="bold">113</span>, 13593–13599 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jp902953t" title="DOI Link to resource 10.1021/jp902953t">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXnvF2kur4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20174618%5Buid%5D" title="PubMed Link to resource 20174618">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/63_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit64">J. Wang, J. J. Sun, Q. Sun and Q. W. Chen, <span class="italic">Mater. Res. Bull.</span>, 2003, <span class="bold">38</span>, 1113–1118 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S0025-5408(03)00129-6" title="DOI Link to resource 10.1016/S0025-5408(03)00129-6">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3sXltFKksrg%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/64_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit65">Z. Stojanović, M. Otoničar, J. Lee, M. M. Stevanović, M. P. Hwang, K. H. Lee, J. Choi and D. Uskoković, <span class="italic">Colloids Surf., B</span>, 2013, <span class="bold">109</span>, 236–243 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.colsurfb.2013.03.053" title="DOI Link to resource 10.1016/j.colsurfb.2013.03.053">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23660309%5Buid%5D" title="PubMed Link to resource 23660309">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/65_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit66">W. Wu, Q. G. He and C. Z. Jiang, <span class="italic">Nanoscale Res. Lett.</span>, 2008, <span class="bold">3</span>, 397–415 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s11671-008-9174-9" title="DOI Link to resource 10.1007/s11671-008-9174-9">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXhsVyhtrvP" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21749733%5Buid%5D" title="PubMed Link to resource 21749733">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/66_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit67">H. Shokrollahi, <span class="italic">Mater. Sci. Eng., C</span>, 2013, <span class="bold">33</span>, 2476–2487 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.msec.2013.03.028" title="DOI Link to resource 10.1016/j.msec.2013.03.028">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXlslWjur0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23623058%5Buid%5D" title="PubMed Link to resource 23623058">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/67_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit68">A. H. Lu, E. L. Salabas and F. Schuth, <span class="italic">Angew. Chem., Int. Ed.</span>, 2007, <span class="bold">46</span>, 1222–1244 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.200602866" title="DOI Link to resource 10.1002/anie.200602866">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2sXitF2lurs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=17278160%5Buid%5D" title="PubMed Link to resource 17278160">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/68_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit69">C. Prashant, M. Dipak, C. T. Yang, K. H. Chuang, D. Jun and S. S. Feng, <span class="italic">Biomaterials</span>, 2010, <span class="bold">31</span>, 5588–5597 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2010.03.070" title="DOI Link to resource 10.1016/j.biomaterials.2010.03.070">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXmtlKitbc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20434210%5Buid%5D" title="PubMed Link to resource 20434210">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/69_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit70">S. M. Lai, J. K. Hsiao, H. P. Yu, C. W. Lu, C. C. Huang, M. J. Shieh and P. S. Lai, <span class="italic">J. Mater. Chem.</span>, 2012, <span class="bold">22</span>, 15160–15167 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C2JM32086J&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C2JM32086J">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/70_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit71">J. Hong, D. M. Xu, J. H. Yu, P. J. Gong, H. J. Ma and S. D. Yao, <span class="italic">Nanotechnology</span>, 2007, <span class="bold">18</span>, 135608 <a target="_blank" class="DOILink" href="https://doi.org/10.1088/0957-4484/18/13/135608" title="DOI Link to resource 10.1088/0957-4484/18/13/135608">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21730385%5Buid%5D" title="PubMed Link to resource 21730385">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/71_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit72">J. C. Li, Y. Hu, J. Yang, W. J. Sun, H. D. Cai, P. Wei, Y. P. Sun, G. X. Zhang, X. Y. Shi and M. W. Shen, <span class="italic">J. Mater. Chem. B</span>, 2015, <span class="bold">3</span>, 5720–5730 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C5TB00849B&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C5TB00849B">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/72_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit73">K. Cheng, M. Yang, R. P. Zhang, C. X. Qin, X. H. Su and Z. Cheng, <span class="italic">ACS Nano</span>, 2014, <span class="bold">8</span>, 9884–9896 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/nn500188y" title="DOI Link to resource 10.1021/nn500188y">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Oiu7%252FJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25283972%5Buid%5D" title="PubMed Link to resource 25283972">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/73_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit74">Z. H. Zhao, Z. J. Zhou, J. F. Bao, Z. Y. Wang, J. Hu, X. Q. Chi, K. Y. Ni, R. F. Wang, X. Y. Chen, Z. Chen and J. H. Gao, <span class="italic">Nat. Commun.</span>, 2013, <span class="bold">4</span>, 2266 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/ncomms3266" title="DOI Link to resource 10.1038/ncomms3266">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23903002%5Buid%5D" title="PubMed Link to resource 23903002">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/74_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit75">M. A. Do, G. J. Yoon, J. H. Yeum, M. Han, Y. Chang and J. H. Choi, <span class="italic">Colloids Surf., B</span>, 2014, <span class="bold">122</span>, 752–759 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.colsurfb.2014.08.015" title="DOI Link to resource 10.1016/j.colsurfb.2014.08.015">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhsVakt7zJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25194592%5Buid%5D" title="PubMed Link to resource 25194592">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/75_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit76">S. Qu, H. Yang, D. Ren, S. Kan, G. Zou, D. Li and M. Li, <span class="italic">J. Colloid Interface Sci.</span>, 1999, <span class="bold">215</span>, 190–192 <a target="_blank" class="DOILink" href="https://doi.org/10.1006/jcis.1999.6185" title="DOI Link to resource 10.1006/jcis.1999.6185">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK1MXjs1Smsb0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=10362489%5Buid%5D" title="PubMed Link to resource 10362489">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/76_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit77">C. T. Seip and C. J. O'Connor, <span class="italic">Nanostruct. Mater.</span>, 1999, <span class="bold">12</span>, 183–186 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S0965-9773(99)00094-X" title="DOI Link to resource 10.1016/S0965-9773(99)00094-X">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/77_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit78">C. Okoli, M. Sanchez-Dominguez, M. Boutonnet, S. Jaras, C. Civera, C. Solans and G. R. Kuttuva, <span class="italic">Langmuir</span>, 2012, <span class="bold">28</span>, 8479–8485 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/la300599q" title="DOI Link to resource 10.1021/la300599q">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XmvFWqur0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22578053%5Buid%5D" title="PubMed Link to resource 22578053">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/78_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit79">R. Hachani, M. Lowdell, M. Birchall, A. Hervault, D. Mertz, S. Begin-Coline and N. T. K. Thanh, <span class="italic">Nanoscale</span>, 2016, <span class="bold">8</span>, 3278–3287 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C5NR03867G&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C5NR03867G">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/79_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit80">F. Q. Hu, K. W. MacRenaris, E. A. Waters, T. Y. Liang, E. A. Schultz-Sikma, A. L. Eckermann and T. J. Meade, <span class="italic">J. Phys. Chem. C</span>, 2009, <span class="bold">113</span>, 20855–20860 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jp907216g" title="DOI Link to resource 10.1021/jp907216g">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXhtlyrsLfN" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24991303%5Buid%5D" title="PubMed Link to resource 24991303">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/80_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit81">H. Xu, L. L. Cui, N. H. Tong and H. C. Gu, <span class="italic">J. Am. Chem. Soc.</span>, 2006, <span class="bold">128</span>, 15582–15583 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja066165a" title="DOI Link to resource 10.1021/ja066165a">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28Xht1SqtL3N" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=17147355%5Buid%5D" title="PubMed Link to resource 17147355">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/81_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit82">S. M. Joscelyne and G. Tragardh, <span class="italic">J. Membr. Sci.</span>, 2000, <span class="bold">169</span>, 107–117 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S0376-7388(99)00334-8" title="DOI Link to resource 10.1016/S0376-7388(99)00334-8">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3cXhs1yrt7Y%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/82_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit83">T. Kado, <span class="italic">J. Appl. Phys.</span>, 2008, <span class="bold">103</span>, 043902 <a target="_blank" class="DOILink" href="https://doi.org/10.1063/1.2840118" title="DOI Link to resource 10.1063/1.2840118">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/83_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit84">G. E. Sterbinsky, J. Cheng, P. T. Chiu, B. W. Wessels and D. J. Keavney, <span class="italic">J. Vac. Sci. Technol., B: Microelectron. Nanometer Struct. – Process., Meas., Phenom.</span>, 2007, <span class="bold">25</span>, 1389–1392 <a target="_blank" class="DOILink" href="https://doi.org/10.1116/1.2757185" title="DOI Link to resource 10.1116/1.2757185">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2sXpt1Kmt78%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/84_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit85">H. Yanagihara, M. Myoka, D. Isaka, T. Niizeki, K. Mibu and E. Kita, <span class="italic">J. Phys. D: Appl. Phys.</span>, 2013, <span class="bold">46</span>, 175004 <a target="_blank" class="DOILink" href="https://doi.org/10.1088/0022-3727/46/17/175004" title="DOI Link to resource 10.1088/0022-3727/46/17/175004">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/85_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit86">A. Kumar, D. K. Pandya and S. Chaudhary, <span class="italic">J. Appl. Phys.</span>, 2012, <span class="bold">112</span>, 073909 <a target="_blank" class="DOILink" href="https://doi.org/10.1063/1.4757012" title="DOI Link to resource 10.1063/1.4757012">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/86_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit87">J. C. Tristao, A. A. S. Oliveira, J. D. Ardisson, A. Dias and R. M. Lago, <span class="italic">Mater. Res. Bull.</span>, 2011, <span class="bold">46</span>, 748–754 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.materresbull.2011.01.008" title="DOI Link to resource 10.1016/j.materresbull.2011.01.008">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXjsFClt7g%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/87_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit88">R. Mantovan, S. Vangelista, S. Cocco, A. Lamperti and O. Salicio, <span class="italic">J. Appl. Phys.</span>, 2012, <span class="bold">111</span>, 07B107 <a target="_blank" class="DOILink" href="https://doi.org/10.1063/1.3683082" title="DOI Link to resource 10.1063/1.3683082">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/88_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit89">S. Vangelista, R. Mantovan, S. Cocco, A. Lamperti, O. Salicio and M. Fanciulli, <span class="italic">Thin Solid Films</span>, 2012, <span class="bold">520</span>, 4617–4621 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.tsf.2011.10.128" title="DOI Link to resource 10.1016/j.tsf.2011.10.128">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Wmsb4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/89_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit90">S. Chatman, A. J. G. Noel and K. M. Poduska, <span class="italic">J. Appl. Phys.</span>, 2005, <span class="bold">98</span>, 113902 <a target="_blank" class="DOILink" href="https://doi.org/10.1063/1.2135892" title="DOI Link to resource 10.1063/1.2135892">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/90_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit91">T. Xia, J. Wang, C. Wu, F. Meng, Z. Shi, J. Lian, J. Feng and J. Meng, <span class="italic">CrystEngComm</span>, 2012, <span class="bold">14</span>, 5741–5744 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C2CE25813G&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C2CE25813G">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/91_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit92">W. B. Grant, <span class="italic">Anticancer Res.</span>, 2012, <span class="bold">32</span>, 2220–2220 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Anticancer%20Res.%5BJour%5D%20AND%2032%5Bvolume%5D%20AND%202220%5Bpage%5D%20and%202012%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/92_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit93">R. Hao, R. J. Xing, Z. C. Xu, Y. L. Hou, S. Gao and S. H. Sun, <span class="italic">Adv. Mater.</span>, 2010, <span class="bold">22</span>, 2729–2742 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201000260" title="DOI Link to resource 10.1002/adma.201000260">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXovVCkt74%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20473985%5Buid%5D" title="PubMed Link to resource 20473985">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/93_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit94">A. Bitar, C. Kaewsaneha, M. M. Eissa, T. Jamshaid, P. Tangboriboonrat, D. Polpanich and A. Elaissari, <span class="italic">J. Colloid Sci. Biotechnol.</span>, 2014, <span class="bold">3</span>, 3–18 <a target="_blank" class="DOILink" href="https://doi.org/10.1166/jcsb.2014.1080" title="DOI Link to resource 10.1166/jcsb.2014.1080">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOrurzN" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/94_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit95">S. Kossatz, R. Ludwig, H. Dahring, V. Ettelt, G. Rimkus, M. Marciello, G. Salas, V. Patel, F. J. Teran and I. Hilger, <span class="italic">Pharm. Res.</span>, 2014, <span class="bold">31</span>, 3274–3288 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s11095-014-1417-0" title="DOI Link to resource 10.1007/s11095-014-1417-0">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXovFKqsLY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24890197%5Buid%5D" title="PubMed Link to resource 24890197">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/95_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit96">R. Dolores, S. Raquel and G. L. Adianez, <span class="italic">Ultrason.
Sonochem.</span>, 2015, <span class="bold">23</span>, 391–398 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.ultsonch.2014.08.005" title="DOI Link to resource 10.1016/j.ultsonch.2014.08.005">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhsFSjtLnE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25218767%5Buid%5D" title="PubMed Link to resource 25218767">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/96_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit97">O. Pascu, E. Carenza, M. Gich, S. Estradé, F. Peiró, G. Herranz and A. Roig, <span class="italic">J. Phys. Chem. C</span>, 2012, <span class="bold">116</span>, 15108–15116 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jp303204d" title="DOI Link to resource 10.1021/jp303204d">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XovFaqsrc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/97_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit98">E. Carenza, V. Barcelo, A. Morancho, J. Montaner, A. Rosell and A. Roig, <span class="italic">Acta Biomater.</span>, 2014, <span class="bold">10</span>, 3775–3785 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.actbio.2014.04.010" title="DOI Link to resource 10.1016/j.actbio.2014.04.010">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXotValsbo%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24755438%5Buid%5D" title="PubMed Link to resource 24755438">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/98_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit99">P. Pradhan, J. Giri, F. Rieken, C. Koch, O. Mykhaylyk, M. Doblinger, R. Banerjee, D. Bahadur and C. Plank, <span class="italic">J. Controlled Release</span>, 2010, <span class="bold">142</span>, 108–121 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jconrel.2009.10.002" title="DOI Link to resource 10.1016/j.jconrel.2009.10.002">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SgsLc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19819275%5Buid%5D" title="PubMed Link to resource 19819275">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/99_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit100">H. Yang, Y. Zhuang, Y. Sun, A. Dai, X. Shi, D. Wu, F. Li, H. Hu and S. Yang, <span class="italic">Biomaterials</span>, 2011, <span class="bold">32</span>, 4584–4593 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2011.03.018" title="DOI Link to resource 10.1016/j.biomaterials.2011.03.018">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXlslSrur0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21458063%5Buid%5D" title="PubMed Link to resource 21458063">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/100_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit101">J. H. Maeng, D. H. Lee, K. H. Jung, Y. H. Bae, I. S. Park, S. Jeong, Y. S. Jeon, C. K. Shim, W. Kim, J. Kim, J. Lee, Y. M. Lee, J. H. Kim, W. H. Kim and S. S. Hong, <span class="italic">Biomaterials</span>, 2010, <span class="bold">31</span>, 4995–5006 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2010.02.068" title="DOI Link to resource 10.1016/j.biomaterials.2010.02.068">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXkvVejsrs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20347138%5Buid%5D" title="PubMed Link to resource 20347138">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/101_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit102">S. Alam, C. Anand, K. Ariga, T. Mori and A. Vinu, <span class="italic">Angew. Chem., Int. Ed.</span>, 2009, <span class="bold">48</span>, 7358–7361 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.200901570" title="DOI Link to resource 10.1002/anie.200901570">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGrsrbI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19725083%5Buid%5D" title="PubMed Link to resource 19725083">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/102_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit103">C. G. Varallyay, L. L. Muldoon, S. Gahramanov, Y. J. Wu, J. A. Goodman, X. Li, M. M. Pike and E. A. Neuwelt, <span class="italic">J. Cereb. Blood Flow Metab.</span>, 2009, <span class="bold">29</span>, 853–860 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/jcbfm.2008.162" title="DOI Link to resource 10.1038/jcbfm.2008.162">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXjsl2hsbc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19142191%5Buid%5D" title="PubMed Link to resource 19142191">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/103_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit104">H. Xie, Y. Zhu, W. Jiang, Q. Zhou, H. Yang, N. Gu, Y. Zhang, H. Xu, H. Xu and X. Yang, <span class="italic">Biomaterials</span>, 2011, <span class="bold">32</span>, 495–502 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2010.09.024" title="DOI Link to resource 10.1016/j.biomaterials.2010.09.024">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXhsVCmsLzO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20970851%5Buid%5D" title="PubMed Link to resource 20970851">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/104_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit105">O. Lunov, T. Syrovets, B. Buchele, X. Jiang, C. Rocker, K. Tron, G. U. Nienhaus, P. Walther, V. Mailander, K. Landfester and T. Simmet, <span class="italic">Biomaterials</span>, 2010, <span class="bold">31</span>, 5063–5071 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2010.03.023" title="DOI Link to resource 10.1016/j.biomaterials.2010.03.023">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXltFKnu70%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20381862%5Buid%5D" title="PubMed Link to resource 20381862">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/105_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit106">P. B. Santhosh and N. P. Ulrih, <span class="italic">Cancer Lett.</span>, 2013, <span class="bold">336</span>, 8–17 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.canlet.2013.04.032" title="DOI Link to resource 10.1016/j.canlet.2013.04.032">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXot1CntLw%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23664890%5Buid%5D" title="PubMed Link to resource 23664890">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/106_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit107">W. Wu, Z. Wu, T. Yu, C. Jiang and W. S. Kim, <span class="italic">Sci. Technol. Adv. Mater.</span>, 2015, <span class="bold">16</span>, 023501 <a target="_blank" class="DOILink" href="https://doi.org/10.1088/1468-6996/16/2/023501" title="DOI Link to resource 10.1088/1468-6996/16/2/023501">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27877761%5Buid%5D" title="PubMed Link to resource 27877761">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/107_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit108">A. S. Teja and P.-Y. Koh, <span class="italic">Prog. Cryst. Growth Charact. Mater.</span>, 2009, <span class="bold">55</span>, 22–45 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.pcrysgrow.2008.08.003" title="DOI Link to resource 10.1016/j.pcrysgrow.2008.08.003">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXktVOkt7g%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/108_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit109">M. M. El-Hammadi and J. L. Arias, <span class="italic">Expert Opin. Ther. Pat.</span>, 2015, <span class="bold">25</span>, 691–709 <a target="_blank" class="DOILink" href="https://doi.org/10.1517/13543776.2015.1028358" title="DOI Link to resource 10.1517/13543776.2015.1028358">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXosVKitLo%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25800416%5Buid%5D" title="PubMed Link to resource 25800416">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/109_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit110">S. Ju, T. Y. Cai, H. S. Lu and C. D. Gong, <span class="italic">J. Am. Chem. Soc.</span>, 2012, <span class="bold">134</span>, 13780–13786 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja305167h" title="DOI Link to resource 10.1021/ja305167h">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XhtVOnu73L" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22823905%5Buid%5D" title="PubMed Link to resource 22823905">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/110_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit111">S. H. Sun and H. Zeng, <span class="italic">J. Am. Chem. Soc.</span>, 2002, <span class="bold">124</span>, 8204–8205 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja026501x" title="DOI Link to resource 10.1021/ja026501x">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD38Xks1arurY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=12105897%5Buid%5D" title="PubMed Link to resource 12105897">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/111_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit112">Z. Zhang and S. Satpathy, <span class="italic">Phys. Rev. B: Condens. Matter Mater. Phys.</span>, 1991, <span class="bold">44</span>, 13319–13331 <a target="_blank" class="DOILink" href="https://doi.org/10.1103/PhysRevB.44.13319" title="DOI Link to resource 10.1103/PhysRevB.44.13319">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK38Xpslyrsg%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=9999534%5Buid%5D" title="PubMed Link to resource 9999534">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/112_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit113">J. Tang, M. Myers, K. A. Bosnick and L. E. Brus, <span class="italic">J. Phys. Chem. B</span>, 2003, <span class="bold">107</span>, 7501–7506 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jp027048e" title="DOI Link to resource 10.1021/jp027048e">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3sXivFantro%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/113_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit114">W. F. J. Fontijn, P. J. van der Zaag, M. A. C. Devillers, V. A. M. Brabers and R. Metselaar, <span class="italic">Phys. Rev. B: Condens. Matter Mater. Phys.</span>, 1997, <span class="bold">56</span>, 5432–5442 <a target="_blank" class="DOILink" href="https://doi.org/10.1103/PhysRevB.56.5432" title="DOI Link to resource 10.1103/PhysRevB.56.5432">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK2sXlvVeltbc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/114_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit115">J. Zaanen, G. A. Sawatzky and J. W. Allen, <span class="italic">Phys. Rev. Lett.</span>, 1985, <span class="bold">55</span>, 418–421 <a target="_blank" class="DOILink" href="https://doi.org/10.1103/PhysRevLett.55.418" title="DOI Link to resource 10.1103/PhysRevLett.55.418">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaL2MXkslKgu70%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=10032345%5Buid%5D" title="PubMed Link to resource 10032345">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/115_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit116">S. F. Alvarado, M. Erbudak and P. Munz, <span class="italic">Physica B+C</span>, 1977, <span class="bold">86–88</span>, 1188–1190 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/0378-4363(77)90839-7" title="DOI Link to resource 10.1016/0378-4363(77)90839-7">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/116_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit117">I. Balberg and H. L. Pinch, <span class="italic">J. Magn. Magn. Mater.</span>, 1978, <span class="bold">7</span>, 12–15 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/0304-8853(78)90138-5" title="DOI Link to resource 10.1016/0304-8853(78)90138-5">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/117_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit118">I. Balberg and J. I. Pankove, <span class="italic">Phys. Rev. Lett.</span>, 1971, <span class="bold">27</span>, 1371–1374 <a target="_blank" class="DOILink" href="https://doi.org/10.1103/PhysRevLett.27.1371" title="DOI Link to resource 10.1103/PhysRevLett.27.1371">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaE38XivFenuw%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/118_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit119">V. N. Antonov, B. N. Harmon, V. P. Antropov, A. Y. Perlov and A. N. Yaresko, <span class="italic">Phys. Rev. B: Condens. Matter Mater. Phys.</span>, 2001, <span class="bold">64</span>, 134410 <a target="_blank" class="DOILink" href="https://doi.org/10.1103/PhysRevB.64.134410" title="DOI Link to resource 10.1103/PhysRevB.64.134410">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/119_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit120">M. E. Sadat, M. K. Baghbador, A. W. Dunn, H. P. Wagner, R. C. Ewing, J. M. Zhang, H. Xu, G. M. Pauletti, D. B. Mast and D. L. Shi, <span class="italic">Appl. Phys. Lett.</span>, 2014, <span class="bold">105</span>, 091903 <a target="_blank" class="DOILink" href="https://doi.org/10.1063/1.4895133" title="DOI Link to resource 10.1063/1.4895133">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/120_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit121">N. J. Cherepy, D. B. Liston, J. A. Lovejoy, H. M. Deng and J. Z. Zhang, <span class="italic">J. Phys. Chem. B</span>, 1998, <span class="bold">102</span>, 770–776 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jp973149e" title="DOI Link to resource 10.1021/jp973149e">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK1cXivFSitg%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/121_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit122">D. Shi, M. E. Sadat, A. W. Dunn and D. B. Mast, <span class="italic">Nanoscale</span>, 2015, <span class="bold">7</span>, 8209–8232 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C5NR01538C&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C5NR01538C">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/122_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit123">C. Boxall, G. Kelsall and Z. Zhang, <span class="italic">J. Chem. Soc., Faraday Trans.</span>, 1996, <span class="bold">92</span>, 791–802 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=FT9969200791&amp;newsite=1" title="Link to RSC resource DOI:10.1039/FT9969200791">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/123_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit124">Y. X. Wang, S. M. Hussain and G. P. Krestin, <span class="italic">Eur. Radiol.</span>, 2001, <span class="bold">11</span>, 2319–2331 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s003300100908" title="DOI Link to resource 10.1007/s003300100908">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADC%252BD3MnkvVygsA%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=11702180%5Buid%5D" title="PubMed Link to resource 11702180">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/124_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit125">P. Tartaj, M. D. Morales, S. Veintemillas-Verdaguer, T. Gonzalez-Carreno and C. J. Serna, <span class="italic">J. Phys. D: Appl. Phys.</span>, 2003, <span class="bold">36</span>, R182–R197 <a target="_blank" class="DOILink" href="https://doi.org/10.1088/0022-3727/36/13/202" title="DOI Link to resource 10.1088/0022-3727/36/13/202">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3sXlvVChs7w%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/125_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit126">U. Jeong, X. W. Teng, Y. Wang, H. Yang and Y. N. Xia, <span class="italic">Adv. Mater.</span>, 2007, <span class="bold">19</span>, 33–60 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.200600674" title="DOI Link to resource 10.1002/adma.200600674">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2sXhslGrtLo%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/126_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit127">S. Bedanta and W. Kleemann, <span class="italic">J. Phys. D: Appl. Phys.</span>, 2009, <span class="bold">42</span>, 013001 <a target="_blank" class="DOILink" href="https://doi.org/10.1088/0022-3727/42/1/013001" title="DOI Link to resource 10.1088/0022-3727/42/1/013001">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/127_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit128">R. S. Chaughule, S. Purushotham and R. V. Ramanujan, <span class="italic">Proc. Natl. Acad. Sci., India, Sect. A</span>, 2012, <span class="bold">82</span>, 257–268 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s40010-012-0038-4" title="DOI Link to resource 10.1007/s40010-012-0038-4">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XhslCkt7%252FF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/128_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit129">K. Elersic, J. I. Pavlic, A. Iglic, A. Vesel and M. Mozetic, <span class="italic">Chem. Phys. Lipids</span>, 2012, <span class="bold">165</span>, 120–124 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.chemphyslip.2011.11.006" title="DOI Link to resource 10.1016/j.chemphyslip.2011.11.006">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38Xht1Gmtw%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22133728%5Buid%5D" title="PubMed Link to resource 22133728">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/129_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit130">S. Balivada, R. S. Rachakatla, H. Wang, T. N. Samarakoon, R. K. Dani, M. Pyle, F. O. Kroh, B. Walker, X. Leaym, O. B. Koper, M. Tamura, V. Chikan, S. H. Bossmann and D. L. Troyer, <span class="italic">BMC Cancer</span>, 2010, <span class="bold">10</span>, 119 <a target="_blank" class="DOILink" href="https://doi.org/10.1186/1471-2407-10-119" title="DOI Link to resource 10.1186/1471-2407-10-119">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20350328%5Buid%5D" title="PubMed Link to resource 20350328">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/130_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit131">F. M. Kievit and M. Q. Zhang, <span class="italic">Acc. Chem. Res.</span>, 2011, <span class="bold">44</span>, 853–862 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ar2000277" title="DOI Link to resource 10.1021/ar2000277">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXlsVOjs7w%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21528865%5Buid%5D" title="PubMed Link to resource 21528865">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/131_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit132">T. K. Jain, S. P. Foy, B. Erokwu, S. Dimitrijevic, C. A. Flask and V. Labhasetwar, <span class="italic">Biomaterials</span>, 2009, <span class="bold">30</span>, 6748–6756 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2009.08.042" title="DOI Link to resource 10.1016/j.biomaterials.2009.08.042">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXht1Oiu77L" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19765817%5Buid%5D" title="PubMed Link to resource 19765817">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/132_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit133">E. S. Day, J. G. Morton and J. L. West, <span class="italic">J. Biomech. Eng.</span>, 2009, <span class="bold">131</span>, 074001 <a target="_blank" class="DOILink" href="https://doi.org/10.1115/1.3156800" title="DOI Link to resource 10.1115/1.3156800">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19640133%5Buid%5D" title="PubMed Link to resource 19640133">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/133_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit134">J. Fang, H. Nakamura and H. Maeda, <span class="italic">Adv. Drug Delivery Rev.</span>, 2011, <span class="bold">63</span>, 136–151 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.addr.2010.04.009" title="DOI Link to resource 10.1016/j.addr.2010.04.009">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXktF2jur8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20441782%5Buid%5D" title="PubMed Link to resource 20441782">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/134_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit135">A. Moore, E. Marecos, A. Bogdanov Jr. and R. Weissleder, <span class="italic">Radiology</span>, 2000, <span class="bold">214</span>, 568–574 <a target="_blank" class="DOILink" href="https://doi.org/10.1148/radiology.214.2.r00fe19568" title="DOI Link to resource 10.1148/radiology.214.2.r00fe19568">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3cXpvF2rtw%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=10671613%5Buid%5D" title="PubMed Link to resource 10671613">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/135_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit136">J. D. Byrne, T. Betancourt and L. Brannon-Peppas, <span class="italic">Adv. Drug Delivery Rev.</span>, 2008, <span class="bold">60</span>, 1615–1626 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.addr.2008.08.005" title="DOI Link to resource 10.1016/j.addr.2008.08.005">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXhsVSjsL%252FP" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18840489%5Buid%5D" title="PubMed Link to resource 18840489">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/136_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit137">J. Dobson, <span class="italic">Drug Dev. Res.</span>, 2006, <span class="bold">67</span>, 55–60 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/ddr.20067" title="DOI Link to resource 10.1002/ddr.20067">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XltF2msb4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/137_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit138">H. Maeda, J. Wu, T. Sawa, Y. Matsumura and K. Hori, <span class="italic">J. Controlled Release</span>, 2000, <span class="bold">65</span>, 271–284 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S0168-3659(99)00248-5" title="DOI Link to resource 10.1016/S0168-3659(99)00248-5">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3cXhtl2qsLo%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=10699287%5Buid%5D" title="PubMed Link to resource 10699287">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/138_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit139">S. C. Wu, J. Chen, H. C. Wang, M. Y. Chou, T. Y. Chang, S. S. Yuan, C. Y. Chen, M. F. Hou, J. T. A. Hsu and Y. M. Wang, <span class="italic">Theranostics</span>, 2016, <span class="bold">6</span>, 118–130 <a target="_blank" class="DOILink" href="https://doi.org/10.7150/thno.13069" title="DOI Link to resource 10.7150/thno.13069">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XntF2nt7g%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26722378%5Buid%5D" title="PubMed Link to resource 26722378">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/139_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit140">S. C. Wu, Y. J. Chen, Y. J. Lin, T. H. Wu and Y. M. Wang, <span class="italic">J. Med. Chem.</span>, 2013, <span class="bold">56</span>, 9100–9109 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jm401060z" title="DOI Link to resource 10.1021/jm401060z">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhs1KktL7M" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24147888%5Buid%5D" title="PubMed Link to resource 24147888">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/140_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit141">C. N. Lee, Y. M. Wang, W. F. Lai, T. J. Chen, M. C. Yu, C. L. Fang, F. L. Yu, Y. H. Tsai, W. H. S. Chang, C. S. Zuo and P. F. Renshaw, <span class="italic">Clin. Microbiol. Infect.</span>, 2012, <span class="bold">18</span>, E149–E157 <a target="_blank" class="DOILink" href="https://doi.org/10.1111/j.1469-0691.2012.03809.x" title="DOI Link to resource 10.1111/j.1469-0691.2012.03809.x">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38Xht1WltLnN" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22439904%5Buid%5D" title="PubMed Link to resource 22439904">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/141_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit142">Y. L. He, W. Song, J. Lei, Z. Li, J. Cao, S. Huang, J. Meng, H. Y. Xu, Z. Y. Jin and H. D. Xue, <span class="italic">Acta Radiol.</span>, 2012, <span class="bold">53</span>, 1049–1058 <a target="_blank" class="DOILink" href="https://doi.org/10.1258/ar.2012.120055" title="DOI Link to resource 10.1258/ar.2012.120055">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23012484%5Buid%5D" title="PubMed Link to resource 23012484">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/142_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit143">J. Meng, J. Fan, G. Galiana, R. T. Branca, P. L. Clasen, S. Ma, J. Zhou, C. Leuschner, C. S. S. R. Kumar, J. Hormes, T. Otiti, A. C. Beye, M. P. Harmer, C. J. Kiely, W. Warren, M. P. Haataja and W. O. Soboyejo, <span class="italic">Mater. Sci. Eng., C</span>, 2009, <span class="bold">29</span>, 1467–1479 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.msec.2008.09.039" title="DOI Link to resource 10.1016/j.msec.2008.09.039">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXltVOgur4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/143_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit144">Y. Haik, J. Chatterjee and C. Jen Chen, <span class="italic">J. Nanopart. Res.</span>, 2005, <span class="bold">7</span>, 675–679 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s11051-005-5467-4" title="DOI Link to resource 10.1007/s11051-005-5467-4">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2MXht1OhsLzE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/144_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit145">O. Veiseh, J. W. Gunn and M. Zhang, <span class="italic">Adv. Drug Delivery Rev.</span>, 2010, <span class="bold">62</span>, 284–304 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.addr.2009.11.002" title="DOI Link to resource 10.1016/j.addr.2009.11.002">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXit1Ont7s%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19909778%5Buid%5D" title="PubMed Link to resource 19909778">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/145_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit146">S. E. Krown, D. W. Northfelt, D. Osoba and J. S. Stewart, <span class="italic">Semin. Oncol.</span>, 2004, <span class="bold">31</span>, 36–52 <a target="_blank" class="DOILink" href="https://doi.org/10.1053/j.seminoncol.2004.08.003" title="DOI Link to resource 10.1053/j.seminoncol.2004.08.003">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2MXhtVyns7Y%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=15717737%5Buid%5D" title="PubMed Link to resource 15717737">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/146_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit147">P. Dames, B. Gleich, A. Flemmer, K. Hajek, N. Seidl, F. Wiekhorst, D. Eberbeck, I. Bittmann, C. Bergemann, T. Weyh, L. Trahms, J. Rosenecker and C. Rudolph, <span class="italic">Nat. Nanotechnol.</span>, 2007, <span class="bold">2</span>, 495–499 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nnano.2007.217" title="DOI Link to resource 10.1038/nnano.2007.217">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18654347%5Buid%5D" title="PubMed Link to resource 18654347">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/147_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit148">T. J. Chen, T. H. Cheng, C. Y. Chen, S. C. Hsu, T. L. Cheng, G. C. Liu and Y. M. Wang, <span class="italic">J. Biol. Inorg. Chem.</span>, 2009, <span class="bold">14</span>, 253–260 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s00775-008-0445-9" title="DOI Link to resource 10.1007/s00775-008-0445-9">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSrsLjJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18975017%5Buid%5D" title="PubMed Link to resource 18975017">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/148_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit149">R. E. Serda, N. L. Adolphi, M. Bisoffi and L. O. Sillerud, <span class="italic">Mol. Imaging</span>, 2007, <span class="bold">6</span>, 277–288 <a target="_blank" class="DOILink" href="https://doi.org/10.2310/7290.2007.00025" title="DOI Link to resource 10.2310/7290.2007.00025">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOlurbK" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/149_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit150">P. Debbage and W. Jaschke, <span class="italic">Histochem. Cell Biol.</span>, 2008, <span class="bold">130</span>, 845–875 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s00418-008-0511-y" title="DOI Link to resource 10.1007/s00418-008-0511-y">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXht1eit7zJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18825403%5Buid%5D" title="PubMed Link to resource 18825403">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/150_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit151">X. H. Peng, X. Qian, H. Mao, A. Y. Wang, Z. G. Chen, S. Nie and D. M. Shin, <span class="italic">Int. J. Nanomed.</span>, 2008, <span class="bold">3</span>, 311–321 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXhtlems7nM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/151_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit152">A. Natarajan, C. Y. Xiong, C. Gruettner, G. L. DeNardo and S. J. DeNardo, <span class="italic">Cancer Biother. Radiopharm.</span>, 2008, <span class="bold">23</span>, 82–91 <a target="_blank" class="DOILink" href="https://doi.org/10.1089/cbr.2007.0410" title="DOI Link to resource 10.1089/cbr.2007.0410">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXisVWhtr0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18298332%5Buid%5D" title="PubMed Link to resource 18298332">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/152_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit153">A. Z. Wang, V. Bagalkot, C. C. Vasilliou, F. Gu, F. Alexis, L. Zhang, M. Shaikh, K. Yuet, M. J. Cima, R. Langer, P. W. Kantoff, N. H. Bander, S. Jon and O. C. Farokhzad, <span class="italic">ChemMedChem</span>, 2008, <span class="bold">3</span>, 1311–1315 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/cmdc.200800091" title="DOI Link to resource 10.1002/cmdc.200800091">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXht1SgurjP" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18613203%5Buid%5D" title="PubMed Link to resource 18613203">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/153_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit154">D. S. Lee, J. Svensson, S. W. Lee, Y. W. Park and E. E. Campbell, <span class="italic">J. Nanosci. Nanotechnol.</span>, 2006, <span class="bold">6</span>, 1325–1330 <a target="_blank" class="DOILink" href="https://doi.org/10.1166/jnn.2006.321" title="DOI Link to resource 10.1166/jnn.2006.321">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XlsF2lu74%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=16792360%5Buid%5D" title="PubMed Link to resource 16792360">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/154_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit155">K. J. Landmark, S. DiMaggio, J. Ward, C. V. Kelly, S. Vogt, S. Hong, A. Kotlyar, A. Myc, T. P. Thomas, J. E. Penner-Hahn, J. R. Baker, M. M. B. Holl and B. G. Orr, <span class="italic">ACS Nano</span>, 2008, <span class="bold">2</span>, 773–783 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/nn800034w" title="DOI Link to resource 10.1021/nn800034w">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXkvVKht70%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19206610%5Buid%5D" title="PubMed Link to resource 19206610">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/155_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit156">X. B. Li, X. K. Du, T. L. Huo, X. Liu, S. Zhang and F. Yuan, <span class="italic">Acta Radiol.</span>, 2009, <span class="bold">50</span>, 583–594 <a target="_blank" class="DOILink" href="https://doi.org/10.1080/02841850902902557" title="DOI Link to resource 10.1080/02841850902902557">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19449236%5Buid%5D" title="PubMed Link to resource 19449236">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/156_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit157">D. Hogemann-Savellano, E. Bos, C. Blondet, F. Sato, T. Abe, L. Josephson, R. Weissleder, J. Gaudet, D. Sgroi, P. J. Peters and J. P. Basilion, <span class="italic">Neoplasia</span>, 2003, <span class="bold">5</span>, 495–506 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S1476-5586(03)80034-9" title="DOI Link to resource 10.1016/S1476-5586(03)80034-9">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=14965443%5Buid%5D" title="PubMed Link to resource 14965443">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/157_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit158">A. Z. Wang, F. Gu, L. F. Zhang, J. M. Chan, A. Radovic-Moreno, M. R. Shaikh and O. C. Farokhzad, <span class="italic">Expert Opin. Biol. Ther.</span>, 2008, <span class="bold">8</span>, 1063–1070 <a target="_blank" class="DOILink" href="https://doi.org/10.1517/14712598.8.8.1063" title="DOI Link to resource 10.1517/14712598.8.8.1063">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXos1ChtrY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18613759%5Buid%5D" title="PubMed Link to resource 18613759">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/158_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit159">N. Desai, V. Trieu and Z. Yao, <span class="italic">Clin. Cancer Res.</span>, 2006, <span class="bold">12</span>, 3869–3869 <a target="_blank" class="DOILink" href="https://doi.org/10.1158/1078-0432.CCR-05-1634" title="DOI Link to resource 10.1158/1078-0432.CCR-05-1634">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28Xot1GhsLo%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=16489089%5Buid%5D" title="PubMed Link to resource 16489089">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/159_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit160">M. Kumar, M. Yigit, G. P. Dai, A. Moore and Z. Medarova, <span class="italic">Cancer Res.</span>, 2010, <span class="bold">70</span>, 7553–7561 <a target="_blank" class="DOILink" href="https://doi.org/10.1158/0008-5472.CAN-10-2070" title="DOI Link to resource 10.1158/0008-5472.CAN-10-2070">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXht1akt7nK" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20702603%5Buid%5D" title="PubMed Link to resource 20702603">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/160_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit161">O. Veiseh, C. Sun, C. Fang, N. Bhattarai, J. Gunn, F. Kievit, K. Du, B. Pullar, D. Lee, R. G. Ellenbogen, J. Olson and M. Q. Zhang, <span class="italic">Cancer Res.</span>, 2009, <span class="bold">69</span>, 6200–6207 <a target="_blank" class="DOILink" href="https://doi.org/10.1158/0008-5472.CAN-09-1157" title="DOI Link to resource 10.1158/0008-5472.CAN-09-1157">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Cgtbo%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19638572%5Buid%5D" title="PubMed Link to resource 19638572">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/161_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit162">S. A. Lyons, J. O'Neal and H. Sontheimer, <span class="italic">Glia</span>, 2002, <span class="bold">39</span>, 162–173 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/glia.10083" title="DOI Link to resource 10.1002/glia.10083">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=12112367%5Buid%5D" title="PubMed Link to resource 12112367">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/162_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit163">E. A. Murphy, B. K. Majeti, L. A. Barnes, M. Makale, S. M. Weis, K. Lutu-Fuga, W. Wrasidlo and D. A. Cheresh, <span class="italic">Proc. Natl. Acad. Sci. U. S. A.</span>, 2008, <span class="bold">105</span>, 9343–9348 <a target="_blank" class="DOILink" href="https://doi.org/10.1073/pnas.0803728105" title="DOI Link to resource 10.1073/pnas.0803728105">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXosFakur8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18607000%5Buid%5D" title="PubMed Link to resource 18607000">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/163_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit164">X. F. He, M. H. Na, J. S. Kim, G. Y. Lee, J. Y. Park, A. S. Hoffman, J. O. Nam, S. E. Han, G. Y. Sim, Y. K. Oh, I. S. Kim and B. H. Lee, <span class="italic">Mol. Pharmaceutics</span>, 2011, <span class="bold">8</span>, 430–438 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/mp100266g" title="DOI Link to resource 10.1021/mp100266g">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKntLY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21222482%5Buid%5D" title="PubMed Link to resource 21222482">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/164_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit165">F. Mongelard and P. Bouvet, <span class="italic">Curr. Opin. Mol. Ther.</span>, 2010, <span class="bold">12</span>, 107–114 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXnt1Kntrg%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/165_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit166">P. R. Bouchard, R. M. Hutabarat and K. M. Thompson, <span class="italic">Annu. Rev. Pharmacol.</span>, 2010, <span class="bold">50</span>, 237–257 <a target="_blank" class="DOILink" href="https://doi.org/10.1146/annurev.pharmtox.010909.105547" title="DOI Link to resource 10.1146/annurev.pharmtox.010909.105547">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXisVeluro%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20055704%5Buid%5D" title="PubMed Link to resource 20055704">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/166_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit167">M. K. Yu, D. Kim, I. H. Lee, J. S. So, Y. Y. Jeong and S. Jon, <span class="italic">Small</span>, 2011, <span class="bold">7</span>, 2241–2249 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/smll.201100472" title="DOI Link to resource 10.1002/smll.201100472">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXpvVWrtLY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21648076%5Buid%5D" title="PubMed Link to resource 21648076">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/167_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit168">J. R. McCarthy, J. Bhaumik, M. R. Karver, S. S. Erdem and R. Weissleder, <span class="italic">Mol. Oncol.</span>, 2010, <span class="bold">4</span>, 511–528 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.molonc.2010.08.003" title="DOI Link to resource 10.1016/j.molonc.2010.08.003">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWmtLnF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20851695%5Buid%5D" title="PubMed Link to resource 20851695">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/168_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit169">H. L. Zhang, Y. Ma and X. L. Sun, <span class="italic">Med. Res. Rev.</span>, 2010, <span class="bold">30</span>, 270–289 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/med.20169" title="DOI Link to resource 10.1002/med.20169">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXktlSku7c%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19634125%5Buid%5D" title="PubMed Link to resource 19634125">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/169_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit170">Z. Y. Shen, W. Wei, H. Tanaka, K. Kohama, G. H. Ma, T. Dobashi, Y. Maki, H. H. Wang, J. X. Bi and S. Dai, <span class="italic">Pharmacol. Res.</span>, 2011, <span class="bold">64</span>, 410–419 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.phrs.2011.06.015" title="DOI Link to resource 10.1016/j.phrs.2011.06.015">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2gsL%252FJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21723392%5Buid%5D" title="PubMed Link to resource 21723392">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/170_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit171">Y. X. Yang, Z. W. Zhang, L. L. Chen, W. W. Gu and Y. P. Li, <span class="italic">Biomacromolecules</span>, 2010, <span class="bold">11</span>, 927–933 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/bm901346m" title="DOI Link to resource 10.1021/bm901346m">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXjs1Wrs74%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20302354%5Buid%5D" title="PubMed Link to resource 20302354">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/171_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit172">A. B. Foraker, C. M. Khantwal and P. W. Swaan, <span class="italic">Adv. Drug Delivery Rev.</span>, 2003, <span class="bold">55</span>, 1467–1483 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.addr.2003.07.005" title="DOI Link to resource 10.1016/j.addr.2003.07.005">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3sXosVKqt74%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=14597141%5Buid%5D" title="PubMed Link to resource 14597141">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/172_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit173">R. Ranganathan, S. Madanmohan, A. Kesavan, G. Baskar, Y. R. Krishnamoorthy, R. Santosham, D. Ponraju, S. K. Rayala and G. Venkatraman, <span class="italic">Int. J. Nanomed.</span>, 2012, <span class="bold">7</span>, 1043–1060 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XjvFWrsb4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/173_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit174">C. B. He, Y. P. Hu, L. C. Yin, C. Tang and C. H. Yin, <span class="italic">Biomaterials</span>, 2010, <span class="bold">31</span>, 3657–3666 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2010.01.065" title="DOI Link to resource 10.1016/j.biomaterials.2010.01.065">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXisFSltrg%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20138662%5Buid%5D" title="PubMed Link to resource 20138662">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/174_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit175">N. Ahmed, H. Fessi and A. Elaissari, <span class="italic">Drug Discovery Today</span>, 2012, <span class="bold">17</span>, 928–934 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.drudis.2012.03.010" title="DOI Link to resource 10.1016/j.drudis.2012.03.010">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XlvVSlu7Y%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22484464%5Buid%5D" title="PubMed Link to resource 22484464">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/175_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit176">M. Kettering, H. Richter, F. Wiekhorst, S. Bremer-Streck, L. Trahms, W. A. Kaiser and I. Hilger, <span class="italic">Nanotechnology</span>, 2011, <span class="bold">22</span>, 505102 <a target="_blank" class="DOILink" href="https://doi.org/10.1088/0957-4484/22/50/505102" title="DOI Link to resource 10.1088/0957-4484/22/50/505102">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22107782%5Buid%5D" title="PubMed Link to resource 22107782">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/176_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit177">H. Xu, L. Cheng, C. Wang, X. Ma, Y. Li and Z. Liu, <span class="italic">Biomaterials</span>, 2011, <span class="bold">32</span>, 9364–9373 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2011.08.053" title="DOI Link to resource 10.1016/j.biomaterials.2011.08.053">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXht1Oqu77J" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21880364%5Buid%5D" title="PubMed Link to resource 21880364">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/177_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit178">K. Hayashi, M. Nakamura, H. Miki, S. Ozaki, M. Abe, T. Matsumoto, W. Sakamoto, T. Yogo and K. Ishimura, <span class="italic">Theranostics</span>, 2014, <span class="bold">4</span>, 834–844 <a target="_blank" class="DOILink" href="https://doi.org/10.7150/thno.9199" title="DOI Link to resource 10.7150/thno.9199">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24955144%5Buid%5D" title="PubMed Link to resource 24955144">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/178_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit179">M. Mahmoudi, S. Sant, B. Wang, S. Laurent and T. Sen, <span class="italic">Adv. Drug Delivery Rev.</span>, 2011, <span class="bold">63</span>, 24–46 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.addr.2010.05.006" title="DOI Link to resource 10.1016/j.addr.2010.05.006">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXjvV2ksbc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20685224%5Buid%5D" title="PubMed Link to resource 20685224">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/179_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit180">J. Xie, G. Liu, H. S. Eden, H. Ai and X. Chen, <span class="italic">Acc. Chem. Res.</span>, 2011, <span class="bold">44</span>, 883–892 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ar200044b" title="DOI Link to resource 10.1021/ar200044b">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXlslKitL4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21548618%5Buid%5D" title="PubMed Link to resource 21548618">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/180_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit181">A. M. Dumitrescu, T. Slatineanu, A. Poiata, A. R. Iordan, C. Mihailescu and M. N. Palamaru, <span class="italic">Colloids Surf., A</span>, 2014, <span class="bold">455</span>, 185–194 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.colsurfa.2014.04.055" title="DOI Link to resource 10.1016/j.colsurfa.2014.04.055">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXpvFSgtLg%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/181_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit182">A. Nacev, C. Beni, O. Bruno and B. Shapiro, <span class="italic">J. Magn. Magn. Mater.</span>, 2011, <span class="bold">323</span>, 651–668 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jmmm.2010.09.008" title="DOI Link to resource 10.1016/j.jmmm.2010.09.008">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SrtrvF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21278859%5Buid%5D" title="PubMed Link to resource 21278859">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/182_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit183">P. Zhang, W. Huang, H. Xu, S. Chang, C. Cao, M. Kong and Y. He, <span class="italic">Microporous Mesoporous Mater.</span>, 2014, <span class="bold">188</span>, 86–92 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.micromeso.2014.01.010" title="DOI Link to resource 10.1016/j.micromeso.2014.01.010">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXivVemt70%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/183_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit184">Y.-S. Li, J. S. Church and A. L. Woodhead, <span class="italic">J. Magn. Magn. Mater.</span>, 2012, <span class="bold">324</span>, 1543–1550 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jmmm.2011.11.065" title="DOI Link to resource 10.1016/j.jmmm.2011.11.065">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38Xnt1Wqug%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/184_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit185">F. M. Muggia, J. D. Hainsworth, S. Jeffers, P. Miller, S. Groshen, M. Tan, L. Roman, B. Uziely, L. Muderspach, A. Garcia, A. Burnett, F. A. Greco, C. P. Morrow, L. J. Paradiso and L. J. Liang, <span class="italic">J. Clin. Oncol.</span>, 1997, <span class="bold">15</span>, 987–993 <a target="_blank" class="DOILink" href="https://doi.org/10.1200/JCO.1997.15.3.987" title="DOI Link to resource 10.1200/JCO.1997.15.3.987">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK2sXitFCgs7k%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=9060537%5Buid%5D" title="PubMed Link to resource 9060537">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/185_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit186">F. Yan, Y. Wang, S. Z. He, S. T. Ku, W. Gu and L. Ye, <span class="italic">J. Mater. Sci.: Mater. Med.</span>, 2013, <span class="bold">24</span>, 2371–2379 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s10856-013-4993-3" title="DOI Link to resource 10.1007/s10856-013-4993-3">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyltrzE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23793566%5Buid%5D" title="PubMed Link to resource 23793566">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/186_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit187">H. Wang, J. Shen, Y. Y. Li, Z. Y. Wei, G. X. Cao, Z. Gai, K. L. Hong, P. Banerjee and S. Q. Zhou, <span class="italic">Biomater. Sci.</span>, 2014, <span class="bold">2</span>, 915–923 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C3BM60297D&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C3BM60297D">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/187_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit188">N. S. Elbialy, M. M. Fathy and W. M. Khalil, <span class="italic">Int. J. Pharm.</span>, 2015, <span class="bold">490</span>, 190–199 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.ijpharm.2015.05.032" title="DOI Link to resource 10.1016/j.ijpharm.2015.05.032">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXosFCjsLk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25997662%5Buid%5D" title="PubMed Link to resource 25997662">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/188_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit189">S. Karamipour, M. S. Sadjadi and N. Farhadyar, <span class="italic">Spectrochim. Acta, Part A</span>, 2015, <span class="bold">148</span>, 146–155 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.saa.2015.03.078" title="DOI Link to resource 10.1016/j.saa.2015.03.078">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXlsVWisbc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25879984%5Buid%5D" title="PubMed Link to resource 25879984">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/189_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit190">N. S. Elbialy, M. M. Fathy and W. M. Khalil, <span class="italic">Phys. Med.</span>, 2014, <span class="bold">30</span>, 843–848 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.ejmp.2014.05.012" title="DOI Link to resource 10.1016/j.ejmp.2014.05.012">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24950615%5Buid%5D" title="PubMed Link to resource 24950615">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/190_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit191">M. D. M. Ramos-Tejada, J. L. Viota, K. Rudzka and A. V. Delgado, <span class="italic">Colloids Surf., B</span>, 2015, <span class="bold">128</span>, 1–7 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.colsurfb.2015.02.002" title="DOI Link to resource 10.1016/j.colsurfb.2015.02.002">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXis1aqs7w%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25710633%5Buid%5D" title="PubMed Link to resource 25710633">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/191_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit192">H. Zhang, D. K. Pan, K. Zou, J. He and X. Duan, <span class="italic">J. Mater. Chem.</span>, 2009, <span class="bold">19</span>, 3069–3077 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=B820176E&amp;newsite=1" title="Link to RSC resource DOI:10.1039/B820176E">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/192_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit193">S. Yu, G. Wu, X. Gu, J. Wang, Y. Wang, H. Gao and J. Ma, <span class="italic">Colloids Surf., B</span>, 2013, <span class="bold">103</span>, 15–22 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.colsurfb.2012.10.041" title="DOI Link to resource 10.1016/j.colsurfb.2012.10.041">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXitlejsL4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23201714%5Buid%5D" title="PubMed Link to resource 23201714">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/193_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit194">A. Shakeri-Zadeh, S. Khoee, M.-B. Shiran, A. M. Sharifi and S. Khoei, <span class="italic">J. Mater. Chem. B</span>, 2015, <span class="bold">3</span>, 1879–1887 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C4TB01708K&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C4TB01708K">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/194_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit195">E. Ebrahimi, A. Akbarzadeh, E. Abbasi, A. A. Khandaghi, F. Abasalizadeh and S. Davaran, <span class="italic">Artif. Cells, Nanomed., Biotechnol.</span>, 2016, <span class="bold">44</span>, 290–297 <a target="_blank" class="DOILink" href="https://doi.org/10.3109/21691401.2014.944646" title="DOI Link to resource 10.3109/21691401.2014.944646">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28Xht12qtrk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25111052%5Buid%5D" title="PubMed Link to resource 25111052">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/195_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit196">G. Szakacs, J. K. Paterson, J. A. Ludwig, C. Booth-Genthe and M. M. Gottesman, <span class="italic">Nat. Rev. Drug Discovery</span>, 2006, <span class="bold">5</span>, 219–234 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nrd1984" title="DOI Link to resource 10.1038/nrd1984">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XhvFOlsr8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=16518375%5Buid%5D" title="PubMed Link to resource 16518375">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/196_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit197">F. M. Kievit, F. Y. Wang, C. Fang, H. Mok, K. Wang, J. R. Silber, R. G. Ellenbogen and M. Zhang, <span class="italic">J. Controlled Release</span>, 2011, <span class="bold">152</span>, 76–83 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jconrel.2011.01.024" title="DOI Link to resource 10.1016/j.jconrel.2011.01.024">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXmvFyksbs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/197_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit198">M. Y. Hua, H. W. Yang, C. K. Chuang, R. Y. Tsai, W. J. Chen, K. L. Chuang, Y. H. Chang, H. C. Chuang and S. T. Pang, <span class="italic">Biomaterials</span>, 2010, <span class="bold">31</span>, 7355–7363 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2010.05.061" title="DOI Link to resource 10.1016/j.biomaterials.2010.05.061">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXpsFSjsb0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20609471%5Buid%5D" title="PubMed Link to resource 20609471">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/198_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit199">H. Otsuka, Y. Nagasaki and K. Kataoka, <span class="italic">Adv. Drug Delivery Rev.</span>, 2003, <span class="bold">55</span>, 403–419 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S0169-409X(02)00226-0" title="DOI Link to resource 10.1016/S0169-409X(02)00226-0">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3sXhs1Cgurg%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=12628324%5Buid%5D" title="PubMed Link to resource 12628324">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/199_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit200">O. Veiseh, C. Sun, C. Fang, N. Bhattarai, J. Gunn, F. Kievit, K. Du, B. Pullar, D. Lee, R. G. Ellenbogen, J. Olson and M. Zhang, <span class="italic">Cancer Res.</span>, 2009, <span class="bold">69</span>, 6200–6207 <a target="_blank" class="DOILink" href="https://doi.org/10.1158/0008-5472.CAN-09-1157" title="DOI Link to resource 10.1158/0008-5472.CAN-09-1157">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Cgtbo%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19638572%5Buid%5D" title="PubMed Link to resource 19638572">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/200_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit201">C. G. Hadjipanayis, R. Machaidze, M. Kaluzova, L. Wang, A. J. Schuette, H. Chen, X. Wu and H. Mao, <span class="italic">Cancer Res.</span>, 2010, <span class="bold">70</span>, 6303–6312 <a target="_blank" class="DOILink" href="https://doi.org/10.1158/0008-5472.CAN-10-1022" title="DOI Link to resource 10.1158/0008-5472.CAN-10-1022">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXpsVCnur8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/201_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit202">D. E. Dorer and D. M. Nettelbeck, <span class="italic">Adv. Drug Delivery Rev.</span>, 2009, <span class="bold">61</span>, 554–571 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.addr.2009.03.013" title="DOI Link to resource 10.1016/j.addr.2009.03.013">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXmsFyhsLs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19394376%5Buid%5D" title="PubMed Link to resource 19394376">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/202_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit203">F. Scherer, M. Anton, U. Schillinger, J. Henke, C. Bergemann, A. Kruger, B. Gansbacher and C. Plank, <span class="italic">Gene Ther.</span>, 2002, <span class="bold">9</span>, 102–109 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/sj.gt.3301624" title="DOI Link to resource 10.1038/sj.gt.3301624">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD38XhsVSjsbg%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=11857068%5Buid%5D" title="PubMed Link to resource 11857068">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/203_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit204">B. Pan, D. Cui, Y. Sheng, C. Ozkan, F. Gao, R. He, Q. Li, P. Xu and T. Huang, <span class="italic">Cancer Res.</span>, 2007, <span class="bold">67</span>, 8156–8163 <a target="_blank" class="DOILink" href="https://doi.org/10.1158/0008-5472.CAN-06-4762" title="DOI Link to resource 10.1158/0008-5472.CAN-06-4762">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2sXpvFKjtbo%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=17804728%5Buid%5D" title="PubMed Link to resource 17804728">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/204_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit205">F. M. Kievit, O. Veiseh, N. Bhattarai, C. Fang, J. W. Gunn, D. Lee, R. G. Ellenbogen, J. M. Olson and M. Zhang, <span class="italic">Adv. Funct. Mater.</span>, 2009, <span class="bold">19</span>, 2244–2251 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.200801844" title="DOI Link to resource 10.1002/adfm.200801844">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXptFGit74%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20160995%5Buid%5D" title="PubMed Link to resource 20160995">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/205_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit206">C. M. Cheng, P. Y. Chu, K. H. Chuang, S. R. Roffler, C. H. Kao, W. L. Tseng, J. Shiea, W. D. Chang, Y. C. Su, B. M. Chen, Y. M. Wang and T. L. Cheng, <span class="italic">Cancer Gene Ther.</span>, 2009, <span class="bold">16</span>, 83–90 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/cgt.2008.50" title="DOI Link to resource 10.1038/cgt.2008.50">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2hsrjI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18802451%5Buid%5D" title="PubMed Link to resource 18802451">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/206_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit207">S. S. Lucky, K. C. Soo and Y. Zhang, <span class="italic">Chem. Rev.</span>, 2015, <span class="bold">115</span>, 1990–2042 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/cr5004198" title="DOI Link to resource 10.1021/cr5004198">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCms70%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25602130%5Buid%5D" title="PubMed Link to resource 25602130">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/207_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit208">J. P. Celli, B. Q. Spring, I. Rizvi, C. L. Evans, K. S. Samkoe, S. Verma, B. W. Pogue and T. Hasan, <span class="italic">Chem. Rev.</span>, 2010, <span class="bold">110</span>, 2795–2838 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/cr900300p" title="DOI Link to resource 10.1021/cr900300p">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXktVeqt7o%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/208_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit209">Y. Liu, X. Zhi, M. Yang, J. Zhang, L. Lin, X. Zhao, W. Hou, C. Zhang, Q. Zhang, F. Pan, G. Alfranca, Y. Yang, J. M. de la Fuente, J. Ni and D. Cui, <span class="italic">Theranostics</span>, 2017, <span class="bold">7</span>, 1650–1662 <a target="_blank" class="DOILink" href="https://doi.org/10.7150/thno.17602" title="DOI Link to resource 10.7150/thno.17602">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXhtFWjs7nN" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28529642%5Buid%5D" title="PubMed Link to resource 28529642">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/209_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit210">D. E. Dolmans, D. Fukumura and R. K. Jain, <span class="italic">Nat. Rev. Cancer</span>, 2003, <span class="bold">3</span>, 380–387 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nrc1071" title="DOI Link to resource 10.1038/nrc1071">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3sXjtlals74%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=12724736%5Buid%5D" title="PubMed Link to resource 12724736">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/210_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit211">Y. N. Konan, R. Gurny and E. Allemann, <span class="italic">J. Photochem. Photobiol., B</span>, 2002, <span class="bold">66</span>, 89–106 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S1011-1344(01)00267-6" title="DOI Link to resource 10.1016/S1011-1344(01)00267-6">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD38XhvVChtL8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/211_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit212">Y. Cheng, J. D. Meyers, A. M. Broome, M. E. Kenney, J. P. Basilion and C. Burda, <span class="italic">J. Am. Chem. Soc.</span>, 2011, <span class="bold">133</span>, 2583–2591 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja108846h" title="DOI Link to resource 10.1021/ja108846h">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhsFanu78%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21294543%5Buid%5D" title="PubMed Link to resource 21294543">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/212_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit213">Z. Li, C. Wang, L. Cheng, H. Gong, S. Yin, Q. Gong, Y. Li and Z. Liu, <span class="italic">Biomaterials</span>, 2013, <span class="bold">34</span>, 9160–9170 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2013.08.041" title="DOI Link to resource 10.1016/j.biomaterials.2013.08.041">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhtlKrt7jJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/213_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit214">X. Zhang, X. Xu, T. Li, M. Lin, X. Lin, H. Zhang, H. Sun and B. Yang, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2014, <span class="bold">6</span>, 14552–14561 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/am503831m" title="DOI Link to resource 10.1021/am503831m">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhtlaisL7O" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25134068%5Buid%5D" title="PubMed Link to resource 25134068">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/214_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit215">G. Fu, W. Liu, Y. Li, Y. Jin, L. Jiang, X. Liang, S. Feng and Z. Dai, <span class="italic">Bioconjugate Chem.</span>, 2014, <span class="bold">25</span>, 1655–1663 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/bc500279w" title="DOI Link to resource 10.1021/bc500279w">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhtlais73P" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25109612%5Buid%5D" title="PubMed Link to resource 25109612">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/215_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit216">S. Wang, Q. Zhang, X. F. Luo, J. Li, H. He, F. Yang, Y. Di, C. Jin, X. G. Jiang, S. Shen and L. Fu de, <span class="italic">Biomaterials</span>, 2014, <span class="bold">35</span>, 9473–9483 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2014.07.064" title="DOI Link to resource 10.1016/j.biomaterials.2014.07.064">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSitLfP" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25175596%5Buid%5D" title="PubMed Link to resource 25175596">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/216_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit217">N. Algret, A. Criado and M. Prato, <span class="italic">Curr. Med. Chem.</span>, 2017, <span class="bold">24</span>, 529–536 <a target="_blank" class="DOILink" href="https://doi.org/10.2174/0929867323666161216144218" title="DOI Link to resource 10.2174/0929867323666161216144218">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27993110%5Buid%5D" title="PubMed Link to resource 27993110">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/217_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit218">X. Shi, H. Gong, Y. Li, C. Wang, L. Cheng and Z. Liu, <span class="italic">Biomaterials</span>, 2013, <span class="bold">34</span>, 4786–4793 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2013.03.023" title="DOI Link to resource 10.1016/j.biomaterials.2013.03.023">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXltVymtrs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23557860%5Buid%5D" title="PubMed Link to resource 23557860">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/218_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit219">Z. Ding, P. Liu, D. Hu, Z. Sheng, H. Yi, G. Gao, Y. Wu, P. Zhang, S. Ling and L. Cai, <span class="italic">Biomater. Sci.</span>, 2017, <span class="bold">5</span>, 762–771 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C6BM00846A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C6BM00846A">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/219_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit220">R. A. Bohara, N. D. Thorat and S. H. Pawar, <span class="italic">RSC Adv.</span>, 2016, <span class="bold">6</span>, 43989–44012 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C6RA02129H&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C6RA02129H">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/220_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit221">A. B. Salunkhe, V. M. Khot and S. H. Pawar, <span class="italic">Curr. Top. Med. Chem.</span>, 2014, <span class="bold">14</span>, 572–594 <a target="_blank" class="DOILink" href="https://doi.org/10.2174/1568026614666140118203550" title="DOI Link to resource 10.2174/1568026614666140118203550">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXjtlylsbk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/221_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit222">Y. Piñeiro, Z. Vargas, J. Rivas and M. A. López-Quintela, <span class="italic">Eur. J. Inorg. Chem.</span>, 2015, <span class="bold">2015</span>, 4495–4509 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/ejic.201500598" title="DOI Link to resource 10.1002/ejic.201500598">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/222_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit223">Z. Bakhtiary, A. A. Saei, M. J. Hajipour, M. Raoufi, O. Vermesh and M. Mahmoudi, <span class="italic">Nanomedicine</span>, 2016, <span class="bold">12</span>, 287–307 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.nano.2015.10.019" title="DOI Link to resource 10.1016/j.nano.2015.10.019">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XjvF2ntw%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26707817%5Buid%5D" title="PubMed Link to resource 26707817">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/223_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit224">C. A. Quinto, P. Mohindra, S. Tong and G. Bao, <span class="italic">Nanoscale</span>, 2015, <span class="bold">7</span>, 12728–12736 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C5NR02718G&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C5NR02718G">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/224_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit225">J.-H. Lee, J.-t. Jang, J.-s. Choi, S. H. Moon, S.-h. Noh, J.-w. Kim, J.-G. Kim, I.-S. Kim, K. I. Park and J. Cheon, <span class="italic">Nat. Nanotechnol.</span>, 2011, <span class="bold">6</span>, 418 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nnano.2011.95" title="DOI Link to resource 10.1038/nnano.2011.95">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXotV2htbs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21706024%5Buid%5D" title="PubMed Link to resource 21706024">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/225_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit226">F. Mohammad, G. Balaji, A. Weber, R. M. Uppu and C. S. S. R. Kumar, <span class="italic">J. Phys. Chem. C</span>, 2010, <span class="bold">114</span>, 19194–19201 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jp105807r" title="DOI Link to resource 10.1021/jp105807r">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXhtlaitL3J" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21103390%5Buid%5D" title="PubMed Link to resource 21103390">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/226_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit227">Q. Tian, J. Hu, Y. Zhu, R. Zou, Z. Chen, S. Yang, R. Li, Q. Su, Y. Han and X. Liu, <span class="italic">J. Am. Chem. Soc.</span>, 2013, <span class="bold">135</span>, 8571–8577 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja4013497" title="DOI Link to resource 10.1021/ja4013497">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXnvFyitLg%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23687972%5Buid%5D" title="PubMed Link to resource 23687972">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/227_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit228">S. A. Sapareto and W. C. Dewey, <span class="italic">Int. J. Radiat. Oncol., Biol., Phys.</span>, 1984, <span class="bold">10</span>, 787–800 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/0360-3016(84)90379-1" title="DOI Link to resource 10.1016/0360-3016(84)90379-1">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADyaL2c3jvFWnsg%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/228_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit229">A. Cervadoro, C. Giverso, R. Pande, S. Sarangi, L. Preziosi, J. Wosik, A. Brazdeikis and P. Decuzzi, <span class="italic">PLoS One</span>, 2013, <span class="bold">8</span>, e57332 <a target="_blank" class="DOILink" href="https://doi.org/10.1371/journal.pone.0057332" title="DOI Link to resource 10.1371/journal.pone.0057332">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXjslykt7g%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23451208%5Buid%5D" title="PubMed Link to resource 23451208">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/229_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit230">K. Hayashi, M. Nakamura, W. Sakamoto, T. Yogo, H. Miki, S. Ozaki, M. Abe, T. Matsumoto and K. Ishimura, <span class="italic">Theranostics</span>, 2013, <span class="bold">3</span>, 366–376 <a target="_blank" class="DOILink" href="https://doi.org/10.7150/thno.5860" title="DOI Link to resource 10.7150/thno.5860">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhtVant7%252FO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23781284%5Buid%5D" title="PubMed Link to resource 23781284">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/230_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit231">H. S. Huang and J. F. Hainfeld, <span class="italic">Int. J. Nanomed.</span>, 2013, <span class="bold">8</span>, 2521–2532 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Int.%20J.%20Nanomed.%5BJour%5D%20AND%208%5Bvolume%5D%20AND%202521%5Bpage%5D%20and%202013%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/231_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit232">L. Prosen, S. Prijic, B. Music, J. Lavrencak, M. Cemazar and G. Sersa, <span class="italic">Mol. Ther. – Nucleic Acids</span>, 2014, <span class="bold">3</span>, e205 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/mtna.2014.56" title="DOI Link to resource 10.1038/mtna.2014.56">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhvVWmtbfP" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25350580%5Buid%5D" title="PubMed Link to resource 25350580">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/232_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit233">L. Prosen, B. Markelc, T. Dolinsek, B. Music, M. Cemazar and G. Sersa, <span class="italic">Mol. Ther. – Nucleic Acids</span>, 2014, <span class="bold">3</span>, e205 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/mtna.2014.56" title="DOI Link to resource 10.1038/mtna.2014.56">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhvVWmtbfP" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25350580%5Buid%5D" title="PubMed Link to resource 25350580">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/233_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit234">D. Li, X. Tang, B. Pulli, C. Lin, P. Zhao, J. Cheng, Z. Lv, X. Yuan, Q. Luo, H. Cai and M. Ye, <span class="italic">Int. J. Nanomed.</span>, 2014, <span class="bold">9</span>, 3347–3361 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Int.%20J.%20Nanomed.%5BJour%5D%20AND%209%5Bvolume%5D%20AND%203347%5Bpage%5D%20and%202014%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/234_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit235">P. Guardia, R. Di Corato, L. Lartigue, C. Wilhelm, A. Espinosa, M. Garcia-Hernandez, F. Gazeau, L. Manna and T. Pellegrino, <span class="italic">ACS Nano</span>, 2012, <span class="bold">6</span>, 3080–3091 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/nn2048137" title="DOI Link to resource 10.1021/nn2048137">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38Xltlahs7g%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22494015%5Buid%5D" title="PubMed Link to resource 22494015">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/235_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit236">A. B. Salunkhe, V. M. Khot and S. H. Pawar, <span class="italic">Curr. Top. Med. Chem.</span>, 2014, <span class="bold">14</span>, 572–594 <a target="_blank" class="DOILink" href="https://doi.org/10.2174/1568026614666140118203550" title="DOI Link to resource 10.2174/1568026614666140118203550">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXjtlylsbk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24444167%5Buid%5D" title="PubMed Link to resource 24444167">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/236_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit237">S. García-Jimeno, R. Ortega-Palacios, M. Cepeda-Rubio, A. Vera, L. Leija and J. Estelrich, <span class="italic">Prog. Electromagn. Res.</span>, 2012, <span class="bold">128</span>, 229–248 <a target="_blank" class="DOILink" href="https://doi.org/10.2528/PIER12020108" title="DOI Link to resource 10.2528/PIER12020108">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/237_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit238">R. Sharma and C. J. Chen, <span class="italic">J. Nanopart. Res.</span>, 2009, <span class="bold">11</span>, 671–689 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s11051-008-9548-z" title="DOI Link to resource 10.1007/s11051-008-9548-z">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXisVGhsL8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/238_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit239">A. E. Deatsch and B. A. Evans, <span class="italic">J. Magn. Magn. Mater.</span>, 2014, <span class="bold">354</span>, 163–172 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jmmm.2013.11.006" title="DOI Link to resource 10.1016/j.jmmm.2013.11.006">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXltlWn" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/239_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit240">B. Thiesen and A. Jordan, <span class="italic">Int. J. Hyperthermia</span>, 2008, <span class="bold">24</span>, 467–474 <a target="_blank" class="DOILink" href="https://doi.org/10.1080/02656730802104757" title="DOI Link to resource 10.1080/02656730802104757">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXht1CqsLvL" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18608593%5Buid%5D" title="PubMed Link to resource 18608593">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/240_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit241">T. J. Chen, T. H. Cheng, Y. C. Hung, K. T. Lin, G. C. Liu and Y. M. Wang, <span class="italic">J. Biomed. Mater. Res.</span>, 2008, <span class="bold">87a</span>, 165–175 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/jbm.a.31752" title="DOI Link to resource 10.1002/jbm.a.31752">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCqsL7L" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18085650%5Buid%5D" title="PubMed Link to resource 18085650">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/241_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit242">P. T. Yin, B. P. Shah and K. B. Lee, <span class="italic">Small</span>, 2014, <span class="bold">10</span>, 4106–4112 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhtVant7vI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/242_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit243">K. Maier-Hauff, F. Ulrich, D. Nestler, H. Niehoff, P. Wust, B. Thiesen, H. Orawa, V. Budach and A. Jordan, <span class="italic">J. Neurooncol.</span>, 2011, <span class="bold">103</span>, 317–324 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s11060-010-0389-0" title="DOI Link to resource 10.1007/s11060-010-0389-0">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20845061%5Buid%5D" title="PubMed Link to resource 20845061">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/243_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit244">A. Jordan, R. Scholz, K. Maier-Hauff, F. K. van Landeghem, N. Waldoefner, U. Teichgraeber, J. Pinkernelle, H. Bruhn, F. Neumann, B. Thiesen, A. von Deimling and R. Felix, <span class="italic">J. Neurooncol.</span>, 2006, <span class="bold">78</span>, 7–14 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s11060-005-9059-z" title="DOI Link to resource 10.1007/s11060-005-9059-z">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XotFeit78%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=16314937%5Buid%5D" title="PubMed Link to resource 16314937">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c9dt00459a/244_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
    </ol>
  <table><tr><td><hr/></td></tr><tr><td><b>This journal is © The Royal Society of Chemistry 2019</b></td></tr></table></div></div></div></body><script src="/content/scripts/CrossMarkIE.js"> </script><SaxonLicenceTest result="pass" message="Licenced Enterprise Edition [ EE 9.3.0.4 ]"/></html>